window.__IS_SSR__=true
window.__INITIAL_STATE__={
"attachmentsReducer": {
"audio_0": {
"type": "attachments",
"id": "audio_0",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background0.jpg"
}
}
},
"audio_1": {
"type": "attachments",
"id": "audio_1",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background1.jpg"
}
}
},
"audio_2": {
"type": "attachments",
"id": "audio_2",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background2.jpg"
}
}
},
"audio_3": {
"type": "attachments",
"id": "audio_3",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background3.jpg"
}
}
},
"audio_4": {
"type": "attachments",
"id": "audio_4",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background4.jpg"
}
}
},
"placeholder": {
"type": "attachments",
"id": "placeholder",
"imgSizes": {
"thumbnail": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-160x107.jpg",
"width": 160,
"height": 107,
"mimeType": "image/jpeg"
},
"medium": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-800x533.jpg",
"width": 800,
"height": 533,
"mimeType": "image/jpeg"
},
"medium_large": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-768x512.jpg",
"width": 768,
"height": 512,
"mimeType": "image/jpeg"
},
"large": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1020x680.jpg",
"width": 1020,
"height": 680,
"mimeType": "image/jpeg"
},
"1536x1536": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1536x1024.jpg",
"width": 1536,
"height": 1024,
"mimeType": "image/jpeg"
},
"fd-lrg": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1536x1024.jpg",
"width": 1536,
"height": 1024,
"mimeType": "image/jpeg"
},
"fd-med": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1020x680.jpg",
"width": 1020,
"height": 680,
"mimeType": "image/jpeg"
},
"fd-sm": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-800x533.jpg",
"width": 800,
"height": 533,
"mimeType": "image/jpeg"
},
"post-thumbnail": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-672x372.jpg",
"width": 672,
"height": 372,
"mimeType": "image/jpeg"
},
"twentyfourteen-full-width": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1038x576.jpg",
"width": 1038,
"height": 576,
"mimeType": "image/jpeg"
},
"xxsmall": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-160x107.jpg",
"width": 160,
"height": 107,
"mimeType": "image/jpeg"
},
"xsmall": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-672x372.jpg",
"width": 672,
"height": 372,
"mimeType": "image/jpeg"
},
"small": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-672x372.jpg",
"width": 672,
"height": 372,
"mimeType": "image/jpeg"
},
"xlarge": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1020x680.jpg",
"width": 1020,
"height": 680,
"mimeType": "image/jpeg"
},
"full-width": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1920x1280.jpg",
"width": 1920,
"height": 1280,
"mimeType": "image/jpeg"
},
"guest-author-32": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 32,
"height": 32,
"mimeType": "image/jpeg"
},
"guest-author-50": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 50,
"height": 50,
"mimeType": "image/jpeg"
},
"guest-author-64": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 64,
"height": 64,
"mimeType": "image/jpeg"
},
"guest-author-96": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 96,
"height": 96,
"mimeType": "image/jpeg"
},
"guest-author-128": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 128,
"height": 128,
"mimeType": "image/jpeg"
},
"detail": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 160,
"height": 160,
"mimeType": "image/jpeg"
},
"kqedFullSize": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1.jpg",
"width": 2000,
"height": 1333
}
}
},
"futureofyou_262413": {
"type": "attachments",
"id": "futureofyou_262413",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "262413",
"found": true
},
"parent": 262412,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/Multitask-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/Multitask-400x267.jpg",
"width": 400,
"mimeType": "image/jpeg",
"height": 267
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/Multitask-960x640.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 640
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/Multitask-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/Multitask.jpg",
"width": 1920,
"height": 1280
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/Multitask-1180x787.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 787
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/Multitask-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/Multitask-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/Multitask-800x533.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 533
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/Multitask-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/Multitask-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/Multitask-1920x1280.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1280
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/Multitask-1180x787.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 787
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/Multitask-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/Multitask-768x512.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 512
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/Multitask-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
}
},
"publishDate": 1476372565,
"modified": 1476372622,
"caption": null,
"description": null,
"title": "Multitask",
"credit": "Teodros Hailye/KQED",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"stateofhealth_248366": {
"type": "attachments",
"id": "stateofhealth_248366",
"meta": {
"index": "attachments_1716263798",
"site": "stateofhealth",
"id": "248366",
"found": true
},
"parent": 248365,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/10/research_enl-f2c8e115d6783c381da679bac9b2ac24ce322932-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/10/research_enl-f2c8e115d6783c381da679bac9b2ac24ce322932-400x266.jpg",
"width": 400,
"mimeType": "image/jpeg",
"height": 266
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/10/research_enl-f2c8e115d6783c381da679bac9b2ac24ce322932-960x639.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 639
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/10/research_enl-f2c8e115d6783c381da679bac9b2ac24ce322932-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/10/research_enl-f2c8e115d6783c381da679bac9b2ac24ce322932.jpg",
"width": 1500,
"height": 999
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/10/research_enl-f2c8e115d6783c381da679bac9b2ac24ce322932-1440x959.jpg",
"width": 1440,
"mimeType": "image/jpeg",
"height": 959
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/10/research_enl-f2c8e115d6783c381da679bac9b2ac24ce322932-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/10/research_enl-f2c8e115d6783c381da679bac9b2ac24ce322932-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/10/research_enl-f2c8e115d6783c381da679bac9b2ac24ce322932-800x533.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 533
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/10/research_enl-f2c8e115d6783c381da679bac9b2ac24ce322932-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/10/research_enl-f2c8e115d6783c381da679bac9b2ac24ce322932-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"jmtc-small-thumb": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/10/research_enl-f2c8e115d6783c381da679bac9b2ac24ce322932-280x150.jpg",
"width": 280,
"mimeType": "image/jpeg",
"height": 150
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/10/research_enl-f2c8e115d6783c381da679bac9b2ac24ce322932-1180x786.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 786
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/10/research_enl-f2c8e115d6783c381da679bac9b2ac24ce322932-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/10/research_enl-f2c8e115d6783c381da679bac9b2ac24ce322932-768x511.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 511
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/10/research_enl-f2c8e115d6783c381da679bac9b2ac24ce322932-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
}
},
"publishDate": 1476472117,
"modified": 1476472165,
"caption": "Since a single scientific study rarely provides a definitive answer, researchers combine the results of several studies to reach clearer conclusions.",
"description": null,
"title": "research_enl-f2c8e115d6783c381da679bac9b2ac24ce322932",
"credit": "Roy Scott/Ikon Images/Getty Images",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_260171": {
"type": "attachments",
"id": "futureofyou_260171",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "260171",
"found": true
},
"parent": 258717,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells5-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells5-400x300.jpg",
"width": 400,
"mimeType": "image/jpeg",
"height": 300
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells5-960x720.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 720
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells5-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells5.jpg",
"width": 3264,
"height": 2448
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells5-1180x885.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 885
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells5-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells5-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells5-800x600.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 600
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells5-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells5-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells5-1920x1440.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1440
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells5-1180x885.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 885
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells5-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells5-768x576.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 576
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells5-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
}
},
"publishDate": 1476072601,
"modified": 1476894048,
"caption": "Ray Ramirez is the first patient in California to participate in a Phase III Clinical Trial of a new kind of dialysis shunt -- one that's made of human tissue.",
"description": null,
"title": "stemcells5",
"credit": "David Gorn/KQED",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"science_1048488": {
"type": "attachments",
"id": "science_1048488",
"meta": {
"index": "attachments_1716263798",
"site": "science",
"id": "1048488",
"found": true
},
"parent": 1048487,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/10/1048487-thumb-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/10/1048487-thumb-400x300.jpg",
"width": 400,
"mimeType": "image/jpeg",
"height": 300
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/10/1048487-thumb-960x720.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 720
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/10/1048487-thumb-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/10/1048487-thumb.jpg",
"width": 3264,
"height": 2448
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/10/1048487-thumb-1440x1080.jpg",
"width": 1440,
"mimeType": "image/jpeg",
"height": 1080
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/10/1048487-thumb-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/10/1048487-thumb-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/10/1048487-thumb-800x600.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 600
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/10/1048487-thumb-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/10/1048487-thumb-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/10/1048487-thumb-1920x1440.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1440
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/10/1048487-thumb-1180x885.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 885
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/10/1048487-thumb-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/10/1048487-thumb-768x576.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 576
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/10/1048487-thumb-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
}
},
"publishDate": 1475601506,
"modified": 1475601506,
"caption": null,
"description": null,
"title": "Thumbnail for 1048487",
"credit": null,
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_256674": {
"type": "attachments",
"id": "futureofyou_256674",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "256674",
"found": true
},
"parent": 256179,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/CurrieResidenceHallConst.Drone_-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/CurrieResidenceHallConst.Drone_-400x225.jpg",
"width": 400,
"mimeType": "image/jpeg",
"height": 225
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/CurrieResidenceHallConst.Drone_-960x540.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 540
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/CurrieResidenceHallConst.Drone_-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/CurrieResidenceHallConst.Drone_.jpg",
"width": 2100,
"height": 1181
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/CurrieResidenceHallConst.Drone_-1180x664.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 664
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/CurrieResidenceHallConst.Drone_-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/CurrieResidenceHallConst.Drone_-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/CurrieResidenceHallConst.Drone_-800x450.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 450
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/CurrieResidenceHallConst.Drone_-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/CurrieResidenceHallConst.Drone_-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/CurrieResidenceHallConst.Drone_-1920x1080.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1080
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/CurrieResidenceHallConst.Drone_-1180x664.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 664
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/CurrieResidenceHallConst.Drone_-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/CurrieResidenceHallConst.Drone_-768x432.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 432
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/CurrieResidenceHallConst.Drone_-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
}
},
"publishDate": 1475595110,
"modified": 1475595203,
"caption": "USC's Malcolm S. Currie Hall during its construction. The building opened this fall and houses graduate students who are on the USC Health Sciences Campus. The university hopes to build a biotechnology park in an adjacent area, at the top of the photo.",
"description": null,
"title": "CurrieResidenceHallConst.Drone",
"credit": "USC",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_256130": {
"type": "attachments",
"id": "futureofyou_256130",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "256130",
"found": true
},
"parent": 256129,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/brain-games_wide-4ff38e458b4f118c80b8482d2a6aa29790b11028-1038x576.jpe",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/brain-games_wide-4ff38e458b4f118c80b8482d2a6aa29790b11028-400x225.jpe",
"width": 400,
"mimeType": "image/jpeg",
"height": 225
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/brain-games_wide-4ff38e458b4f118c80b8482d2a6aa29790b11028-960x540.jpe",
"width": 960,
"mimeType": "image/jpeg",
"height": 540
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/brain-games_wide-4ff38e458b4f118c80b8482d2a6aa29790b11028-672x372.jpe",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/brain-games_wide-4ff38e458b4f118c80b8482d2a6aa29790b11028.jpe",
"width": 2995,
"height": 1684
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/brain-games_wide-4ff38e458b4f118c80b8482d2a6aa29790b11028-1180x663.jpe",
"width": 1180,
"mimeType": "image/jpeg",
"height": 663
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/brain-games_wide-4ff38e458b4f118c80b8482d2a6aa29790b11028-50x50.jpe",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/brain-games_wide-4ff38e458b4f118c80b8482d2a6aa29790b11028-96x96.jpe",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/brain-games_wide-4ff38e458b4f118c80b8482d2a6aa29790b11028-800x450.jpe",
"width": 800,
"mimeType": "image/jpeg",
"height": 450
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/brain-games_wide-4ff38e458b4f118c80b8482d2a6aa29790b11028-64x64.jpe",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/brain-games_wide-4ff38e458b4f118c80b8482d2a6aa29790b11028-32x32.jpe",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/brain-games_wide-4ff38e458b4f118c80b8482d2a6aa29790b11028-1920x1080.jpe",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1080
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/brain-games_wide-4ff38e458b4f118c80b8482d2a6aa29790b11028-1180x663.jpe",
"width": 1180,
"mimeType": "image/jpeg",
"height": 663
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/brain-games_wide-4ff38e458b4f118c80b8482d2a6aa29790b11028-150x150.jpe",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/brain-games_wide-4ff38e458b4f118c80b8482d2a6aa29790b11028-768x432.jpe",
"width": 768,
"mimeType": "image/jpeg",
"height": 432
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/10/brain-games_wide-4ff38e458b4f118c80b8482d2a6aa29790b11028-128x128.jpe",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
}
},
"publishDate": 1475511640,
"modified": 1475512421,
"caption": null,
"description": "A new study says brain games won't make you smarter.",
"title": "A new study says brain games won't make you smarter.",
"credit": "Image by Katherine Streeter for NPR",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_254630": {
"type": "attachments",
"id": "futureofyou_254630",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "254630",
"found": true
},
"parent": 254629,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/670g-closed-system_wide-e9d05553e75894a2f9e9d783b5e6eacc94cf6f9c-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/670g-closed-system_wide-e9d05553e75894a2f9e9d783b5e6eacc94cf6f9c-400x225.jpg",
"width": 400,
"mimeType": "image/jpeg",
"height": 225
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/670g-closed-system_wide-e9d05553e75894a2f9e9d783b5e6eacc94cf6f9c-960x539.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 539
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/670g-closed-system_wide-e9d05553e75894a2f9e9d783b5e6eacc94cf6f9c-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/670g-closed-system_wide-e9d05553e75894a2f9e9d783b5e6eacc94cf6f9c.jpg",
"width": 1041,
"height": 585
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/670g-closed-system_wide-e9d05553e75894a2f9e9d783b5e6eacc94cf6f9c-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/670g-closed-system_wide-e9d05553e75894a2f9e9d783b5e6eacc94cf6f9c-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/670g-closed-system_wide-e9d05553e75894a2f9e9d783b5e6eacc94cf6f9c-800x450.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 450
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/670g-closed-system_wide-e9d05553e75894a2f9e9d783b5e6eacc94cf6f9c-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/670g-closed-system_wide-e9d05553e75894a2f9e9d783b5e6eacc94cf6f9c-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/670g-closed-system_wide-e9d05553e75894a2f9e9d783b5e6eacc94cf6f9c-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/670g-closed-system_wide-e9d05553e75894a2f9e9d783b5e6eacc94cf6f9c-768x432.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 432
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/670g-closed-system_wide-e9d05553e75894a2f9e9d783b5e6eacc94cf6f9c-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
}
},
"publishDate": 1475255667,
"modified": 1475256142,
"caption": null,
"description": "The MiniMed 670G hybrid closed loop system is the closest thing yet to an artificial pancreas for people with Type 1 diabetes.",
"title": "The MiniMed 670G hybrid closed loop system is the closest thing yet to an artificial pancreas for people with Type 1 diabetes.",
"credit": "Medtronic",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_242691": {
"type": "attachments",
"id": "futureofyou_242691",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "242691",
"found": true
},
"parent": 242687,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/Stem-Cell-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/Stem-Cell-400x276.jpg",
"width": 400,
"mimeType": "image/jpeg",
"height": 276
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/Stem-Cell-960x661.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 661
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/Stem-Cell-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/Stem-Cell-e1473526384488.jpg",
"width": 1920,
"height": 1322
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/Stem-Cell-1180x813.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 813
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/Stem-Cell-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/Stem-Cell-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/Stem-Cell-800x551.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 551
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/Stem-Cell-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/Stem-Cell-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/Stem-Cell-1920x1322.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1322
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/Stem-Cell-1180x813.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 813
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/Stem-Cell-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/Stem-Cell-768x529.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 529
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/09/Stem-Cell-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
}
},
"publishDate": 1473526343,
"modified": 1489697206,
"caption": "Kris Boesen in 2016, after doctors at Keck Medical Center of USC injected 10 million stem cells into his damaged spine as part of a multisite clinical trial.",
"description": "Shortly after doctors at Keck Medical Center of USC injected 10 million stem cells into his spine as part of a multi-site clinical trial, Kris Boesen began to show signs of improvement.",
"title": "Stem Cell",
"credit": "Greg Iger/Keck Medicine of USC)",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"stateofhealth_239878": {
"type": "attachments",
"id": "stateofhealth_239878",
"meta": {
"index": "attachments_1716263798",
"site": "stateofhealth",
"id": "239878",
"found": true
},
"parent": 239875,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/14434927_10103121033670301_6175966939445261829_o-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/14434927_10103121033670301_6175966939445261829_o-400x267.jpg",
"width": 400,
"mimeType": "image/jpeg",
"height": 267
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/14434927_10103121033670301_6175966939445261829_o-960x640.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 640
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/14434927_10103121033670301_6175966939445261829_o-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/14434927_10103121033670301_6175966939445261829_o-e1474487037693.jpg",
"width": 1920,
"height": 1280
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/14434927_10103121033670301_6175966939445261829_o-1440x960.jpg",
"width": 1440,
"mimeType": "image/jpeg",
"height": 960
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/14434927_10103121033670301_6175966939445261829_o-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/14434927_10103121033670301_6175966939445261829_o-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/14434927_10103121033670301_6175966939445261829_o-800x533.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 533
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/14434927_10103121033670301_6175966939445261829_o-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/14434927_10103121033670301_6175966939445261829_o-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"jmtc-small-thumb": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/14434927_10103121033670301_6175966939445261829_o-280x150.jpg",
"width": 280,
"mimeType": "image/jpeg",
"height": 150
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/14434927_10103121033670301_6175966939445261829_o-1920x1280.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1280
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/14434927_10103121033670301_6175966939445261829_o-1180x786.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 786
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/14434927_10103121033670301_6175966939445261829_o-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/14434927_10103121033670301_6175966939445261829_o-768x512.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 512
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/14434927_10103121033670301_6175966939445261829_o-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
}
},
"publishDate": 1474485905,
"modified": 1474487058,
"caption": null,
"description": null,
"title": "14434927_10103121033670301_6175966939445261829_o",
"credit": "via Facebook",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"science_1008622": {
"type": "attachments",
"id": "science_1008622",
"meta": {
"index": "attachments_1716263798",
"site": "science",
"id": "1008622",
"found": true
},
"parent": 993029,
"imgSizes": {
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/09/jrc_water_edited-400x266.jpg",
"width": 400,
"mimeType": "image/jpeg",
"height": 266
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/09/jrc_water_edited-640x372.jpg",
"width": 640,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/09/jrc_water_edited.jpg",
"width": 640,
"height": 426
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/09/jrc_water_edited-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/09/jrc_water_edited-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/09/jrc_water_edited-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/09/jrc_water_edited-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/09/jrc_water_edited-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2016/09/jrc_water_edited-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
}
},
"publishDate": 1474320763,
"modified": 1519778569,
"caption": "Water flows out of a pipe in California. ",
"description": null,
"title": "jrc_water_edited",
"credit": "John Chacon/California Department of Water Resources",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"stateofhealth_236882": {
"type": "attachments",
"id": "stateofhealth_236882",
"meta": {
"index": "attachments_1716263798",
"site": "stateofhealth",
"id": "236882",
"found": true
},
"parent": 236832,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/Screen-Shot-2016-09-13-at-2.51.17-PM-1038x576.png",
"width": 1038,
"mimeType": "image/png",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/Screen-Shot-2016-09-13-at-2.51.17-PM-400x184.png",
"width": 400,
"mimeType": "image/png",
"height": 184
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/Screen-Shot-2016-09-13-at-2.51.17-PM-960x441.png",
"width": 960,
"mimeType": "image/png",
"height": 441
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/Screen-Shot-2016-09-13-at-2.51.17-PM-672x372.png",
"width": 672,
"mimeType": "image/png",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/Screen-Shot-2016-09-13-at-2.51.17-PM.png",
"width": 1920,
"height": 881
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/Screen-Shot-2016-09-13-at-2.51.17-PM-1440x661.png",
"width": 1440,
"mimeType": "image/png",
"height": 661
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/Screen-Shot-2016-09-13-at-2.51.17-PM-50x50.png",
"width": 50,
"mimeType": "image/png",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/Screen-Shot-2016-09-13-at-2.51.17-PM-96x96.png",
"width": 96,
"mimeType": "image/png",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/Screen-Shot-2016-09-13-at-2.51.17-PM-800x367.png",
"width": 800,
"mimeType": "image/png",
"height": 367
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/Screen-Shot-2016-09-13-at-2.51.17-PM-64x64.png",
"width": 64,
"mimeType": "image/png",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/Screen-Shot-2016-09-13-at-2.51.17-PM-32x32.png",
"width": 32,
"mimeType": "image/png",
"height": 32
},
"jmtc-small-thumb": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/Screen-Shot-2016-09-13-at-2.51.17-PM-280x150.png",
"width": 280,
"mimeType": "image/png",
"height": 150
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/Screen-Shot-2016-09-13-at-2.51.17-PM-1920x881.png",
"width": 1920,
"mimeType": "image/png",
"height": 881
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/Screen-Shot-2016-09-13-at-2.51.17-PM-1180x541.png",
"width": 1180,
"mimeType": "image/png",
"height": 541
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/Screen-Shot-2016-09-13-at-2.51.17-PM-150x150.png",
"width": 150,
"mimeType": "image/png",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/Screen-Shot-2016-09-13-at-2.51.17-PM-768x352.png",
"width": 768,
"mimeType": "image/png",
"height": 352
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/Screen-Shot-2016-09-13-at-2.51.17-PM-128x128.png",
"width": 128,
"mimeType": "image/png",
"height": 128
}
},
"publishDate": 1473803590,
"modified": 1473803655,
"caption": null,
"description": null,
"title": "Screen Shot 2016-09-13 at 2.51.17 PM",
"credit": "Screenshot/YouTube",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"stateofhealth_236793": {
"type": "attachments",
"id": "stateofhealth_236793",
"meta": {
"index": "attachments_1716263798",
"site": "stateofhealth",
"id": "236793",
"found": true
},
"parent": 236779,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/iStock_79382537_LARGE-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/iStock_79382537_LARGE-400x267.jpg",
"width": 400,
"mimeType": "image/jpeg",
"height": 267
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/iStock_79382537_LARGE-960x640.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 640
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/iStock_79382537_LARGE-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/iStock_79382537_LARGE-e1473783800807.jpg",
"width": 1920,
"height": 1280
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/iStock_79382537_LARGE-1440x960.jpg",
"width": 1440,
"mimeType": "image/jpeg",
"height": 960
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/iStock_79382537_LARGE-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/iStock_79382537_LARGE-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/iStock_79382537_LARGE-800x533.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 533
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/iStock_79382537_LARGE-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/iStock_79382537_LARGE-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"jmtc-small-thumb": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/iStock_79382537_LARGE-280x150.jpg",
"width": 280,
"mimeType": "image/jpeg",
"height": 150
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/iStock_79382537_LARGE-1920x1280.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1280
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/iStock_79382537_LARGE-1180x787.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 787
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/iStock_79382537_LARGE-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/iStock_79382537_LARGE-768x512.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 512
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/27/2016/09/iStock_79382537_LARGE-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
}
},
"publishDate": 1473783702,
"modified": 1473783850,
"caption": "O",
"description": null,
"title": "iStock_79382537_LARGE",
"credit": "iStock/Getty images",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
}
},
"audioPlayerReducer": {
"postId": "stream_live",
"isPaused": true,
"isPlaying": false,
"pfsActive": false,
"pledgeModalIsOpen": true,
"playerDrawerIsOpen": false,
"liveAudioPlayStartedAt": 0,
"liveAudioPlayContext": ""
},
"authorsReducer": {
"byline_stateofhealth_248365": {
"type": "authors",
"id": "byline_stateofhealth_248365",
"meta": {
"override": true
},
"slug": "byline_stateofhealth_248365",
"name": "Richard Harris \u003cbr> NPR Shots",
"isLoading": false
},
"byline_futureofyou_258717": {
"type": "authors",
"id": "byline_futureofyou_258717",
"meta": {
"override": true
},
"slug": "byline_futureofyou_258717",
"name": "David Gorn",
"isLoading": false
},
"byline_futureofyou_256179": {
"type": "authors",
"id": "byline_futureofyou_256179",
"meta": {
"override": true
},
"slug": "byline_futureofyou_256179",
"name": "\u003cstrong>\u003ca href=\"https://ww2.kqed.org/news/author/scuevas/\">Steven Cuevas\u003c/a>\u003c/strong> and \u003cstrong>\u003ca href=\"https://ww2.kqed.org/news/author/katsnow/\">Kat Snow\u003c/a>\u003c/strong>",
"isLoading": false
},
"byline_futureofyou_256129": {
"type": "authors",
"id": "byline_futureofyou_256129",
"meta": {
"override": true
},
"slug": "byline_futureofyou_256129",
"name": "Jon Hamilton\u003cbr />NPR Shots",
"isLoading": false
},
"byline_futureofyou_254629": {
"type": "authors",
"id": "byline_futureofyou_254629",
"meta": {
"override": true
},
"slug": "byline_futureofyou_254629",
"name": "Miriam E. Tucker\u003cbr />NPR Shots",
"isLoading": false
},
"byline_stateofhealth_239875": {
"type": "authors",
"id": "byline_stateofhealth_239875",
"meta": {
"override": true
},
"slug": "byline_stateofhealth_239875",
"name": "Associated Press",
"isLoading": false
},
"byline_stateofhealth_236779": {
"type": "authors",
"id": "byline_stateofhealth_236779",
"meta": {
"override": true
},
"slug": "byline_stateofhealth_236779",
"name": "Martha Bebinger \u003cbr />\u003ca href=\"http://www.npr.org/sections/health-shots/\">NPR Shots\u003c/a>",
"isLoading": false
},
"lindseyhoshaw": {
"type": "authors",
"id": "5432",
"meta": {
"index": "authors_1716337520",
"id": "5432",
"found": true
},
"name": "Lindsey Hoshaw",
"firstName": "Lindsey",
"lastName": "Hoshaw",
"slug": "lindseyhoshaw",
"email": "lhoshaw@kqed.org",
"display_author_email": false,
"staff_mastheads": [],
"title": "KQED Contributor",
"bio": "Lindsey Hoshaw is a former interactive producer for KQED Science. Before joining KQED, Lindsey was a science correspondent for The New York Times, The Boston Globe, Forbes and Scientific American. On Twitter @lindseyhoshaw",
"avatar": "https://secure.gravatar.com/avatar/274b07694c998eaa8f26cfabaa941186?s=600&d=mm&r=g",
"twitter": "lindseyhoshaw",
"facebook": "lindsey.hoshaw.9",
"instagram": null,
"linkedin": null,
"sites": [
{
"site": "arts",
"roles": [
"author"
]
},
{
"site": "news",
"roles": [
"subscriber"
]
},
{
"site": "futureofyou",
"roles": [
"editor"
]
},
{
"site": "bayareabites",
"roles": [
"contributor"
]
},
{
"site": "stateofhealth",
"roles": [
"author"
]
},
{
"site": "science",
"roles": [
"edit_theme_options",
"subscriber"
]
},
{
"site": "quest",
"roles": [
"edit_post_subscriptions",
"edit_usergroups",
"unfiltered_html",
"unfiltered_upload",
"leadcoordinator",
"editor"
]
},
{
"site": "food",
"roles": []
}
],
"headData": {
"title": "Lindsey Hoshaw | KQED",
"description": "KQED Contributor",
"ogImgSrc": "https://secure.gravatar.com/avatar/274b07694c998eaa8f26cfabaa941186?s=600&d=mm&r=g",
"twImgSrc": "https://secure.gravatar.com/avatar/274b07694c998eaa8f26cfabaa941186?s=600&d=mm&r=g"
},
"isLoading": false,
"link": "/author/lindseyhoshaw"
},
"dgorn": {
"type": "authors",
"id": "8656",
"meta": {
"index": "authors_1716337520",
"id": "8656",
"found": true
},
"name": "David Gorn",
"firstName": "David",
"lastName": "Gorn",
"slug": "dgorn",
"email": "dgorn+donotmail@sbcglobal.net",
"display_author_email": false,
"staff_mastheads": [],
"title": "KQED Contributor",
"bio": "David Gorn is the former Deputy News Director of KQED Radio. His public radio pieces have appeared on NPR, the World, Marketplace and the California Report.",
"avatar": "https://secure.gravatar.com/avatar/a6ad3e1eec1712e19b986b9395614010?s=600&d=blank&r=g",
"twitter": null,
"facebook": null,
"instagram": null,
"linkedin": null,
"sites": [
{
"site": "news",
"roles": [
"subscriber"
]
},
{
"site": "futureofyou",
"roles": [
"author"
]
},
{
"site": "science",
"roles": [
"author"
]
},
{
"site": "quest",
"roles": [
"editor"
]
}
],
"headData": {
"title": "David Gorn | KQED",
"description": "KQED Contributor",
"ogImgSrc": "https://secure.gravatar.com/avatar/a6ad3e1eec1712e19b986b9395614010?s=600&d=blank&r=g",
"twImgSrc": "https://secure.gravatar.com/avatar/a6ad3e1eec1712e19b986b9395614010?s=600&d=blank&r=g"
},
"isLoading": false,
"link": "/author/dgorn"
},
"dventon": {
"type": "authors",
"id": "11088",
"meta": {
"index": "authors_1716337520",
"id": "11088",
"found": true
},
"name": "Danielle Venton",
"firstName": "Danielle",
"lastName": "Venton",
"slug": "dventon",
"email": "dventon@kqed.org",
"display_author_email": true,
"staff_mastheads": [
"science"
],
"title": "Science reporter",
"bio": "Danielle Venton is a reporter for KQED Science. She covers wildfires, space and oceans (though she is prone to sea sickness).\r\n\r\nBefore joining KQED in 2015, Danielle was a staff reporter at KRCB in Sonoma County and a freelancer. She studied science communication at UC Santa Cruz and formerly worked at CERN in Geneva, Switzerland where she wrote about computing. She lives in Sonoma County and enjoys backpacking.",
"avatar": "https://secure.gravatar.com/avatar/37b292b5c40c8d93959c4f48d73b5286f41b7abd8588277e941905a3ed4c801c?s=600&d=blank&r=g",
"twitter": "DanielleVenton",
"bluesky": null,
"facebook": null,
"instagram": null,
"linkedin": null,
"sites": [
{
"site": "arts",
"roles": [
"contributor"
]
},
{
"site": "news",
"roles": [
"editor"
]
},
{
"site": "futureofyou",
"roles": [
"editor"
]
},
{
"site": "science",
"roles": [
"editor"
]
},
{
"site": "liveblog",
"roles": [
"contributor"
]
}
],
"headData": {
"title": "Danielle Venton | KQED",
"description": "Science reporter",
"ogImgSrc": "https://secure.gravatar.com/avatar/37b292b5c40c8d93959c4f48d73b5286f41b7abd8588277e941905a3ed4c801c?s=600&d=blank&r=g",
"twImgSrc": "https://secure.gravatar.com/avatar/37b292b5c40c8d93959c4f48d73b5286f41b7abd8588277e941905a3ed4c801c?s=600&d=blank&r=g"
},
"isLoading": false,
"link": "/author/dventon"
},
"lisafine": {
"type": "authors",
"id": "11105",
"meta": {
"index": "authors_1716337520",
"id": "11105",
"found": true
},
"name": "Lisa Fine",
"firstName": "Lisa",
"lastName": "Fine",
"slug": "lisafine",
"email": "lisacfine@gmail.com",
"display_author_email": false,
"staff_mastheads": [],
"title": null,
"bio": "Lisa Fine is a veteran journalist who's written for papers including the Washington Post, Philadelphia Inquirer, Richmond (Va.) Times-Dispatch and Education Week.\r\n\r\n ",
"avatar": "https://secure.gravatar.com/avatar/a9390ffc82e66cee761ae45f61cef865?s=600&d=blank&r=g",
"twitter": "@Lisa_Fine",
"facebook": null,
"instagram": null,
"linkedin": null,
"sites": [
{
"site": "futureofyou",
"roles": [
"author"
]
},
{
"site": "stateofhealth",
"roles": [
"editor"
]
}
],
"headData": {
"title": "Lisa Fine | KQED",
"description": null,
"ogImgSrc": "https://secure.gravatar.com/avatar/a9390ffc82e66cee761ae45f61cef865?s=600&d=blank&r=g",
"twImgSrc": "https://secure.gravatar.com/avatar/a9390ffc82e66cee761ae45f61cef865?s=600&d=blank&r=g"
},
"isLoading": false,
"link": "/author/lisafine"
},
"lesleymcclurg": {
"type": "authors",
"id": "11229",
"meta": {
"index": "authors_1716337520",
"id": "11229",
"found": true
},
"name": "Lesley McClurg",
"firstName": "Lesley",
"lastName": "McClurg",
"slug": "lesleymcclurg",
"email": "lmcclurg@KQED.org",
"display_author_email": false,
"staff_mastheads": [
"news",
"science"
],
"title": "KQED Health Correspondent",
"bio": "Lesley McClurg is a health correspondent and fill-in host whose work is regularly rebroadcast on NPR and PBS programs. She’s earned multiple regional Emmy awards, a national and a regional Edward R. Murrow award, and was named Best Beat Reporter by the Association of Health Care Journalists. The Society of Professional Journalists has recognized her work several times, and the Society of Environmental Journalists spotlighted her coverage of California’s historic drought.\r\n\r\nBefore joining KQED in 2016, Lesley covered food and sustainability for Capital Public Radio, environmental issues for Colorado Public Radio, and reported for KUOW and KCTS 9 in Seattle. Away from the newsroom, she loves skiing with her daughter, mountain biking with her partner, and playing with Ollie, the family’s goldendoodle. On deadline, she runs almost entirely on chocolate chips.\r\n\r\n ",
"avatar": "https://secure.gravatar.com/avatar/bab49e972ea10c774fe0f5e29dba1722b158f7c0d58a360923d1389d380b2978?s=600&d=blank&r=g",
"twitter": "lesleywmcclurg",
"bluesky": null,
"facebook": null,
"instagram": null,
"linkedin": null,
"sites": [
{
"site": "arts",
"roles": [
"author"
]
},
{
"site": "news",
"roles": [
"editor"
]
},
{
"site": "futureofyou",
"roles": [
"editor"
]
},
{
"site": "stateofhealth",
"roles": [
"author"
]
},
{
"site": "science",
"roles": [
"editor"
]
},
{
"site": "quest",
"roles": [
"subscriber"
]
},
{
"site": "forum",
"roles": [
"administrator"
]
},
{
"site": "liveblog",
"roles": [
"author"
]
}
],
"headData": {
"title": "Lesley McClurg | KQED",
"description": "KQED Health Correspondent",
"ogImgSrc": "https://secure.gravatar.com/avatar/bab49e972ea10c774fe0f5e29dba1722b158f7c0d58a360923d1389d380b2978?s=600&d=blank&r=g",
"twImgSrc": "https://secure.gravatar.com/avatar/bab49e972ea10c774fe0f5e29dba1722b158f7c0d58a360923d1389d380b2978?s=600&d=blank&r=g"
},
"isLoading": false,
"link": "/author/lesleymcclurg"
}
},
"pagesReducer": {
"science_category_health": {
"type": "terms",
"id": "science_39",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "39",
"score": 10.889519
},
"featImg": null,
"name": "Health",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Health Archives | KQED Science",
"ogDescription": null
},
"ttid": 41,
"slug": "health",
"isLoading": false,
"title": "Health",
"pageMeta": {
"site": "science",
"WpPageTemplate": "page-topic-editorial",
"currentPage": 56
},
"blocks": [
{
"blockName": "kqed/post-list",
"attrs": {
"layout": "cardArticle2",
"query": "posts/science?category=health",
"seeMore": false,
"paginated": true,
"page": 56
}
},
{
"blockName": "kqed/ad"
}
]
}
},
"pfsSessionReducer": {},
"postsReducer": {
"stream_live": {
"type": "live",
"id": "stream_live",
"audioUrl": "https://streams.kqed.org/kqedradio",
"title": "Live Stream",
"excerpt": "Live Stream information currently unavailable.",
"link": "/radio",
"featImg": "",
"label": {
"name": "KQED Live",
"link": "/"
}
},
"stream_kqedNewscast": {
"type": "posts",
"id": "stream_kqedNewscast",
"audioUrl": "https://www.kqed.org/.stream/anon/radio/RDnews/newscast.mp3?_=1",
"title": "KQED Newscast",
"featImg": "",
"label": {
"name": "88.5 FM",
"link": "/"
}
},
"futureofyou_262412": {
"type": "posts",
"id": "futureofyou_262412",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "262412",
"score": null,
"sort": [
1478097022000
]
},
"parent": 0,
"labelTerm": {
"site": "futureofyou"
},
"blocks": [],
"publishDate": 1478097022,
"format": "audio",
"disqusTitle": "All That Multitasking is Harming, Not Helping Your Productivity. Here's Why",
"title": "All That Multitasking is Harming, Not Helping Your Productivity. Here's Why",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>I'll admit it. I even take my phone with me to fire off a few texts when I go to the restroom. Or I'll scroll through my email when I leave the office for lunch. My eyes are often glued to my phone from the moment I wake up, but I often reach the end of my days wondering what I've accomplished.\u003c/p>\n\u003caside class=\"alignright\">\n\u003ch2>Tips for Productivity at Work\u003c/h2>\n\u003cul>\n\u003cli>Start by clearing off your work space. Remove mobile devices and any extraneous papers.\u003c/li>\n\u003cli>Use one computer screen. Shut down all unnecessary programs and apps. Open one browser and use only one tab.\u003c/li>\n\u003cli>Turn off email.\u003c/li>\n\u003cli>Set expectations. Tell your boss you’re going offline for a while. Or, set an auto response for both your texts and emails explaining that you’ll be offline for a set period of time.\u003c/li>\n\u003cli>Work in a quiet environment devoid of people. If you must work in a coffee shop use noise-cancelling headphones.\u003c/li>\n\u003cli>Display a “no interruption zone” at your desk or on your office door.\u003c/li>\n\u003cli>Check out helpful apps like SelfControl, Freedom, or FocusMe\u003c/li>\n\u003c/ul>\n\u003c/aside>\n\u003cp>My productivity mystery was solved after reading “The Distracted Mind: Ancient Brains in a High Tech World,\" by University of California, San Francisco neuroscientist Dr. \u003ca href=\"http://gazzaleylab.ucsf.edu/people-profiles/adam-gazzaley/\">Adam Gazzaley \u003c/a>and California State University, Dominguez Hills professor emeritus Larry Rosen. The book explains why the brain can't multitask, and why my near-obsessive efforts to keep up on emails is likely lowering my productive output.\u003c/p>\n\u003cp>\u003cstrong>How the Digital Age Zaps Productivity\u003c/strong>\u003c/p>\n\u003cp>I visited Gazzaley in his UCSF laboratory, Neuroscape, to learn more about the science of distraction. Gazzaley pulled up, on a TV screen, a 3-D image of a brain, created from an MRI Scan. He pointed to different sections to explain what's going on when our attention flits between tasks.\u003c/p>\n\u003cp>[contextly_sidebar id=\"mQNeLsl599Zl2MgROKE009FDdid0LEJr\"]\"The prefrontal cortex is the area most challenged,\" Gazzely says. \"And then visual areas, auditory areas, and the hippocampus — these networks are really what's challenged when we are constantly switching between multiple tasks that our technological world might throw at us.\"\u003c/p>\n\u003caside class=\"pullquote alignright\">If you're working on a project and you stop to answer an email, research shows, it will take you nearly a half-hour to get back on task.\u003c/aside>\n\u003cp>When you engage in one task at a time, the prefrontal cortex works in harmony with other parts of the brain, but when you toss in another task it forces the left and right sides of the brain to work independently. The process of splitting our attention usually leads to mistakes.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>In other words, each time our eyes glance away from our computer monitor to sneak a peak at a text message, the brain takes in new information, which reduces our primary focus. We \u003cem>think\u003c/em> the mind can juggle two or three activities successfully at once, but Gazzaley says we woefully overestimate our ability to multitask.\u003c/p>\n\u003cp>\"An example is when you attempt to check your email while on a conference call,\" says Gazzaley. \"The act of doing that makes it so incredibly obvious how you can't really parallel process two attention-demanding tasks. You either have to catch up and ask what happened in the conversation, or you have to read over the email before you send it — if you're wise!\"\u003c/p>\n\u003cp>\u003cstrong>Answering an Email Takes A Lot Longer Than You Think\u003cbr>\n\u003c/strong>\u003c/p>\n\u003cp>Gazzaley stresses that our tendency to respond immediately to emails and texts hinders high-level thinking. If you're working on a project and you stop to answer an email, the \u003ca href=\"http://research.microsoft.com/en-us/um/people/horvitz/CHI_2007_Iqbal_Horvitz.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">research\u003c/a> shows, it will take you nearly a half-hour to get back on task.\u003c/p>\n\u003caside class=\"pullquote alignright\">Research has found that high-tech jugglers struggle to pay attention, recall information, or complete one task at a time.\u003c/aside>\n\u003cp>\"When a focused stream of thought is interrupted it needs to be reset,\" explains Gazzaley. \"You can't just press a button and switch back to it. You have to re-engage those thought processes, and recreate all the elements of what you were engaged in. That takes time, and frequently one interruption leads to another.\"\u003c/p>\n\u003cp>In other words, repetitively switching tasks lowers performance and productivity because your brain can only fully and efficiently focus on one thing at a time.\u003c/p>\n\u003cfigure id=\"attachment_262693\" class=\"wp-caption aligncenter\" style=\"max-width: 800px\">\u003cimg class=\"size-medium wp-image-262693\" src=\"http://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2016/10/Gazzeley-800x600.jpg\" alt=\"When UCSF neuroscientist Adam Gazzeley needs to focus on a high level project he clears his desk, works on one screen and turns off all distracting digital devices.\" width=\"800\" height=\"600\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2016/10/Gazzeley-800x600.jpg 800w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/Gazzeley-400x300.jpg 400w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/Gazzeley-768x576.jpg 768w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/Gazzeley-1180x885.jpg 1180w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/Gazzeley-1920x1440.jpg 1920w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/Gazzeley-960x720.jpg 960w\" sizes=\"(max-width: 800px) 100vw, 800px\">\u003cfigcaption class=\"wp-caption-text\">When UCSF neuroscientist Adam Gazzeley needs to focus on a high level project he clears his desk, works on one screen and turns off all distracting digital devices. \u003ccite>(Sierra Niblett )\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>Plus, \u003ca href=\"http://journalistsresource.org/studies/society/social-media/multitasking-social-media-distraction-what-does-research-say\" target=\"_blank\" rel=\"noopener noreferrer\">mounting evidence\u003c/a> shows that multitasking could impair the brain's cognitive abilities. \u003ca href=\"http://news.stanford.edu/2009/08/24/multitask-research-study-082409/\" target=\"_blank\" rel=\"noopener noreferrer\">Stanford researchers\u003c/a> studied the minds of people who regularly engage in several digital communication streams at once. They found that high-tech jugglers struggle to pay attention, recall information, or complete one task at a time.\u003c/p>\n\u003cp>“When they’re in situations where there are multiple sources of information coming from the external world or emerging out of memory, they’re not able to filter out what’s not relevant to their current goal,” says Stanford neuroscientist\u003ca href=\"https://psychology.stanford.edu/awagner\" target=\"_blank\" rel=\"noopener noreferrer\"> Anthony Wagner\u003c/a>. “That failure to filter means they’re slowed down by that irrelevant information.”\u003c/p>\n\u003cp>The researchers are still studying what's causing multitaskers to perform poorly on cognitive tests. It could be that they are born with an inability to concentrate, or digital distractions are taking a toll. In any case, the researchers believe the minds of multitaskers are not performing optimally.\u003c/p>\n\u003cp>And the habit of multitasking could lower your score on an IQ test, according to researchers at the \u003ca href=\"http://discovery.ucl.ac.uk/1465496/\" target=\"_blank\" rel=\"noopener noreferrer\">University of London\u003c/a>.\u003c/p>\n\u003cp>\u003cstrong>Creating Digital Boundaries\u003c/strong>\u003c/p>\n\u003cp>But don't worry. Gazzaley says. It’s not about opting out of technology. In fact, there's a time and place for multitasking. If you’re in the midst of a mundane task that just has to get done, it’s probably not detrimental to have your phone nearby or a bunch of tabs open. The distractions may reduce boredom and help you stay engaged. But if you’re finishing a business plan, or a high-level writing project, then it’s a good idea to set yourself up to stay focused.\u003c/p>\n\u003cp>Check out Gazzaley's tips for turning off distractions in the sidebar above.\u003c/p>\n\u003cp>[ad floatright]\u003c/p>\n\u003cp>Now, get back to work!\u003c/p>\n\n",
"disqusIdentifier": "262412 http://ww2.kqed.org/futureofyou/?p=262412",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2016/11/02/your-devices-are-probably-lowering-your-productivity-heres-why/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 1061,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 22
},
"modified": 1504652665,
"excerpt": "UCSF neuroscientist Adam Gazzaley says our brains can't multitask, and when we try to force them to, we lose focus. ",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "UCSF neuroscientist Adam Gazzaley says our brains can't multitask, and when we try to force them to, we lose focus. ",
"title": "All That Multitasking is Harming, Not Helping Your Productivity. Here's Why | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "All That Multitasking is Harming, Not Helping Your Productivity. Here's Why",
"datePublished": "2016-11-02T07:30:22-07:00",
"dateModified": "2017-09-05T16:04:25-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "your-devices-are-probably-lowering-your-productivity-heres-why",
"status": "publish",
"customPermalink": "2016/10/17/your-devices-are-probably-lowering-your-productivity-heres-why/",
"audioUrl": "http://www.kqed.org/.stream/anon/radio/science/2016/10/WEBGazzaleyTwoWay161017.mp3",
"path": "/futureofyou/262412/your-devices-are-probably-lowering-your-productivity-heres-why",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>I'll admit it. I even take my phone with me to fire off a few texts when I go to the restroom. Or I'll scroll through my email when I leave the office for lunch. My eyes are often glued to my phone from the moment I wake up, but I often reach the end of my days wondering what I've accomplished.\u003c/p>\n\u003caside class=\"alignright\">\n\u003ch2>Tips for Productivity at Work\u003c/h2>\n\u003cul>\n\u003cli>Start by clearing off your work space. Remove mobile devices and any extraneous papers.\u003c/li>\n\u003cli>Use one computer screen. Shut down all unnecessary programs and apps. Open one browser and use only one tab.\u003c/li>\n\u003cli>Turn off email.\u003c/li>\n\u003cli>Set expectations. Tell your boss you’re going offline for a while. Or, set an auto response for both your texts and emails explaining that you’ll be offline for a set period of time.\u003c/li>\n\u003cli>Work in a quiet environment devoid of people. If you must work in a coffee shop use noise-cancelling headphones.\u003c/li>\n\u003cli>Display a “no interruption zone” at your desk or on your office door.\u003c/li>\n\u003cli>Check out helpful apps like SelfControl, Freedom, or FocusMe\u003c/li>\n\u003c/ul>\n\u003c/aside>\n\u003cp>My productivity mystery was solved after reading “The Distracted Mind: Ancient Brains in a High Tech World,\" by University of California, San Francisco neuroscientist Dr. \u003ca href=\"http://gazzaleylab.ucsf.edu/people-profiles/adam-gazzaley/\">Adam Gazzaley \u003c/a>and California State University, Dominguez Hills professor emeritus Larry Rosen. The book explains why the brain can't multitask, and why my near-obsessive efforts to keep up on emails is likely lowering my productive output.\u003c/p>\n\u003cp>\u003cstrong>How the Digital Age Zaps Productivity\u003c/strong>\u003c/p>\n\u003cp>I visited Gazzaley in his UCSF laboratory, Neuroscape, to learn more about the science of distraction. Gazzaley pulled up, on a TV screen, a 3-D image of a brain, created from an MRI Scan. He pointed to different sections to explain what's going on when our attention flits between tasks.\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003c/p>\u003cp>\"The prefrontal cortex is the area most challenged,\" Gazzely says. \"And then visual areas, auditory areas, and the hippocampus — these networks are really what's challenged when we are constantly switching between multiple tasks that our technological world might throw at us.\"\u003c/p>\n\u003caside class=\"pullquote alignright\">If you're working on a project and you stop to answer an email, research shows, it will take you nearly a half-hour to get back on task.\u003c/aside>\n\u003cp>When you engage in one task at a time, the prefrontal cortex works in harmony with other parts of the brain, but when you toss in another task it forces the left and right sides of the brain to work independently. The process of splitting our attention usually leads to mistakes.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>In other words, each time our eyes glance away from our computer monitor to sneak a peak at a text message, the brain takes in new information, which reduces our primary focus. We \u003cem>think\u003c/em> the mind can juggle two or three activities successfully at once, but Gazzaley says we woefully overestimate our ability to multitask.\u003c/p>\n\u003cp>\"An example is when you attempt to check your email while on a conference call,\" says Gazzaley. \"The act of doing that makes it so incredibly obvious how you can't really parallel process two attention-demanding tasks. You either have to catch up and ask what happened in the conversation, or you have to read over the email before you send it — if you're wise!\"\u003c/p>\n\u003cp>\u003cstrong>Answering an Email Takes A Lot Longer Than You Think\u003cbr>\n\u003c/strong>\u003c/p>\n\u003cp>Gazzaley stresses that our tendency to respond immediately to emails and texts hinders high-level thinking. If you're working on a project and you stop to answer an email, the \u003ca href=\"http://research.microsoft.com/en-us/um/people/horvitz/CHI_2007_Iqbal_Horvitz.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">research\u003c/a> shows, it will take you nearly a half-hour to get back on task.\u003c/p>\n\u003caside class=\"pullquote alignright\">Research has found that high-tech jugglers struggle to pay attention, recall information, or complete one task at a time.\u003c/aside>\n\u003cp>\"When a focused stream of thought is interrupted it needs to be reset,\" explains Gazzaley. \"You can't just press a button and switch back to it. You have to re-engage those thought processes, and recreate all the elements of what you were engaged in. That takes time, and frequently one interruption leads to another.\"\u003c/p>\n\u003cp>In other words, repetitively switching tasks lowers performance and productivity because your brain can only fully and efficiently focus on one thing at a time.\u003c/p>\n\u003cfigure id=\"attachment_262693\" class=\"wp-caption aligncenter\" style=\"max-width: 800px\">\u003cimg class=\"size-medium wp-image-262693\" src=\"http://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2016/10/Gazzeley-800x600.jpg\" alt=\"When UCSF neuroscientist Adam Gazzeley needs to focus on a high level project he clears his desk, works on one screen and turns off all distracting digital devices.\" width=\"800\" height=\"600\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2016/10/Gazzeley-800x600.jpg 800w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/Gazzeley-400x300.jpg 400w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/Gazzeley-768x576.jpg 768w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/Gazzeley-1180x885.jpg 1180w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/Gazzeley-1920x1440.jpg 1920w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/Gazzeley-960x720.jpg 960w\" sizes=\"(max-width: 800px) 100vw, 800px\">\u003cfigcaption class=\"wp-caption-text\">When UCSF neuroscientist Adam Gazzeley needs to focus on a high level project he clears his desk, works on one screen and turns off all distracting digital devices. \u003ccite>(Sierra Niblett )\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>Plus, \u003ca href=\"http://journalistsresource.org/studies/society/social-media/multitasking-social-media-distraction-what-does-research-say\" target=\"_blank\" rel=\"noopener noreferrer\">mounting evidence\u003c/a> shows that multitasking could impair the brain's cognitive abilities. \u003ca href=\"http://news.stanford.edu/2009/08/24/multitask-research-study-082409/\" target=\"_blank\" rel=\"noopener noreferrer\">Stanford researchers\u003c/a> studied the minds of people who regularly engage in several digital communication streams at once. They found that high-tech jugglers struggle to pay attention, recall information, or complete one task at a time.\u003c/p>\n\u003cp>“When they’re in situations where there are multiple sources of information coming from the external world or emerging out of memory, they’re not able to filter out what’s not relevant to their current goal,” says Stanford neuroscientist\u003ca href=\"https://psychology.stanford.edu/awagner\" target=\"_blank\" rel=\"noopener noreferrer\"> Anthony Wagner\u003c/a>. “That failure to filter means they’re slowed down by that irrelevant information.”\u003c/p>\n\u003cp>The researchers are still studying what's causing multitaskers to perform poorly on cognitive tests. It could be that they are born with an inability to concentrate, or digital distractions are taking a toll. In any case, the researchers believe the minds of multitaskers are not performing optimally.\u003c/p>\n\u003cp>And the habit of multitasking could lower your score on an IQ test, according to researchers at the \u003ca href=\"http://discovery.ucl.ac.uk/1465496/\" target=\"_blank\" rel=\"noopener noreferrer\">University of London\u003c/a>.\u003c/p>\n\u003cp>\u003cstrong>Creating Digital Boundaries\u003c/strong>\u003c/p>\n\u003cp>But don't worry. Gazzaley says. It’s not about opting out of technology. In fact, there's a time and place for multitasking. If you’re in the midst of a mundane task that just has to get done, it’s probably not detrimental to have your phone nearby or a bunch of tabs open. The distractions may reduce boredom and help you stay engaged. But if you’re finishing a business plan, or a high-level writing project, then it’s a good idea to set yourself up to stay focused.\u003c/p>\n\u003cp>Check out Gazzaley's tips for turning off distractions in the sidebar above.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "floatright"
},
"numeric": [
"floatright"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>Now, get back to work!\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/262412/your-devices-are-probably-lowering-your-productivity-heres-why",
"authors": [
"11229"
],
"categories": [
"futureofyou_452",
"futureofyou_73",
"futureofyou_1061"
],
"tags": [
"futureofyou_56",
"futureofyou_1103",
"futureofyou_80",
"futureofyou_59"
],
"featImg": "futureofyou_262413",
"label": "futureofyou"
},
"stateofhealth_248365": {
"type": "posts",
"id": "stateofhealth_248365",
"meta": {
"index": "posts_1716263798",
"site": "stateofhealth",
"id": "248365",
"score": null,
"sort": [
1476472406000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1476472406,
"format": "standard",
"disqusTitle": "Reviews of Medical Studies May be Tainted by Funders' Influence",
"title": "Reviews of Medical Studies May be Tainted by Funders' Influence",
"headTitle": "State of Health | KQED News",
"content": "\u003cp>When doctors want to help untangle confusing and sometimes contradictory findings in the scientific literature, they often turn to specially crafted summary studies. These are considered the gold standard for evidence. But one of the leading advocates for this practice is now raising alarm about them, because they are increasingly being tainted by commercial interests.\u003c/p>\n\u003cp>For many years, these studies — called meta-analyses and systematic reviews — seemed to solve a big problem. Doctors who had once relied on each other's expert opinions to select the best treatments gradually turned to careful scientific studies instead.\u003c/p>\n\u003cp>But the number of studies mushroomed and often came to different conclusions. So in the 1990s, doctors and medical advisory committees started relying on studies that combined results from many different research projects to streamline the search for answers.\u003c/p>\n\u003cp>These kinds of studies are \"extremely important,\" says \u003ca href=\"https://med.stanford.edu/profiles/john-ioannidis\">Dr. John Ioannidis\u003c/a>, a professor of medicine health research and policy at Stanford University. He has conducted many of these types of studies over the course of his career. \"They're trying to make some sense out of a very convoluted scientific and medical literature.\"\u003c/p>\n\u003cp>But Ioannidis says unfortunately things have gotten out of hand. First, \"the problem is that there are just too many meta-analyses,\" Ioannidis says.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>In a \u003ca href=\"http://www.milbank.org/wp-content/files/documents/The_Mass_Production_of_Redundant_Misleading_and_Conflicted_Systematic_Reviews_and_Meta-Analyses.pdf\">recent study on the subject\u003c/a>, titled \"The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-Analyses,\" he chose as an example studies involving antidepressant drugs. \"There are 185 of them published in the literature within seven years, which means about 25 of them published every year for the very same drugs and the very same indication, major depression,\" Ioannidis said.\u003c/p>\n\u003cp>What's worse, they're increasingly being generated by scientists who have financial interests in the outcome, Ioannidis \u003ca href=\"https://www.ncbi.nlm.nih.gov/pubmed/26399904\">found\u003c/a>.\u003c/p>\n\u003cp>\"About 80 percent of them have been funded or have some other conflicts of interest with manufacturers of these drugs,\" he says. \"If you look at what their conclusions are, those that have been authored by industry employees, practically all of them, with one exception, have claimed that there are no caveats about antidepressants.\"\u003c/p>\n\u003cp>You have to read deep into the studies to find warnings about potential suicide risks, for example — if downsides are mentioned at all.\u003c/p>\n\u003cp>That's potentially misleading to doctors who turn to this kind of analysis to get a quick take on what works and what doesn't. Ioannidis says the drug industry has started using meta-analysis for commercial purposes, rather than as a disinterested look at the evidence.\u003c/p>\n\u003cp>\"They can get the results or at least the interpretation that fits their needs. So you have the most powerful and most prestigious design in current medical evidence, and it can be easily manipulated as an advertisement, as a marketing tool.\"\u003c/p>\n\u003cp>And that defeats one of the main purposes of these studies, which is to make an overflowing scientific literature more manageable.\u003c/p>\n\u003cp>Peter Kramer, a clinical professor emeritus at Brown University and author of \u003cem>Listening to Prozac,\u003c/em> took a deep dive into meta-analyses when he was writing his latest book, \u003ca href=\"http://www.wbur.org/onpoint/2016/06/16/peter-kramers-new-defense-of-antidepressants\">Ordinarily Well\u003c/a>. He found the situation even worse than Ioannidis suggests.\u003c/p>\n\u003cp>\"In some ways my doubts are stronger than his,\" Kramer told Shots.\u003c/p>\n\u003cp>Some analyses he looked at were trying to parse very subtle differences — for example, comparing two very similar antidepressants. You could get any answer you want, depending on how you set up the study, Kramer says.\u003c/p>\n\u003cp>And the problems he found aren't simply commercial conflicts of interest. For example, he saw biases among academics who were wedded to the notion that placebos are just as good as actual drugs for depression.\u003c/p>\n\u003cp>\"Even on that side of the equation, where there's no adverse sponsorship but just an allegiance to an idea, I thought it wasn't always the case that everybody's hands were on the table,\" Kramer said.\u003c/p>\n\u003cp>But financial conflicts are easier to identify. Five years ago, the National Academy's Institute of Medicine (now called the National Academy of Medicine) suggested dozens of standards that should apply to systematic reviews of the research literature.\u003c/p>\n\u003cp>The influence of funders is a concern, says \u003ca href=\"https://depts.washington.edu/fammed/profile/?id=00041\">Dr. Alfred Berg\u003c/a>, a professor emeritus of family medicine at the University of Washington who chaired one of the committees.\u003c/p>\n\u003cp>\"If there's obvious sponsorship from an organization that might have a conflict of interest, that's probably not a good idea,\" he says. It's reasonable to suggest that scientists with clear financial conflicts of interest should not be producing these studies. \"Is it going to happen in my lifetime?\" Berg says. \"Probably not!\"\u003c/p>\n\u003cp>Pfizer, one of the many drug companies that fund meta-analyses involving their own products, declined an interview request. But the company noted in an emailed statement that the drug company \"shares data from its clinical trials with outside members of the research community for them to conduct their own independent meta-analyses.\"\u003c/p>\n\u003cp>Fortunately, scientific journals are starting to do a better job of making sure researchers disclose their financial interests. It's up to readers now to take heed.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\u003cem>Email Richard Harris at \u003ca href=\"mailto:rharris@npr.org\">rharris@npr.org.\u003c/a>\u003c/em>\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2016 NPR. To see more, visit http://www.npr.org/.\u003cimg src=\"http://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=Reviews+Of+Medical+Studies+May+Be+Tainted+By+Funders%27+Influence&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n",
"disqusIdentifier": "248365 http://ww2.kqed.org/stateofhealth/?p=248365",
"disqusUrl": "https://ww2.kqed.org/stateofhealth/2016/10/14/reviews-of-medical-studies-may-be-tainted-by-funders-influence/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 868,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 25
},
"modified": 1476488138,
"excerpt": "Researchers often combine the results of many medical studies to evaluate treatments. But when the combiners have a financial interest, the results might be inaccurate, a scientist says.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Researchers often combine the results of many medical studies to evaluate treatments. But when the combiners have a financial interest, the results might be inaccurate, a scientist says.",
"title": "Reviews of Medical Studies May be Tainted by Funders' Influence | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Reviews of Medical Studies May be Tainted by Funders' Influence",
"datePublished": "2016-10-14T12:13:26-07:00",
"dateModified": "2016-10-14T16:35:38-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "reviews-of-medical-studies-may-be-tainted-by-funders-influence",
"status": "publish",
"nprApiLink": "http://api.npr.org/query?id=497550681&apiKey=MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004",
"nprStoryDate": "Wed, 12 Oct 2016 12:16:00 -0400",
"nprLastModifiedDate": "Fri, 14 Oct 2016 10:43:51 -0400",
"nprHtmlLink": "http://www.npr.org/sections/health-shots/2016/10/12/497550681/reviews-of-medical-studies-may-be-tainted-by-funders-influence?ft=nprml&f=497550681",
"nprAudio": "https://ondemand.npr.org/anon.npr-mp3/npr/atc/2016/10/20161012_atc_reviews_of_medical_studies_may_be_tainted_by_funders_influence.mp3?orgId=1&topicId=1128&d=266&p=2&story=497550681&t=progseg&e=497640285&seg=5&ft=nprml&f=497550681",
"nprImageAgency": "Ikon Images/Getty Images",
"source": "NPR",
"nprAudioM3u": "http://api.npr.org/m3u/1497715254-8f09f1.m3u?orgId=1&topicId=1128&d=266&p=2&story=497550681&t=progseg&e=497640285&seg=5&ft=nprml&f=497550681",
"nprStoryId": "497550681",
"nprByline": "Richard Harris \u003cbr> NPR Shots",
"nprImageCredit": "Roy Scott",
"nprRetrievedStory": "1",
"nprPubDate": "Fri, 14 Oct 2016 10:43:00 -0400",
"path": "/stateofhealth/248365/reviews-of-medical-studies-may-be-tainted-by-funders-influence",
"audioUrl": "https://ondemand.npr.org/anon.npr-mp3/npr/atc/2016/10/20161012_atc_reviews_of_medical_studies_may_be_tainted_by_funders_influence.mp3?orgId=1&topicId=1128&d=266&p=2&story=497550681&t=progseg&e=497640285&seg=5&ft=nprml&f=497550681",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>When doctors want to help untangle confusing and sometimes contradictory findings in the scientific literature, they often turn to specially crafted summary studies. These are considered the gold standard for evidence. But one of the leading advocates for this practice is now raising alarm about them, because they are increasingly being tainted by commercial interests.\u003c/p>\n\u003cp>For many years, these studies — called meta-analyses and systematic reviews — seemed to solve a big problem. Doctors who had once relied on each other's expert opinions to select the best treatments gradually turned to careful scientific studies instead.\u003c/p>\n\u003cp>But the number of studies mushroomed and often came to different conclusions. So in the 1990s, doctors and medical advisory committees started relying on studies that combined results from many different research projects to streamline the search for answers.\u003c/p>\n\u003cp>These kinds of studies are \"extremely important,\" says \u003ca href=\"https://med.stanford.edu/profiles/john-ioannidis\">Dr. John Ioannidis\u003c/a>, a professor of medicine health research and policy at Stanford University. He has conducted many of these types of studies over the course of his career. \"They're trying to make some sense out of a very convoluted scientific and medical literature.\"\u003c/p>\n\u003cp>But Ioannidis says unfortunately things have gotten out of hand. First, \"the problem is that there are just too many meta-analyses,\" Ioannidis says.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>In a \u003ca href=\"http://www.milbank.org/wp-content/files/documents/The_Mass_Production_of_Redundant_Misleading_and_Conflicted_Systematic_Reviews_and_Meta-Analyses.pdf\">recent study on the subject\u003c/a>, titled \"The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-Analyses,\" he chose as an example studies involving antidepressant drugs. \"There are 185 of them published in the literature within seven years, which means about 25 of them published every year for the very same drugs and the very same indication, major depression,\" Ioannidis said.\u003c/p>\n\u003cp>What's worse, they're increasingly being generated by scientists who have financial interests in the outcome, Ioannidis \u003ca href=\"https://www.ncbi.nlm.nih.gov/pubmed/26399904\">found\u003c/a>.\u003c/p>\n\u003cp>\"About 80 percent of them have been funded or have some other conflicts of interest with manufacturers of these drugs,\" he says. \"If you look at what their conclusions are, those that have been authored by industry employees, practically all of them, with one exception, have claimed that there are no caveats about antidepressants.\"\u003c/p>\n\u003cp>You have to read deep into the studies to find warnings about potential suicide risks, for example — if downsides are mentioned at all.\u003c/p>\n\u003cp>That's potentially misleading to doctors who turn to this kind of analysis to get a quick take on what works and what doesn't. Ioannidis says the drug industry has started using meta-analysis for commercial purposes, rather than as a disinterested look at the evidence.\u003c/p>\n\u003cp>\"They can get the results or at least the interpretation that fits their needs. So you have the most powerful and most prestigious design in current medical evidence, and it can be easily manipulated as an advertisement, as a marketing tool.\"\u003c/p>\n\u003cp>And that defeats one of the main purposes of these studies, which is to make an overflowing scientific literature more manageable.\u003c/p>\n\u003cp>Peter Kramer, a clinical professor emeritus at Brown University and author of \u003cem>Listening to Prozac,\u003c/em> took a deep dive into meta-analyses when he was writing his latest book, \u003ca href=\"http://www.wbur.org/onpoint/2016/06/16/peter-kramers-new-defense-of-antidepressants\">Ordinarily Well\u003c/a>. He found the situation even worse than Ioannidis suggests.\u003c/p>\n\u003cp>\"In some ways my doubts are stronger than his,\" Kramer told Shots.\u003c/p>\n\u003cp>Some analyses he looked at were trying to parse very subtle differences — for example, comparing two very similar antidepressants. You could get any answer you want, depending on how you set up the study, Kramer says.\u003c/p>\n\u003cp>And the problems he found aren't simply commercial conflicts of interest. For example, he saw biases among academics who were wedded to the notion that placebos are just as good as actual drugs for depression.\u003c/p>\n\u003cp>\"Even on that side of the equation, where there's no adverse sponsorship but just an allegiance to an idea, I thought it wasn't always the case that everybody's hands were on the table,\" Kramer said.\u003c/p>\n\u003cp>But financial conflicts are easier to identify. Five years ago, the National Academy's Institute of Medicine (now called the National Academy of Medicine) suggested dozens of standards that should apply to systematic reviews of the research literature.\u003c/p>\n\u003cp>The influence of funders is a concern, says \u003ca href=\"https://depts.washington.edu/fammed/profile/?id=00041\">Dr. Alfred Berg\u003c/a>, a professor emeritus of family medicine at the University of Washington who chaired one of the committees.\u003c/p>\n\u003cp>\"If there's obvious sponsorship from an organization that might have a conflict of interest, that's probably not a good idea,\" he says. It's reasonable to suggest that scientists with clear financial conflicts of interest should not be producing these studies. \"Is it going to happen in my lifetime?\" Berg says. \"Probably not!\"\u003c/p>\n\u003cp>Pfizer, one of the many drug companies that fund meta-analyses involving their own products, declined an interview request. But the company noted in an emailed statement that the drug company \"shares data from its clinical trials with outside members of the research community for them to conduct their own independent meta-analyses.\"\u003c/p>\n\u003cp>Fortunately, scientific journals are starting to do a better job of making sure researchers disclose their financial interests. It's up to readers now to take heed.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\u003cem>Email Richard Harris at \u003ca href=\"mailto:rharris@npr.org\">rharris@npr.org.\u003c/a>\u003c/em>\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2016 NPR. To see more, visit http://www.npr.org/.\u003cimg src=\"http://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=Reviews+Of+Medical+Studies+May+Be+Tainted+By+Funders%27+Influence&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/stateofhealth/248365/reviews-of-medical-studies-may-be-tainted-by-funders-influence",
"authors": [
"byline_stateofhealth_248365"
],
"categories": [
"stateofhealth_1"
],
"tags": [
"stateofhealth_2808",
"stateofhealth_2519",
"stateofhealth_2898",
"stateofhealth_461"
],
"featImg": "stateofhealth_248366",
"label": "source_stateofhealth_248365"
},
"futureofyou_258717": {
"type": "posts",
"id": "futureofyou_258717",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "258717",
"score": null,
"sort": [
1476282658000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1476282658,
"format": "audio",
"disqusTitle": "'Holy Grail' Device Would Make Kidney Dialysis Much Easier",
"title": "'Holy Grail' Device Would Make Kidney Dialysis Much Easier",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>There’s new hope of a better and longer life for many patients with failing kidneys.\u003c/p>\n\u003cp>When someone’s kidneys stop working effectively to cleanse wastes from the blood, patients must have it done mechanically, using a dialysis machine to remove the blood, clean it, and send it back into the body. That process is hard on the veins because it requires such a large opening to do it.\u003c/p>\n\u003caside class=\"pullquote alignright\">'It transitions over the period of a few months into something that’s indistinguishable from your own tissue.'\u003ccite>Jeff Lawson, Humacyte\u003c/cite>\u003c/aside>\n\u003cp>Currently, patients get a plastic tube, or shunt, surgically inserted in a vein to hold it open for dialysis. But those shunts can get infected over time, or rejected by a patient’s immune system, and in any case, they need to be replaced about every year.\u003c/p>\n\u003cp>Now researchers are testing a new kind of shunt—one made out of human tissue. It combines with a patient’s stem cells to make the device part of the patient’s body; theoretically, it could last a lifetime.\u003c/p>\n\u003cp>\u003cstrong>‘I Just Accept It’\u003c/strong>\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>The first patient in California to participate in the Phase III clinical trial for the new shunt is dialysis patient Raymond Ramirez. (A Phase III clinical trial is the stage of research required before submitting a treatment for FDA approval.)\u003c/p>\n\u003cp>The 67-year-old resident of Whittier, Calif., just east of Los Angeles, says he’s a bit of a train wreck. He’s in a wheelchair because of an above-the-knee amputation on his right leg, and he stops rolling around his TV room for a minute to list some of his maladies.\u003c/p>\n\u003cfigure id=\"attachment_260201\" class=\"wp-caption aligncenter\" style=\"max-width: 3264px\">\u003ca href=\"http://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2016/10/stemcells2.jpg\">\u003cimg class=\"size-full wp-image-260201\" src=\"http://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2016/10/stemcells2.jpg\" alt=\"The most challenging of Ray Ramirez's health problems right now is his kidney disease, because his veins are failing, making dialysis difficult.\" width=\"3264\" height=\"2448\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells2.jpg 3264w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells2-400x300.jpg 400w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells2-800x600.jpg 800w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells2-768x576.jpg 768w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells2-1180x885.jpg 1180w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells2-1920x1440.jpg 1920w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells2-960x720.jpg 960w\" sizes=\"(max-width: 3264px) 100vw, 3264px\">\u003c/a>\u003cfigcaption class=\"wp-caption-text\">The most challenging of Ray Ramirez's health problems right now is his kidney disease, because his veins are failing, making dialysis difficult. \u003ccite>(David Gorn/KQED)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>“Omigod, it’s never-ending,” he says with a laugh. “In Vietnam, when I got wounded, they took out my ribs. So, on my left side, my ribs they’re just gone.” He has to think a minute for more.\u003c/p>\n\u003cp>“I’ve had intestinal problems, I’ve had bladder cancer, a tumor in my bladder,” he says, “I have a blind eye in my right eye. Blood clot in my retina.\"\u003c/p>\n\u003cp>Ramirez says he’s not one of those guys who likes to dwell on his problems.\u003c/p>\n\u003cp>“I’ve always been a happy guy,” he says. “I don’t like it, no, hell no, it hurts. I’ve hurt like crazy since I was a youngster. I just accept it.”\u003c/p>\n\u003cp>Right now, the big challenge for Ramirez is dialysis, because his veins are failing. And that's how he ended up in the Veterans Affairs Hospital in Long Beach on a recent day for an appointment with vascular surgeon Ian Gordon. Since the Phase III study is randomized, Ramirez has a 50-50 of getting the experimental human tissue shunt or the traditional plastic one.\u003c/p>\n\u003cp>\u003cstrong>How Does the Shunt Work?\u003c/strong>\u003c/p>\n\u003cp>Imagine one of those long foam noodles kids play with in the pool—hollow and kind of like cellulose—only it’s the diameter of your little finger. That’s what the shunts look like. But it’s an intricate process to get them to that stage.\u003c/p>\n\u003caside class=\"pullquote alignright\">'One of the holy grails, if you can use that phrase, in vascular surgery is to come up with a prosthetic artificial graft that has the same properties as the patient’s own blood vessels.'\u003ccite>Dr. Ian Gordon,\u003cbr>\nVA Hospital, Long Beach\u003c/cite>\u003c/aside>\n\u003cp>First, you take human muscle cells from organ donors, and grow them into a tubular shape, says Jeff Lawson, chief medical officer at Humacyte, the North Carolina company that makes these things. As they grow, the cells secrete a sticky form of cellulose that holds them in the shape.\u003c/p>\n\u003cp>“So what’s left then is a scaffold of human tissue,” Lawson says. “We call it human extracellular matrix.”\u003c/p>\n\u003cp>Then you use a chemical wash to slough off the original donor cells, leaving the sticky cellulose structure behind—the foam noodle the diameter of your pinky finger.\u003c/p>\n\u003cp>The stem cell part of the equation, Lawson says, happens inside the patient.\u003c/p>\n\u003cp>“This scaffold, once implanted, uniquely becomes repopulated with their own stem cells,\" he says. \"That then turns back into something that looks like a vascular cell. And it now transitions over the period of a few months into something that’s indistinguishable from your own tissue.”\u003c/p>\n\u003cp>If it works, applications of this technology are endless, says Dr. Gordon, from vein replacement to heart surgery.\u003c/p>\n\u003cp>“One of the holy grails, if you can use that phrase, in vascular surgery is to come up with a prosthetic artificial graft,” he says, “that has the same properties as the patient’s own blood vessels.”\u003c/p>\n\u003cp>So far, this one seems to do that.\u003c/p>\n\u003cp>\u003cstrong>A Voter Mandate to Get Results\u003c/strong>\u003c/p>\n\u003cp>This is the kind of success the state stem cell agency was aiming for, when California voters created it in 2004 by approving Proposition 71. The California Institute for Regenerative Medicine (CIRM), based in Oakland, now has just four years of funding left, and is putting more money into mature clinical trials.\u003c/p>\n\u003cp>While many people think of stem cell therapy as an a treatment that injects the cells into a patient’s body, there are other types of treatments that rely on stem cells.\u003c/p>\n\u003cp>“At CIRM we’re interested in anything that involves or uses stem cells in the correction of a disease process,” says CIRM CEO Randall Mills. “About a quarter of our portfolio product itself isn’t a stem cell.”\u003c/p>\n\u003cp>There are a couple of important reasons for CIRM’s move to fund more clinical studies, says UC-San Diego’s director of stem cell research, Larry Goldstein\u003c/p>\n\u003cp>“Ten years ago I don’t think there were that many projects that were really ready for clinical trials,” Goldstein said. “The field itself has developed projects that are at clinical stage.”\u003c/p>\n\u003cp>And, Goldstein says, the voters who created the agency wanted it to produce results.\u003c/p>\n\u003cp>“The voter mandate was more than just basic research,\" he says, \"it was basic plus clinical.”\u003c/p>\n\u003cp>If the agency keeps pumping out these types of clinical results, Goldstein says, California voters may soon see another ballot measure to keep it going.\u003c/p>\n\u003cp>Humacyte officials say 118 patients around the world have received the new type of human tissue shunt – in both Phase II and Phase III of the clinical trial. About that many have participated in the trials and received the plastic shunt—neither the patient nor the doctor knows which shunt is to be installed until the moment in the surgery when a computer tells the doctor which one to use.\u003c/p>\n\u003cp>[ad floatright]\u003c/p>\n\u003cp>In the case of Ray Ramirez, he found out after he woke up from surgery, he got the plastic one.\u003c/p>\n\n",
"disqusIdentifier": "258717 http://ww2.kqed.org/futureofyou/?p=258717",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2016/10/12/new-stem-cell-technology-could-make-life-easier-for-kidney-disease-patients/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 1203,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 35
},
"modified": 1657038786,
"excerpt": "California's stem cell agency is funding a clinical trial of a technology that relies on a patient's own stem cells to work effectively.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "California's stem cell agency is funding a clinical trial of a technology that relies on a patient's own stem cells to work effectively.",
"title": "‘Holy Grail’ Device Would Make Kidney Dialysis Much Easier - KQED Future of You",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "'Holy Grail' Device Would Make Kidney Dialysis Much Easier",
"datePublished": "2016-10-12T07:30:58-07:00",
"dateModified": "2022-07-05T09:33:06-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "new-stem-cell-technology-could-make-life-easier-for-kidney-disease-patients",
"status": "publish",
"customPermalink": "2016/10/10/new-stem-cell-technology-could-make-life-easier-for-kidney-disease-patients/",
"templateType": "standard",
"audioUrl": "http://www.kqed.org/.stream/anon/radio/science/2016/10/StemCellKidneysGornWEB2161010.mp3",
"nprByline": "David Gorn",
"excludeFromSiteSearch": "Include",
"featuredImageType": "standard",
"source": "Hope/Hype",
"showOnAuthorArchivePages": "No",
"path": "/futureofyou/258717/new-stem-cell-technology-could-make-life-easier-for-kidney-disease-patients",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>There’s new hope of a better and longer life for many patients with failing kidneys.\u003c/p>\n\u003cp>When someone’s kidneys stop working effectively to cleanse wastes from the blood, patients must have it done mechanically, using a dialysis machine to remove the blood, clean it, and send it back into the body. That process is hard on the veins because it requires such a large opening to do it.\u003c/p>\n\u003caside class=\"pullquote alignright\">'It transitions over the period of a few months into something that’s indistinguishable from your own tissue.'\u003ccite>Jeff Lawson, Humacyte\u003c/cite>\u003c/aside>\n\u003cp>Currently, patients get a plastic tube, or shunt, surgically inserted in a vein to hold it open for dialysis. But those shunts can get infected over time, or rejected by a patient’s immune system, and in any case, they need to be replaced about every year.\u003c/p>\n\u003cp>Now researchers are testing a new kind of shunt—one made out of human tissue. It combines with a patient’s stem cells to make the device part of the patient’s body; theoretically, it could last a lifetime.\u003c/p>\n\u003cp>\u003cstrong>‘I Just Accept It’\u003c/strong>\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>The first patient in California to participate in the Phase III clinical trial for the new shunt is dialysis patient Raymond Ramirez. (A Phase III clinical trial is the stage of research required before submitting a treatment for FDA approval.)\u003c/p>\n\u003cp>The 67-year-old resident of Whittier, Calif., just east of Los Angeles, says he’s a bit of a train wreck. He’s in a wheelchair because of an above-the-knee amputation on his right leg, and he stops rolling around his TV room for a minute to list some of his maladies.\u003c/p>\n\u003cfigure id=\"attachment_260201\" class=\"wp-caption aligncenter\" style=\"max-width: 3264px\">\u003ca href=\"http://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2016/10/stemcells2.jpg\">\u003cimg class=\"size-full wp-image-260201\" src=\"http://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2016/10/stemcells2.jpg\" alt=\"The most challenging of Ray Ramirez's health problems right now is his kidney disease, because his veins are failing, making dialysis difficult.\" width=\"3264\" height=\"2448\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells2.jpg 3264w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells2-400x300.jpg 400w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells2-800x600.jpg 800w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells2-768x576.jpg 768w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells2-1180x885.jpg 1180w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells2-1920x1440.jpg 1920w, https://ww2.kqed.org/app/uploads/sites/13/2016/10/stemcells2-960x720.jpg 960w\" sizes=\"(max-width: 3264px) 100vw, 3264px\">\u003c/a>\u003cfigcaption class=\"wp-caption-text\">The most challenging of Ray Ramirez's health problems right now is his kidney disease, because his veins are failing, making dialysis difficult. \u003ccite>(David Gorn/KQED)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>“Omigod, it’s never-ending,” he says with a laugh. “In Vietnam, when I got wounded, they took out my ribs. So, on my left side, my ribs they’re just gone.” He has to think a minute for more.\u003c/p>\n\u003cp>“I’ve had intestinal problems, I’ve had bladder cancer, a tumor in my bladder,” he says, “I have a blind eye in my right eye. Blood clot in my retina.\"\u003c/p>\n\u003cp>Ramirez says he’s not one of those guys who likes to dwell on his problems.\u003c/p>\n\u003cp>“I’ve always been a happy guy,” he says. “I don’t like it, no, hell no, it hurts. I’ve hurt like crazy since I was a youngster. I just accept it.”\u003c/p>\n\u003cp>Right now, the big challenge for Ramirez is dialysis, because his veins are failing. And that's how he ended up in the Veterans Affairs Hospital in Long Beach on a recent day for an appointment with vascular surgeon Ian Gordon. Since the Phase III study is randomized, Ramirez has a 50-50 of getting the experimental human tissue shunt or the traditional plastic one.\u003c/p>\n\u003cp>\u003cstrong>How Does the Shunt Work?\u003c/strong>\u003c/p>\n\u003cp>Imagine one of those long foam noodles kids play with in the pool—hollow and kind of like cellulose—only it’s the diameter of your little finger. That’s what the shunts look like. But it’s an intricate process to get them to that stage.\u003c/p>\n\u003caside class=\"pullquote alignright\">'One of the holy grails, if you can use that phrase, in vascular surgery is to come up with a prosthetic artificial graft that has the same properties as the patient’s own blood vessels.'\u003ccite>Dr. Ian Gordon,\u003cbr>\nVA Hospital, Long Beach\u003c/cite>\u003c/aside>\n\u003cp>First, you take human muscle cells from organ donors, and grow them into a tubular shape, says Jeff Lawson, chief medical officer at Humacyte, the North Carolina company that makes these things. As they grow, the cells secrete a sticky form of cellulose that holds them in the shape.\u003c/p>\n\u003cp>“So what’s left then is a scaffold of human tissue,” Lawson says. “We call it human extracellular matrix.”\u003c/p>\n\u003cp>Then you use a chemical wash to slough off the original donor cells, leaving the sticky cellulose structure behind—the foam noodle the diameter of your pinky finger.\u003c/p>\n\u003cp>The stem cell part of the equation, Lawson says, happens inside the patient.\u003c/p>\n\u003cp>“This scaffold, once implanted, uniquely becomes repopulated with their own stem cells,\" he says. \"That then turns back into something that looks like a vascular cell. And it now transitions over the period of a few months into something that’s indistinguishable from your own tissue.”\u003c/p>\n\u003cp>If it works, applications of this technology are endless, says Dr. Gordon, from vein replacement to heart surgery.\u003c/p>\n\u003cp>“One of the holy grails, if you can use that phrase, in vascular surgery is to come up with a prosthetic artificial graft,” he says, “that has the same properties as the patient’s own blood vessels.”\u003c/p>\n\u003cp>So far, this one seems to do that.\u003c/p>\n\u003cp>\u003cstrong>A Voter Mandate to Get Results\u003c/strong>\u003c/p>\n\u003cp>This is the kind of success the state stem cell agency was aiming for, when California voters created it in 2004 by approving Proposition 71. The California Institute for Regenerative Medicine (CIRM), based in Oakland, now has just four years of funding left, and is putting more money into mature clinical trials.\u003c/p>\n\u003cp>While many people think of stem cell therapy as an a treatment that injects the cells into a patient’s body, there are other types of treatments that rely on stem cells.\u003c/p>\n\u003cp>“At CIRM we’re interested in anything that involves or uses stem cells in the correction of a disease process,” says CIRM CEO Randall Mills. “About a quarter of our portfolio product itself isn’t a stem cell.”\u003c/p>\n\u003cp>There are a couple of important reasons for CIRM’s move to fund more clinical studies, says UC-San Diego’s director of stem cell research, Larry Goldstein\u003c/p>\n\u003cp>“Ten years ago I don’t think there were that many projects that were really ready for clinical trials,” Goldstein said. “The field itself has developed projects that are at clinical stage.”\u003c/p>\n\u003cp>And, Goldstein says, the voters who created the agency wanted it to produce results.\u003c/p>\n\u003cp>“The voter mandate was more than just basic research,\" he says, \"it was basic plus clinical.”\u003c/p>\n\u003cp>If the agency keeps pumping out these types of clinical results, Goldstein says, California voters may soon see another ballot measure to keep it going.\u003c/p>\n\u003cp>Humacyte officials say 118 patients around the world have received the new type of human tissue shunt – in both Phase II and Phase III of the clinical trial. About that many have participated in the trials and received the plastic shunt—neither the patient nor the doctor knows which shunt is to be installed until the moment in the surgery when a computer tells the doctor which one to use.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "floatright"
},
"numeric": [
"floatright"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>In the case of Ray Ramirez, he found out after he woke up from surgery, he got the plastic one.\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/258717/new-stem-cell-technology-could-make-life-easier-for-kidney-disease-patients",
"authors": [
"byline_futureofyou_258717"
],
"categories": [
"futureofyou_452",
"futureofyou_1062",
"futureofyou_1"
],
"tags": [
"futureofyou_1081",
"futureofyou_1080",
"futureofyou_80",
"futureofyou_801"
],
"featImg": "futureofyou_260171",
"label": "source_futureofyou_258717"
},
"science_1048487": {
"type": "posts",
"id": "science_1048487",
"meta": {
"index": "posts_1716263798",
"site": "science",
"id": "1048487",
"score": null,
"sort": [
1475600416000
]
},
"parent": 0,
"labelTerm": {
"site": "futureofyou"
},
"blocks": [],
"publishDate": 1475600416,
"format": "standard",
"title": "Researchers Hunt for a Link Between Microbiome and Autism",
"headTitle": "Researchers Hunt for a Link Between Microbiome and Autism | KQED",
"content": "\u003cp>Maude Magali David and Christine Tataru work in a neat and clean office. Sitting on bright pink exercise balls, the research duo analyzes data, occasionally standing to write on a whiteboard.\u003c/p>\n\u003cp>The tidy setting belies the nature of the less-than-sanitary subject of their work.\u003c/p>\n\u003cp>David and Tataru are interested in poop. Specifically, \u003ca id=\"rssmi_more\" href=\"https://ww2.kqed.org/futureofyou/2016/10/04/microbiome_autism/\" target=\"_self\" rel=\"nofollow noopener\">Read More …\u003c/a>\u003c/p>\n\u003cp>Source:: \u003ca title=\"Researchers Hunt for the Link Between Microbiome and Autism\" href=\"https://ww2.kqed.org/futureofyou/2016/10/04/microbiome_autism/\" target=\"_self\" rel=\"nofollow noopener\">Future of You – tagged “kqedscience”\u003c/a>\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\u003cp>\u003c/p>\n",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 68,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 6
},
"modified": 1704929550,
"excerpt": "Some research has found a correlation between autism spectrum disorder and gastrointestinal symptoms, leading researchers to look for clues in the microbiome.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Some research has found a correlation between autism spectrum disorder and gastrointestinal symptoms, leading researchers to look for clues in the microbiome.",
"title": "Researchers Hunt for a Link Between Microbiome and Autism | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Researchers Hunt for a Link Between Microbiome and Autism",
"datePublished": "2016-10-04T10:00:16-07:00",
"dateModified": "2024-01-10T15:32:30-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "researchers-hunt-for-the-link-between-microbiome-and-autism",
"status": "publish",
"redirect": {
"type": "external",
"url": "https://ww2.kqed.org/futureofyou/2016/10/04/microbiome_autism/"
},
"rssmiSourceLink": "https://ww2.kqed.org/futureofyou/2016/10/04/microbiome_autism/",
"sticky": false,
"path": "/science/1048487/researchers-hunt-for-the-link-between-microbiome-and-autism",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>Maude Magali David and Christine Tataru work in a neat and clean office. Sitting on bright pink exercise balls, the research duo analyzes data, occasionally standing to write on a whiteboard.\u003c/p>\n\u003cp>The tidy setting belies the nature of the less-than-sanitary subject of their work.\u003c/p>\n\u003cp>David and Tataru are interested in poop. Specifically, \u003ca id=\"rssmi_more\" href=\"https://ww2.kqed.org/futureofyou/2016/10/04/microbiome_autism/\" target=\"_self\" rel=\"nofollow noopener\">Read More …\u003c/a>\u003c/p>\n\u003cp>Source:: \u003ca title=\"Researchers Hunt for the Link Between Microbiome and Autism\" href=\"https://ww2.kqed.org/futureofyou/2016/10/04/microbiome_autism/\" target=\"_self\" rel=\"nofollow noopener\">Future of You – tagged “kqedscience”\u003c/a>\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "https://ww2.kqed.org/futureofyou/2016/10/04/microbiome_autism/",
"authors": [
"11088"
],
"categories": [
"science_39"
],
"featImg": "science_1048488",
"label": "science"
},
"futureofyou_256179": {
"type": "posts",
"id": "futureofyou_256179",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "256179",
"score": null,
"sort": [
1475532327000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1475532327,
"format": "standard",
"disqusTitle": "USC Looks to Make East L.A. a Hub for Biotech",
"title": "USC Looks to Make East L.A. a Hub for Biotech",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>The University of Southern California is working to make East Los Angeles a hub for biotech research.\u003c/p>\n\u003cp>“(W)e’re hoping to develop our biotech industry in order to basically keep our students and stop the brain drain,\" says Martha Escutia, USC’s vice president of government relations.\u003c/p>\n\u003cp>The effort picked up steam in 2012, when the Los Angeles County Board of Supervisors commissioned a \u003ca href=\"http://file.lacounty.gov/SDSInter/bos/bc/217012_REPORTONCONSULTANTEVALUATIONFORAPOTENTIALCOUNTYWIDEBIOTECHNOLOGY.pdf\" target=\"_blank\">master plan\u003c/a> for developing a \u003ca href=\"http://www.latimes.com/opinion/op-ed/la-oe-0226-nikias-los-angeles-biotech-corridor-20150226-story.html\" target=\"_blank\">local biotech industry\u003c/a> that could make L.A. competitive with similar initiatives in San Francisco and San Diego.\u003c/p>\n\u003cp>The quest to develop a biotech center stems in part from the unavailability of local jobs in the field. In 2010, higher education institutions in Los Angeles County graduated more than 5,000 students with bioscience-related degrees. Many, however, have had to leave the region to find work. It took L.A. county nearly a decade, from 2001 to 2010, to add just 4,500 bioscience jobs, according to the master plan. Among the regional impediments for biotech firms is a lack of laboratory and office space close to research universities.\u003c/p>\n\u003cp>[soundcloud url=\"https://api.soundcloud.com/tracks/285881433\" params=\"color=ff5500&auto_play=false&hide_related=false&show_comments=true&show_user=true&show_reposts=false\" width=\"100%\" height=\"166\" iframe=\"true\" /]\u003c/p>\n\u003cp>A biotech hub would expand USC’s existing medical campus in East L.A. and is a high priority for USC president C.L. Max Nikias, who says dozens of biotech startups with roots in USC research have left the region to set up shop.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>\"We are at the dawn of this new technological revolution, which is biotech,\" Nikias says. \"I don't want us to be marginalized or fall behind in this new industrial revolution.\"\u003c/p>\n\u003caside class=\"pullquote alignright\">'Why wouldn’t the local community want to receive benefits in terms of jobs, research opportunities for their students; why wouldn’t people want that?'\u003c/aside>\n\u003cp>To that end, he says, USC has recruited dozens of professors in bioscience fields over the past several years. Research institutes on brain science, Alzheimer's treatment and diabetes and obesity are located at the university.\u003c/p>\n\u003cp>USC's proposal for a biotech hub is a partnership with the California Institute of Technology, whose scientists would potentially be able to locate their startups in the area; and the Los Angeles Unified School District. Nikias envisions establishing a training center in the area for high school and community college graduates who want biotech jobs.\u003c/p>\n\u003cp>Officials at USC say the hub could create 3,000 construction and 4,000 permanent jobs that would provide employment opportunities in the largely Latino, low-income neighborhood.\u003c/p>\n\u003caside class=\"pullquote alignright\">'It is going to change the complexion of the neighborhood, literally.'\u003c/aside>\n\u003cp>\"Now why wouldn’t we want to have that in L.A.?\" Escutia says. \"And why wouldn’t the local community want to receive benefits in terms of jobs, research opportunities for their students; why wouldn’t people want that?”\u003c/p>\n\u003cp>But county officials have told USC that to move forward with the proposal, the university must first address the concerns of the area's existing community.\u003c/p>\n\u003cp>“It is going to change the complexion of the neighborhood, literally,” says Abel Salas, a poet who lives and works out of a warehouse space a few blocks north of the USC expansion site. He and others worry it could displace residents and won’t live up to the promise of job training for young people.\u003c/p>\n\u003cp>“It doesn’t seem realistic to expect people who are among the poorest and least likely to graduate from high school … to suddenly be trained or retrained to have a biotech job, and what’s going to happen to them?”\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>The university held its first community information meeting on Saturday. If the plan moves forward, it also requires a land deal between USC and L.A. County, which is still being hammered out.\u003c/p>\n\n",
"disqusIdentifier": "256179 http://ww2.kqed.org/futureofyou/?p=256179",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2016/10/03/usc-looks-to-make-east-l-a-a-hub-for-biotech/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 674,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 17
},
"modified": 1475595222,
"excerpt": "'(W)e’re hoping to develop our biotech industry in order to basically keep our students and stop the brain drain,' says USC official.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "'(W)e’re hoping to develop our biotech industry in order to basically keep our students and stop the brain drain,' says USC official.",
"title": "USC Looks to Make East L.A. a Hub for Biotech | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "USC Looks to Make East L.A. a Hub for Biotech",
"datePublished": "2016-10-03T15:05:27-07:00",
"dateModified": "2016-10-04T08:33:42-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "usc-looks-to-make-east-l-a-a-hub-for-biotech",
"status": "publish",
"nprByline": "\u003cstrong>\u003ca href=\"https://ww2.kqed.org/news/author/scuevas/\">Steven Cuevas\u003c/a>\u003c/strong> and \u003cstrong>\u003ca href=\"https://ww2.kqed.org/news/author/katsnow/\">Kat Snow\u003c/a>\u003c/strong>",
"source": "Future of You",
"path": "/futureofyou/256179/usc-looks-to-make-east-l-a-a-hub-for-biotech",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>The University of Southern California is working to make East Los Angeles a hub for biotech research.\u003c/p>\n\u003cp>“(W)e’re hoping to develop our biotech industry in order to basically keep our students and stop the brain drain,\" says Martha Escutia, USC’s vice president of government relations.\u003c/p>\n\u003cp>The effort picked up steam in 2012, when the Los Angeles County Board of Supervisors commissioned a \u003ca href=\"http://file.lacounty.gov/SDSInter/bos/bc/217012_REPORTONCONSULTANTEVALUATIONFORAPOTENTIALCOUNTYWIDEBIOTECHNOLOGY.pdf\" target=\"_blank\">master plan\u003c/a> for developing a \u003ca href=\"http://www.latimes.com/opinion/op-ed/la-oe-0226-nikias-los-angeles-biotech-corridor-20150226-story.html\" target=\"_blank\">local biotech industry\u003c/a> that could make L.A. competitive with similar initiatives in San Francisco and San Diego.\u003c/p>\n\u003cp>The quest to develop a biotech center stems in part from the unavailability of local jobs in the field. In 2010, higher education institutions in Los Angeles County graduated more than 5,000 students with bioscience-related degrees. Many, however, have had to leave the region to find work. It took L.A. county nearly a decade, from 2001 to 2010, to add just 4,500 bioscience jobs, according to the master plan. Among the regional impediments for biotech firms is a lack of laboratory and office space close to research universities.\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003cdiv class='utils-parseShortcode-shortcodes-__shortcodes__shortcodeWrapper'>\n \u003ciframe width='100%' height='166'\n scrolling='no' frameborder='no'\n src='https://w.soundcloud.com/player/?url=https://api.soundcloud.com/tracks/285881433&visual=true&color=ff5500&auto_play=false&hide_related=false&show_comments=true&show_user=true&show_reposts=false'\n title='https://api.soundcloud.com/tracks/285881433'>\n \u003c/iframe>\n \u003c/div>\u003c/p>\u003cp>\u003c/p>\n\u003cp>A biotech hub would expand USC’s existing medical campus in East L.A. and is a high priority for USC president C.L. Max Nikias, who says dozens of biotech startups with roots in USC research have left the region to set up shop.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>\"We are at the dawn of this new technological revolution, which is biotech,\" Nikias says. \"I don't want us to be marginalized or fall behind in this new industrial revolution.\"\u003c/p>\n\u003caside class=\"pullquote alignright\">'Why wouldn’t the local community want to receive benefits in terms of jobs, research opportunities for their students; why wouldn’t people want that?'\u003c/aside>\n\u003cp>To that end, he says, USC has recruited dozens of professors in bioscience fields over the past several years. Research institutes on brain science, Alzheimer's treatment and diabetes and obesity are located at the university.\u003c/p>\n\u003cp>USC's proposal for a biotech hub is a partnership with the California Institute of Technology, whose scientists would potentially be able to locate their startups in the area; and the Los Angeles Unified School District. Nikias envisions establishing a training center in the area for high school and community college graduates who want biotech jobs.\u003c/p>\n\u003cp>Officials at USC say the hub could create 3,000 construction and 4,000 permanent jobs that would provide employment opportunities in the largely Latino, low-income neighborhood.\u003c/p>\n\u003caside class=\"pullquote alignright\">'It is going to change the complexion of the neighborhood, literally.'\u003c/aside>\n\u003cp>\"Now why wouldn’t we want to have that in L.A.?\" Escutia says. \"And why wouldn’t the local community want to receive benefits in terms of jobs, research opportunities for their students; why wouldn’t people want that?”\u003c/p>\n\u003cp>But county officials have told USC that to move forward with the proposal, the university must first address the concerns of the area's existing community.\u003c/p>\n\u003cp>“It is going to change the complexion of the neighborhood, literally,” says Abel Salas, a poet who lives and works out of a warehouse space a few blocks north of the USC expansion site. He and others worry it could displace residents and won’t live up to the promise of job training for young people.\u003c/p>\n\u003cp>“It doesn’t seem realistic to expect people who are among the poorest and least likely to graduate from high school … to suddenly be trained or retrained to have a biotech job, and what’s going to happen to them?”\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>The university held its first community information meeting on Saturday. If the plan moves forward, it also requires a land deal between USC and L.A. County, which is still being hammered out.\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/256179/usc-looks-to-make-east-l-a-a-hub-for-biotech",
"authors": [
"byline_futureofyou_256179"
],
"categories": [
"futureofyou_452",
"futureofyou_1",
"futureofyou_73"
],
"tags": [
"futureofyou_647",
"futureofyou_80"
],
"featImg": "futureofyou_256674",
"label": "source_futureofyou_256179"
},
"futureofyou_256129": {
"type": "posts",
"id": "futureofyou_256129",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "256129",
"score": null,
"sort": [
1475512481000
]
},
"parent": 0,
"labelTerm": {
"site": "futureofyou"
},
"blocks": [],
"publishDate": 1475512481,
"format": "standard",
"disqusTitle": "Little Evidence for Effectiveness of 'Brain Training' Programs: Study",
"title": "Little Evidence for Effectiveness of 'Brain Training' Programs: Study",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>Want to be smarter? More focused? Free of memory problems as you age?\u003c/p>\n\u003cp>If so, don't count on brain games to help you.\u003c/p>\n\u003cp>That's the conclusion of an exhaustive evaluation of the scientific literature on brain training games and programs. It was \u003ca href=\"http://psi.sagepub.com/content/current\">published\u003c/a> Monday in the journal \u003cem>Psychological Science in the Public Interest.\u003c/em>\u003c/p>\n\u003cp>\"It's disappointing that the evidence isn't stronger,\" says \u003ca href=\"http://www.psychology.illinois.edu/people/dsimons\">Daniel Simons\u003c/a>, an author of the article and a psychology professor at the University of Illinois at Urbana-Champaign.\u003c/p>\n\u003cp>\"It would be really nice if you could play some games and have it radically change your cognitive abilities,\" Simons says. \"But the studies don't show that on objectively measured real-world outcomes.\"\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>The evaluation, done by a team of seven scientists, is a response to a very public disagreement about the effectiveness of brain games, Simons says.\u003c/p>\n\u003cp>In October 2014, more than 70 scientists published an \u003ca href=\"http://longevity3.stanford.edu/blog/2014/10/15/the-consensus-on-the-brain-training-industry-from-the-scientific-community-2/\">open letter\u003c/a> objecting to marketing claims made by brain training companies. Pretty soon, another group, with more than 100 scientists, published a \u003ca href=\"http://www.cognitivetrainingdata.org/the-controversy-does-brain-training-work/response-letter/\">rebuttal\u003c/a> saying brain training has a solid scientific base.\u003c/p>\n\u003cp>\"So you had two consensus statements, each signed by many, many people, that came to essentially opposite conclusions,\" Simons says.\u003c/p>\n\u003cp>In an effort to clarify the issue, Simons and six other scientists reviewed more than 130 studies of brain games and other forms of cognitive training. The evaluation included studies of products from industry giant \u003ca href=\"https://www.lumosity.com/\">Lumosity\u003c/a>, which has been a prominent sponsor of NPR and other public radio programming.\u003c/p>\n\u003cp>\"We went through each paper and tried to look at the kind of evidence it provided,\" Simons says.\u003c/p>\n\u003cp>That meant asking questions like: How big was the study? Did it have an appropriate control group? Do the results support the marketing claims made by companies?\u003c/p>\n\u003cp>The scientists found that \"many of the studies did not really adhere to what we think of as the best practices,\" Simons says.\u003c/p>\n\u003cp>Some of the studies included only a few participants. Others lacked adequate control groups or failed to account for the placebo effect, which causes people to improve on a test simply because they are trying harder or are more confident.\u003c/p>\n\u003cp>There were some good studies, Simons says. And they showed that brain games do help people get better at a specific task.\u003c/p>\n\u003cp>\"You can practice, for example, scanning baggage at an airport and looking for a knife,\" he says. \"And you get really, really good at spotting that knife.\"\u003c/p>\n\u003cp>But there was less evidence that people got better at related tasks, like spotting other suspicious items, Simons says. And there was no strong evidence that practicing a narrow skill led to overall improvements in memory or thinking.\u003c/p>\n\u003cp>That's disappointing, Simons says, because \"what you want to do is be better able to function at work or at school.\"\u003c/p>\n\u003cp>The evaluation got a warm reception from at least some of the scientists who had signed the 2014 letter defending the science behind brain training.\u003c/p>\n\u003cp>\"The evaluation was very even-handed and raised many excellent points,\" says \u003ca href=\"http://www.hopkinsmedicine.org/profiles/results/directory/profile/9783561/george-rebok\">George Rebok\u003c/a>, a psychologist at Johns Hopkins University who has been involved in brain training research for the past 20 years. \"It really helped raise the bar in terms of the level of science that we must aspire to.\"\u003c/p>\n\u003cp>Rebok, who says he has no ties to brain training companies, remains optimistic that the right program of brain exercises can improve mental functioning and delay the effects of aging.\u003c/p>\n\u003cp>One reason brain games haven't shown a clear benefit so far, he says, may be that they don't work the brain hard enough or over a long enough time period.\u003c/p>\n\u003cp>\"It takes mental effort and practice to be able to see results,\" Rebok says. \"If we can implement that long range, I think that there will be a big dividend eventually.\"\u003c/p>\n\u003cp>In the meantime, the brain training industry is facing scrutiny from the Federal Trade Commission.\u003c/p>\n\u003cp>In January, the company behind Lumosity agreed to \u003ca href=\"https://www.ftc.gov/news-events/press-releases/2016/01/lumosity-pay-2-million-settle-ftc-deceptive-advertising-charges\">pay a $2 million fine\u003c/a> to settle \u003ca href=\"https://www.ftc.gov/system/files/documents/cases/160105lumoslabsstip.pdf\">FTC charges\u003c/a> that it made unfounded claims about its brain training program.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>And in May, a smaller brain training company called LearningRx agreed to pay a $200,000 fine to settle \u003ca href=\"https://www.ftc.gov/news-events/press-releases/2016/05/marketers-one-one-brain-training-programs-settle-ftc-charges\">similar charges\u003c/a>. Even so, the \u003ca href=\"http://www.learningrx.com/\">Learning Rx website\u003c/a> still promises \"A better brain at any age.\"\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2016 NPR. To see more, visit http://www.npr.org/.\u003cimg src=\"http://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=Brain+Game+Claims+Fail+A+Big+Scientific+Test&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n",
"disqusIdentifier": "256129 http://ww2.kqed.org/futureofyou/?p=256129",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2016/10/03/little-evidence-for-effectiveness-of-brain-training-programs-study/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 728,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 27
},
"modified": 1475595387,
"excerpt": "When a team of researchers evaluated the scientific literature on brain games, they found little evidence that the products improve memory or thinking in real-world tasks.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "When a team of researchers evaluated the scientific literature on brain games, they found little evidence that the products improve memory or thinking in real-world tasks.",
"title": "Little Evidence for Effectiveness of 'Brain Training' Programs: Study | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Little Evidence for Effectiveness of 'Brain Training' Programs: Study",
"datePublished": "2016-10-03T09:34:41-07:00",
"dateModified": "2016-10-04T08:36:27-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "little-evidence-for-effectiveness-of-brain-training-programs-study",
"status": "publish",
"nprApiLink": "http://api.npr.org/query?id=496120962&apiKey=MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004",
"nprByline": "Jon Hamilton\u003cbr />NPR Shots",
"nprStoryDate": "Mon, 03 Oct 2016 00:02:00 -0400",
"nprLastModifiedDate": "Mon, 03 Oct 2016 08:34:37 -0400",
"nprHtmlLink": "http://www.npr.org/sections/health-shots/2016/10/03/496120962/brain-game-claims-fail-a-big-scientific-test?ft=nprml&f=496120962",
"nprAudio": "https://ondemand.npr.org/anon.npr-mp3/npr/me/2016/10/20161003_me_brain_game_claims_fail_a_big_scientific_test.mp3?orgId=1&topicId=1128&d=231&p=3&story=496120962&t=progseg&e=496362216&seg=7&ft=nprml&f=496120962",
"nprImageAgency": " Katherine Streeter for NPR",
"nprAudioM3u": "http://api.npr.org/m3u/1496362272-ed5bc9.m3u?orgId=1&topicId=1128&d=231&p=3&story=496120962&t=progseg&e=496362216&seg=7&ft=nprml&f=496120962",
"nprStoryId": "496120962",
"nprRetrievedStory": "1",
"nprPubDate": "Mon, 03 Oct 2016 08:34:00 -0400",
"path": "/futureofyou/256129/little-evidence-for-effectiveness-of-brain-training-programs-study",
"audioUrl": "https://ondemand.npr.org/anon.npr-mp3/npr/me/2016/10/20161003_me_brain_game_claims_fail_a_big_scientific_test.mp3?orgId=1&topicId=1128&d=231&p=3&story=496120962&t=progseg&e=496362216&seg=7&ft=nprml&f=496120962",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>Want to be smarter? More focused? Free of memory problems as you age?\u003c/p>\n\u003cp>If so, don't count on brain games to help you.\u003c/p>\n\u003cp>That's the conclusion of an exhaustive evaluation of the scientific literature on brain training games and programs. It was \u003ca href=\"http://psi.sagepub.com/content/current\">published\u003c/a> Monday in the journal \u003cem>Psychological Science in the Public Interest.\u003c/em>\u003c/p>\n\u003cp>\"It's disappointing that the evidence isn't stronger,\" says \u003ca href=\"http://www.psychology.illinois.edu/people/dsimons\">Daniel Simons\u003c/a>, an author of the article and a psychology professor at the University of Illinois at Urbana-Champaign.\u003c/p>\n\u003cp>\"It would be really nice if you could play some games and have it radically change your cognitive abilities,\" Simons says. \"But the studies don't show that on objectively measured real-world outcomes.\"\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>The evaluation, done by a team of seven scientists, is a response to a very public disagreement about the effectiveness of brain games, Simons says.\u003c/p>\n\u003cp>In October 2014, more than 70 scientists published an \u003ca href=\"http://longevity3.stanford.edu/blog/2014/10/15/the-consensus-on-the-brain-training-industry-from-the-scientific-community-2/\">open letter\u003c/a> objecting to marketing claims made by brain training companies. Pretty soon, another group, with more than 100 scientists, published a \u003ca href=\"http://www.cognitivetrainingdata.org/the-controversy-does-brain-training-work/response-letter/\">rebuttal\u003c/a> saying brain training has a solid scientific base.\u003c/p>\n\u003cp>\"So you had two consensus statements, each signed by many, many people, that came to essentially opposite conclusions,\" Simons says.\u003c/p>\n\u003cp>In an effort to clarify the issue, Simons and six other scientists reviewed more than 130 studies of brain games and other forms of cognitive training. The evaluation included studies of products from industry giant \u003ca href=\"https://www.lumosity.com/\">Lumosity\u003c/a>, which has been a prominent sponsor of NPR and other public radio programming.\u003c/p>\n\u003cp>\"We went through each paper and tried to look at the kind of evidence it provided,\" Simons says.\u003c/p>\n\u003cp>That meant asking questions like: How big was the study? Did it have an appropriate control group? Do the results support the marketing claims made by companies?\u003c/p>\n\u003cp>The scientists found that \"many of the studies did not really adhere to what we think of as the best practices,\" Simons says.\u003c/p>\n\u003cp>Some of the studies included only a few participants. Others lacked adequate control groups or failed to account for the placebo effect, which causes people to improve on a test simply because they are trying harder or are more confident.\u003c/p>\n\u003cp>There were some good studies, Simons says. And they showed that brain games do help people get better at a specific task.\u003c/p>\n\u003cp>\"You can practice, for example, scanning baggage at an airport and looking for a knife,\" he says. \"And you get really, really good at spotting that knife.\"\u003c/p>\n\u003cp>But there was less evidence that people got better at related tasks, like spotting other suspicious items, Simons says. And there was no strong evidence that practicing a narrow skill led to overall improvements in memory or thinking.\u003c/p>\n\u003cp>That's disappointing, Simons says, because \"what you want to do is be better able to function at work or at school.\"\u003c/p>\n\u003cp>The evaluation got a warm reception from at least some of the scientists who had signed the 2014 letter defending the science behind brain training.\u003c/p>\n\u003cp>\"The evaluation was very even-handed and raised many excellent points,\" says \u003ca href=\"http://www.hopkinsmedicine.org/profiles/results/directory/profile/9783561/george-rebok\">George Rebok\u003c/a>, a psychologist at Johns Hopkins University who has been involved in brain training research for the past 20 years. \"It really helped raise the bar in terms of the level of science that we must aspire to.\"\u003c/p>\n\u003cp>Rebok, who says he has no ties to brain training companies, remains optimistic that the right program of brain exercises can improve mental functioning and delay the effects of aging.\u003c/p>\n\u003cp>One reason brain games haven't shown a clear benefit so far, he says, may be that they don't work the brain hard enough or over a long enough time period.\u003c/p>\n\u003cp>\"It takes mental effort and practice to be able to see results,\" Rebok says. \"If we can implement that long range, I think that there will be a big dividend eventually.\"\u003c/p>\n\u003cp>In the meantime, the brain training industry is facing scrutiny from the Federal Trade Commission.\u003c/p>\n\u003cp>In January, the company behind Lumosity agreed to \u003ca href=\"https://www.ftc.gov/news-events/press-releases/2016/01/lumosity-pay-2-million-settle-ftc-deceptive-advertising-charges\">pay a $2 million fine\u003c/a> to settle \u003ca href=\"https://www.ftc.gov/system/files/documents/cases/160105lumoslabsstip.pdf\">FTC charges\u003c/a> that it made unfounded claims about its brain training program.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>And in May, a smaller brain training company called LearningRx agreed to pay a $200,000 fine to settle \u003ca href=\"https://www.ftc.gov/news-events/press-releases/2016/05/marketers-one-one-brain-training-programs-settle-ftc-charges\">similar charges\u003c/a>. Even so, the \u003ca href=\"http://www.learningrx.com/\">Learning Rx website\u003c/a> still promises \"A better brain at any age.\"\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2016 NPR. To see more, visit http://www.npr.org/.\u003cimg src=\"http://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=Brain+Game+Claims+Fail+A+Big+Scientific+Test&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/256129/little-evidence-for-effectiveness-of-brain-training-programs-study",
"authors": [
"byline_futureofyou_256129"
],
"categories": [
"futureofyou_452",
"futureofyou_1062",
"futureofyou_1",
"futureofyou_73",
"futureofyou_1061"
],
"tags": [
"futureofyou_692",
"futureofyou_80",
"futureofyou_691",
"futureofyou_1000"
],
"featImg": "futureofyou_256130",
"label": "futureofyou"
},
"futureofyou_254629": {
"type": "posts",
"id": "futureofyou_254629",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "254629",
"score": null,
"sort": [
1475256233000
]
},
"parent": 0,
"labelTerm": {
"site": "futureofyou"
},
"blocks": [],
"publishDate": 1475256233,
"format": "standard",
"disqusTitle": "First Automated Insulin System Approved For Type 1 Diabetes",
"title": "First Automated Insulin System Approved For Type 1 Diabetes",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>The Food and Drug Administration's approval of a new insulin delivery system for people with Type 1 diabetes is a big deal.\u003c/p>\n\u003cp>With Type 1 diabetes, the pancreas makes little or no insulin so people have to replace it with either multiple daily injections or a pump. In either case, that process involves constant error-prone adjustments, particularly around food and exercise. Over the long term, high blood sugar levels can lead to organ damage, but over-correcting by giving more insulin can cause dangerous low blood sugars that can lead to unconsciousness.\u003c/p>\n\u003cp>The device, Medtronic's MiniMed 670G hybrid closed loop system, is made up of an insulin pump and continuous glucose monitor (CGM), both of which are already on the market separately. The new part involves the communication between the two devices.\u003c/p>\n\u003cp>Medtronic's \u003ca href=\"http://www.npr.org/sections/health-shots/2015/01/30/382172052/diabetes-technology-inches-closer-to-an-artificial-pancreas\">previous system \u003c/a>already had a feature that would shut down the insulin pump if the wearer's blood sugar dropped too low. But the 670G predicts when a person's blood sugar is dropping and prevents the low in the first place, and also corrects high blood sugars.\u003c/p>\n\u003cp>This is the first such machine in the world with that level of automation, and thus it is informally being called the first \"artificial pancreas\" system.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>However, it's called a hybrid rather than a fully closed-loop system because users will still need to signal that they're about to eat and estimate the carbohydrate count of the food so the device can calculate the additional amount of insulin needed. That means there's still the possibility of mistakes. But now if that count is off, the 670G will correct the error automatically.\u003c/p>\n\u003cp>For people with Type 1 diabetes, the new capabilities mean they can both sleep through the night without worrying about their blood sugars dropping too low and can go through their day without having to think about their diabetes all the time, according to Aaron Kowalski, chief mission officer for the JDRF, the organization that funds much of the \"artificial pancreas\" research.\u003c/p>\n\u003cp>\"You get almost normalized overnight blood glucose. For people with Type 1 diabetes, that's massively important,\" he said, adding that the overall 24/7 burden reduction means better quality of life. \"The diabetes isn't gone, but [wearers] can think about it less ...This is a historic milestone.\"\u003c/p>\n\u003cp>And more systems like this are coming.\u003c/p>\n\u003cp>Medtronic, via the Minimed division that it acquired in 2001, was the first to market because it's still the only company that manufactures both the insulin pump and CGM technology. But at least five other partnerships between other manufacturers are now developing closed-loop systems, some using already-available pumps and CGMs, others creating new devices. The systems will likely differ from one another in form, user interface, and in the algorithmic approaches embedded in the communication software, \"so people with diabetes will have more choices,\" Kowalski says, noting that JDRF is \"celebrating Medtronic because it's the first commercial system, but we're supporting the entire field.\"\u003c/p>\n\u003cp>Of course, the field still faces challenges. One of the major technological problems is that insulin deposited just under the skin takes too long to begin working; that's why people still need to signal ahead that they're about to eat. The JDRF is currently funding several initiatives working on making faster-acting insulins.\u003c/p>\n\u003cp>\"The faster the insulin works, the more closed the loop will be,\" Kowalski notes. \"It's not easy, but there's a lot of work going on.\"\u003c/p>\n\u003cp>Wearability is another issue. Some people simply don't want to be strapped to devices, even if it means better diabetes control. So, the JDRF has recently announced new funding for miniaturization of the devices.\u003c/p>\n\u003cp>And of course, there's the problem of access. While insurance coverage for insulin pumps is widely established, this is not the case for the CGM component. Medicare doesn't cover CGM technology, meaning that people now must give up those devices or pay out of pocket when they reach age 65. The JDRF is one of several organizations lobbying to change that, as well as to make sure that all payers recognize both the health and economic advantages of new diabetes technologies.\u003c/p>\n\u003cp>\"This is a priority for us,\" Kowalski says. \"We need to make sure people have access. Not just rich people, but anybody who will benefit.\"\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>For now, the 670G, which the FDA gave the nod on Wednesday, is only \u003ca href=\"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/UCM522974.htm\">approved\u003c/a> for people aged 14 years and older. But Medtronic is studying it in children ages 7-13 with the aim of making it available for them, too.\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2016 NPR. To see more, visit http://www.npr.org/.\u003cimg src=\"http://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=FDA+Approves+The+First+Automated+Insulin+System+For+Type+1+Diabetes&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n",
"disqusIdentifier": "254629 http://ww2.kqed.org/futureofyou/?p=254629",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2016/09/30/first-automated-insulin-system-approved-for-type-1-diabetes/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 786,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 18
},
"modified": 1475595446,
"excerpt": "The new system joins a continuous glucose monitor with an insulin pump, which work together to keep blood sugar from going too high or too low. That will make it safer to sleep through the night.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "The new system joins a continuous glucose monitor with an insulin pump, which work together to keep blood sugar from going too high or too low. That will make it safer to sleep through the night.",
"title": "First Automated Insulin System Approved For Type 1 Diabetes | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "First Automated Insulin System Approved For Type 1 Diabetes",
"datePublished": "2016-09-30T10:23:53-07:00",
"dateModified": "2016-10-04T08:37:26-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "first-automated-insulin-system-approved-for-type-1-diabetes",
"status": "publish",
"nprApiLink": "http://api.npr.org/query?id=495914413&apiKey=MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004",
"nprByline": "Miriam E. Tucker\u003cbr />NPR Shots",
"nprStoryDate": "Fri, 30 Sep 2016 05:00:00 -0400",
"nprLastModifiedDate": "Fri, 30 Sep 2016 09:21:23 -0400",
"nprHtmlLink": "http://www.npr.org/sections/health-shots/2016/09/30/495914413/fda-approves-the-first-automated-insulin-system-for-type-1-diabetes?ft=nprml&f=495914413",
"nprImageAgency": "Medtronic",
"nprStoryId": "495914413",
"nprRetrievedStory": "1",
"nprPubDate": "Fri, 30 Sep 2016 09:21:00 -0400",
"path": "/futureofyou/254629/first-automated-insulin-system-approved-for-type-1-diabetes",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>The Food and Drug Administration's approval of a new insulin delivery system for people with Type 1 diabetes is a big deal.\u003c/p>\n\u003cp>With Type 1 diabetes, the pancreas makes little or no insulin so people have to replace it with either multiple daily injections or a pump. In either case, that process involves constant error-prone adjustments, particularly around food and exercise. Over the long term, high blood sugar levels can lead to organ damage, but over-correcting by giving more insulin can cause dangerous low blood sugars that can lead to unconsciousness.\u003c/p>\n\u003cp>The device, Medtronic's MiniMed 670G hybrid closed loop system, is made up of an insulin pump and continuous glucose monitor (CGM), both of which are already on the market separately. The new part involves the communication between the two devices.\u003c/p>\n\u003cp>Medtronic's \u003ca href=\"http://www.npr.org/sections/health-shots/2015/01/30/382172052/diabetes-technology-inches-closer-to-an-artificial-pancreas\">previous system \u003c/a>already had a feature that would shut down the insulin pump if the wearer's blood sugar dropped too low. But the 670G predicts when a person's blood sugar is dropping and prevents the low in the first place, and also corrects high blood sugars.\u003c/p>\n\u003cp>This is the first such machine in the world with that level of automation, and thus it is informally being called the first \"artificial pancreas\" system.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>However, it's called a hybrid rather than a fully closed-loop system because users will still need to signal that they're about to eat and estimate the carbohydrate count of the food so the device can calculate the additional amount of insulin needed. That means there's still the possibility of mistakes. But now if that count is off, the 670G will correct the error automatically.\u003c/p>\n\u003cp>For people with Type 1 diabetes, the new capabilities mean they can both sleep through the night without worrying about their blood sugars dropping too low and can go through their day without having to think about their diabetes all the time, according to Aaron Kowalski, chief mission officer for the JDRF, the organization that funds much of the \"artificial pancreas\" research.\u003c/p>\n\u003cp>\"You get almost normalized overnight blood glucose. For people with Type 1 diabetes, that's massively important,\" he said, adding that the overall 24/7 burden reduction means better quality of life. \"The diabetes isn't gone, but [wearers] can think about it less ...This is a historic milestone.\"\u003c/p>\n\u003cp>And more systems like this are coming.\u003c/p>\n\u003cp>Medtronic, via the Minimed division that it acquired in 2001, was the first to market because it's still the only company that manufactures both the insulin pump and CGM technology. But at least five other partnerships between other manufacturers are now developing closed-loop systems, some using already-available pumps and CGMs, others creating new devices. The systems will likely differ from one another in form, user interface, and in the algorithmic approaches embedded in the communication software, \"so people with diabetes will have more choices,\" Kowalski says, noting that JDRF is \"celebrating Medtronic because it's the first commercial system, but we're supporting the entire field.\"\u003c/p>\n\u003cp>Of course, the field still faces challenges. One of the major technological problems is that insulin deposited just under the skin takes too long to begin working; that's why people still need to signal ahead that they're about to eat. The JDRF is currently funding several initiatives working on making faster-acting insulins.\u003c/p>\n\u003cp>\"The faster the insulin works, the more closed the loop will be,\" Kowalski notes. \"It's not easy, but there's a lot of work going on.\"\u003c/p>\n\u003cp>Wearability is another issue. Some people simply don't want to be strapped to devices, even if it means better diabetes control. So, the JDRF has recently announced new funding for miniaturization of the devices.\u003c/p>\n\u003cp>And of course, there's the problem of access. While insurance coverage for insulin pumps is widely established, this is not the case for the CGM component. Medicare doesn't cover CGM technology, meaning that people now must give up those devices or pay out of pocket when they reach age 65. The JDRF is one of several organizations lobbying to change that, as well as to make sure that all payers recognize both the health and economic advantages of new diabetes technologies.\u003c/p>\n\u003cp>\"This is a priority for us,\" Kowalski says. \"We need to make sure people have access. Not just rich people, but anybody who will benefit.\"\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>For now, the 670G, which the FDA gave the nod on Wednesday, is only \u003ca href=\"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/UCM522974.htm\">approved\u003c/a> for people aged 14 years and older. But Medtronic is studying it in children ages 7-13 with the aim of making it available for them, too.\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2016 NPR. To see more, visit http://www.npr.org/.\u003cimg src=\"http://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=FDA+Approves+The+First+Automated+Insulin+System+For+Type+1+Diabetes&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/254629/first-automated-insulin-system-approved-for-type-1-diabetes",
"authors": [
"byline_futureofyou_254629"
],
"categories": [
"futureofyou_452",
"futureofyou_1062",
"futureofyou_1",
"futureofyou_73"
],
"tags": [
"futureofyou_309",
"futureofyou_1071",
"futureofyou_80"
],
"featImg": "futureofyou_254630",
"label": "futureofyou"
},
"futureofyou_242687": {
"type": "posts",
"id": "futureofyou_242687",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "242687",
"score": null,
"sort": [
1474644619000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1474644619,
"format": "standard",
"disqusTitle": "Paralyzed Patients in Stem Cell Study Regain Some Movement, Company Says",
"title": "Paralyzed Patients in Stem Cell Study Regain Some Movement, Company Says",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>\u003cstrong>Update Sept. 23:\u003c/strong> You can read our original post about the remarkable case of Kris Boesen after this update. But some \u003ca href=\"http://asteriasbiotherapeutics.com/wp-content/uploads/2016/09/Wirth-ISCoS-14SEP2016-talk-FINAL.pdf\" target=\"_blank\">data\u003c/a> on the trial that Boesen is participating in was released last week by Asterias Biotherapeutics, the company that developed the stem cells injected into Boesen and other patients with cervical spinal cord injuries.\u003c/p>\n\u003cp>Asterias \u003ca href=\"http://asteriasbiotherapeutics.com/asterias-biotherapeutics-announces-positive-efficacy-data-in-patients-with-complete-cervical-spinal-cord-injuries-treated-with-ast-opc1/\" target=\"_blank\">says\u003c/a> the trial results to date are encouraging. The sample is still extremely small and nothing is really proven at this point, but the data are certainly positive for other patients besides Boesen.\u003c/p>\n\u003cp>There are two groups of patients: three who received a dose of 2 million stem cells and five who received a larger dose of 10 million.\u003c/p>\n\u003cp>To measure improvement, researchers use the \u003ca href=\"http://www.nature.com/sc/journal/v45/n3/fig_tab/3102008t1.html\" target=\"_blank\">Upper Extremity Motor Scale\u003c/a>, or UEMS. The scale runs from zero, which indicates total paralysis, to five, which means a patient has active movement.\u003c/p>\n\u003cp>The results:\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>First cohort, 2 million stem cells injected: On the six-point UEMS scale, one of three patients improved one motor level on one side of the body, while the other two patients improved one level on both sides.\u003c/p>\n\u003cp>Second cohort, 10 million stem cells: One of four patients improved two levels on both sides. Two other patients showed two levels of improvement on one side. And the fourth patient improved one level on one side. (One of the five patients in this group has not yet reached the 90-day point at which results are measured, so no report on that patient yet.)\u003c/p>\n\u003cp>The other significant finding, Asterias said, is that no one showed any measurable negative effects of the therapy -- researchers started with the smaller dose to make sure patients weren't harmed by the experimental trial, then went to the higher 10-million-cell dose.\u003c/p>\n\u003cp>Researchers have said the optimal dosage target is 20 million cells, but that point has not been reached yet in the trial.\u003c/p>\n\u003cp>The next milestone for getting a clearer picture of the results will be at the six-month mark for the second cohort, in January 2017.\u003c/p>\n\u003cp>All patients in the trial, being conducted at six sites around the country, have either \"lost all movement below their injury site and experience severe paralysis of the upper and lower limbs,\" or \"lost all motor function but may retain some minimal sensory function below their injury site,\" according to Asterias.\u003c/p>\n\u003cp>You can see more info on the study, which is called \u003ca href=\"http://www.scistar-study.com/\" target=\"_blank\">SCIStar\u003c/a>, at\u003ca href=\"https://clinicaltrials.gov/ct2/show/study/NCT02302157?term=NCT02302157&rank=1\" target=\"_blank\"> ClinicalTrials.gov.\u003c/a>\u003c/p>\n\u003cp>\u003cstrong>Original post\u003c/strong>\u003c/p>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">Rod Boesen says his son, Kris, was so bad off he couldn't move a muscle from the neck down, and needed a ventilator to keep him drawing breath.\u003c/span>\u003c/p>\n\u003cp class=\"p2\">In March, Kris, then 20, was driving on a wet road when he crashed his car into a tree and a telephone poll, crushing three of his vertebrae. The accident left him with almost no feeling south of his neck, and doctors foresaw that he would lead the life of a paraplegic.\u003c/p>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">\"They thought he was going to be totally, from the head on down, paralyzed,\" says Rod\u003c/span>\u003c/p>\n\u003cp class=\"p2\">But that has not been the case; Kris has regained the use of his hands and arms.\u003c/p>\n\u003caside class=\"pullquote alignright\">'They thought he was going to be totally, from the head on down, paralyzed.'\u003c/aside>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">In April, as part of a research trial, a surgical team from USC's Keck Medical Center injected millions of embryonic stem cells into Boesen's spine. Two weeks later, Boesen began to show some improvement. After six weeks, he was discharged and returned home to Bakersfield, California to continue his rehabilitation.\u003cbr>\n\u003c/span>\u003c/p>\n\u003cp class=\"p2\">Now, five months after the stem cell injection, Boesen is remarkably self-sufficient, considering the initial prognosis. From feeding himself to talking on the phone to being able to twist the cap off a soda bottle, life is a degree more normal than anyone thought possible.\u003c/p>\n\u003cp class=\"p2\">\"We used to lift weights, that's something we used to do together,\" his dad says. \"Now we're doing that again. Only it's a lot less weight.\"\u003c/p>\n\u003cp class=\"p2\">The goal of the experimental stem cell treatment is to regrow the protective myelin sheath around each nerve, giving them a chance to heal. Whether this has occurred in Boesen yet is unknown--doctors would need to administer a spinal tap to find out, and that is dangerous for patients in this condition.\u003c/p>\n\u003cp class=\"p2\">So researchers don't know yet whether Boesen's recovery is due to the injection of stem cells. All they can say is that his progress has been remarkable, if not unprecedented for this type of spine injury.\u003c/p>\n\u003cfigure id=\"attachment_243385\" class=\"wp-caption alignright\" style=\"max-width: 640px\">\u003ca href=\"http://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2016/09/Neurosurgery-Stem-Cell-spine-patient-Kris-Boesen_04.jpg\">\u003cimg class=\"wp-image-243385 size-large\" src=\"http://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2016/09/Neurosurgery-Stem-Cell-spine-patient-Kris-Boesen_04-1180x775.jpg\" alt=\"Lifting weights is part of Kris Boesen’s regular program of physical therapy. \" width=\"640\" height=\"420\">\u003c/a>\u003cfigcaption class=\"wp-caption-text\">Lifting weights is part of Kris Boesen’s regular program of physical therapy. \u003ccite>(Greg Iger/Keck Medicine of USC))\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">The clinical mid-stage trial is very small; if it's successful, FDA approval would still be many years away. But the results in Boesen and four other patients have thus far been very encouraging.\u003c/span>\u003c/p>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">With most spinal injuries, doctors and physical therapists usually look to see what's still intact, then try to make incremental improvements. As a matter of course, people don't recover much of the movement or function they've lost.\u003c/span>\u003c/p>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">Charles Liu, a neurosurgeon and director of the USC Neurorestoration Center that's leading the research, \u003c/span>\u003cspan class=\"s1\">says the goal is not to attempt to repair the entire vertebral column, but to target the \u003ca href=\"http://www.spine-health.com/video/cervical-spine-anatomy-video\" target=\"_blank\">cervical spine\u003c/a> and restore neurological function.\u003c/span>\u003c/p>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">The other four patients in the cohort have shown some progress, but not as much as Boesen, according to Liu. Each person received one shot of stem cells, and the other patients got lower doses than the 10 million stem cells injected into Boesen's cervical spinal cord. \u003c/span>\u003c/p>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">Boesen's recovery may have been helped by his young age, and by the fact that he received the stem-cell injection so soon – just five weeks after his car crash, Liu said. \u003c/span>\u003c/p>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">\"This is unique, yes,\" Liu said of the clinical trial. \"No one has taken this approach before.\" \u003c/span>\u003c/p>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">Or achieved these kind of results. Liu cautioned that not all spinal injury victims will benefit from this type of treatment, but he said it does offer hope that there may be a remedy for some spinal injuries.\u003c/span>\u003c/p>\n\u003cp>[ad floatright]\u003c/p>\n\u003cp class=\"p2\">Data from patients in the study is set to be released on Wednesday.\u003c/p>\n\n",
"disqusIdentifier": "242687 http://ww2.kqed.org/futureofyou/?p=242687",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2016/09/23/stem-cells-may-have-restored-use-of-hands-and-arms-in-paralyzed-man/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 1079,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 15
},
"modified": 1490133459,
"excerpt": "Researchers at Keck Medical Center in L.A. may have achieved a breakthrough by injecting millions of embryonic stem cells into the spines of paralyzed patients.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Researchers at Keck Medical Center in L.A. may have achieved a breakthrough by injecting millions of embryonic stem cells into the spines of paralyzed patients.",
"title": "Paralyzed Patients in Stem Cell Study Regain Some Movement, Company Says | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Paralyzed Patients in Stem Cell Study Regain Some Movement, Company Says",
"datePublished": "2016-09-23T08:30:19-07:00",
"dateModified": "2017-03-21T14:57:39-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "stem-cells-may-have-restored-use-of-hands-and-arms-in-paralyzed-man",
"status": "publish",
"customPermalink": "2016/09/12/stem-cells-may-have-restored-use-of-hands-and-arms-in-paralyzed-man/",
"source": "Future of You",
"path": "/futureofyou/242687/stem-cells-may-have-restored-use-of-hands-and-arms-in-paralyzed-man",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>\u003cstrong>Update Sept. 23:\u003c/strong> You can read our original post about the remarkable case of Kris Boesen after this update. But some \u003ca href=\"http://asteriasbiotherapeutics.com/wp-content/uploads/2016/09/Wirth-ISCoS-14SEP2016-talk-FINAL.pdf\" target=\"_blank\">data\u003c/a> on the trial that Boesen is participating in was released last week by Asterias Biotherapeutics, the company that developed the stem cells injected into Boesen and other patients with cervical spinal cord injuries.\u003c/p>\n\u003cp>Asterias \u003ca href=\"http://asteriasbiotherapeutics.com/asterias-biotherapeutics-announces-positive-efficacy-data-in-patients-with-complete-cervical-spinal-cord-injuries-treated-with-ast-opc1/\" target=\"_blank\">says\u003c/a> the trial results to date are encouraging. The sample is still extremely small and nothing is really proven at this point, but the data are certainly positive for other patients besides Boesen.\u003c/p>\n\u003cp>There are two groups of patients: three who received a dose of 2 million stem cells and five who received a larger dose of 10 million.\u003c/p>\n\u003cp>To measure improvement, researchers use the \u003ca href=\"http://www.nature.com/sc/journal/v45/n3/fig_tab/3102008t1.html\" target=\"_blank\">Upper Extremity Motor Scale\u003c/a>, or UEMS. The scale runs from zero, which indicates total paralysis, to five, which means a patient has active movement.\u003c/p>\n\u003cp>The results:\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>First cohort, 2 million stem cells injected: On the six-point UEMS scale, one of three patients improved one motor level on one side of the body, while the other two patients improved one level on both sides.\u003c/p>\n\u003cp>Second cohort, 10 million stem cells: One of four patients improved two levels on both sides. Two other patients showed two levels of improvement on one side. And the fourth patient improved one level on one side. (One of the five patients in this group has not yet reached the 90-day point at which results are measured, so no report on that patient yet.)\u003c/p>\n\u003cp>The other significant finding, Asterias said, is that no one showed any measurable negative effects of the therapy -- researchers started with the smaller dose to make sure patients weren't harmed by the experimental trial, then went to the higher 10-million-cell dose.\u003c/p>\n\u003cp>Researchers have said the optimal dosage target is 20 million cells, but that point has not been reached yet in the trial.\u003c/p>\n\u003cp>The next milestone for getting a clearer picture of the results will be at the six-month mark for the second cohort, in January 2017.\u003c/p>\n\u003cp>All patients in the trial, being conducted at six sites around the country, have either \"lost all movement below their injury site and experience severe paralysis of the upper and lower limbs,\" or \"lost all motor function but may retain some minimal sensory function below their injury site,\" according to Asterias.\u003c/p>\n\u003cp>You can see more info on the study, which is called \u003ca href=\"http://www.scistar-study.com/\" target=\"_blank\">SCIStar\u003c/a>, at\u003ca href=\"https://clinicaltrials.gov/ct2/show/study/NCT02302157?term=NCT02302157&rank=1\" target=\"_blank\"> ClinicalTrials.gov.\u003c/a>\u003c/p>\n\u003cp>\u003cstrong>Original post\u003c/strong>\u003c/p>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">Rod Boesen says his son, Kris, was so bad off he couldn't move a muscle from the neck down, and needed a ventilator to keep him drawing breath.\u003c/span>\u003c/p>\n\u003cp class=\"p2\">In March, Kris, then 20, was driving on a wet road when he crashed his car into a tree and a telephone poll, crushing three of his vertebrae. The accident left him with almost no feeling south of his neck, and doctors foresaw that he would lead the life of a paraplegic.\u003c/p>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">\"They thought he was going to be totally, from the head on down, paralyzed,\" says Rod\u003c/span>\u003c/p>\n\u003cp class=\"p2\">But that has not been the case; Kris has regained the use of his hands and arms.\u003c/p>\n\u003caside class=\"pullquote alignright\">'They thought he was going to be totally, from the head on down, paralyzed.'\u003c/aside>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">In April, as part of a research trial, a surgical team from USC's Keck Medical Center injected millions of embryonic stem cells into Boesen's spine. Two weeks later, Boesen began to show some improvement. After six weeks, he was discharged and returned home to Bakersfield, California to continue his rehabilitation.\u003cbr>\n\u003c/span>\u003c/p>\n\u003cp class=\"p2\">Now, five months after the stem cell injection, Boesen is remarkably self-sufficient, considering the initial prognosis. From feeding himself to talking on the phone to being able to twist the cap off a soda bottle, life is a degree more normal than anyone thought possible.\u003c/p>\n\u003cp class=\"p2\">\"We used to lift weights, that's something we used to do together,\" his dad says. \"Now we're doing that again. Only it's a lot less weight.\"\u003c/p>\n\u003cp class=\"p2\">The goal of the experimental stem cell treatment is to regrow the protective myelin sheath around each nerve, giving them a chance to heal. Whether this has occurred in Boesen yet is unknown--doctors would need to administer a spinal tap to find out, and that is dangerous for patients in this condition.\u003c/p>\n\u003cp class=\"p2\">So researchers don't know yet whether Boesen's recovery is due to the injection of stem cells. All they can say is that his progress has been remarkable, if not unprecedented for this type of spine injury.\u003c/p>\n\u003cfigure id=\"attachment_243385\" class=\"wp-caption alignright\" style=\"max-width: 640px\">\u003ca href=\"http://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2016/09/Neurosurgery-Stem-Cell-spine-patient-Kris-Boesen_04.jpg\">\u003cimg class=\"wp-image-243385 size-large\" src=\"http://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2016/09/Neurosurgery-Stem-Cell-spine-patient-Kris-Boesen_04-1180x775.jpg\" alt=\"Lifting weights is part of Kris Boesen’s regular program of physical therapy. \" width=\"640\" height=\"420\">\u003c/a>\u003cfigcaption class=\"wp-caption-text\">Lifting weights is part of Kris Boesen’s regular program of physical therapy. \u003ccite>(Greg Iger/Keck Medicine of USC))\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">The clinical mid-stage trial is very small; if it's successful, FDA approval would still be many years away. But the results in Boesen and four other patients have thus far been very encouraging.\u003c/span>\u003c/p>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">With most spinal injuries, doctors and physical therapists usually look to see what's still intact, then try to make incremental improvements. As a matter of course, people don't recover much of the movement or function they've lost.\u003c/span>\u003c/p>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">Charles Liu, a neurosurgeon and director of the USC Neurorestoration Center that's leading the research, \u003c/span>\u003cspan class=\"s1\">says the goal is not to attempt to repair the entire vertebral column, but to target the \u003ca href=\"http://www.spine-health.com/video/cervical-spine-anatomy-video\" target=\"_blank\">cervical spine\u003c/a> and restore neurological function.\u003c/span>\u003c/p>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">The other four patients in the cohort have shown some progress, but not as much as Boesen, according to Liu. Each person received one shot of stem cells, and the other patients got lower doses than the 10 million stem cells injected into Boesen's cervical spinal cord. \u003c/span>\u003c/p>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">Boesen's recovery may have been helped by his young age, and by the fact that he received the stem-cell injection so soon – just five weeks after his car crash, Liu said. \u003c/span>\u003c/p>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">\"This is unique, yes,\" Liu said of the clinical trial. \"No one has taken this approach before.\" \u003c/span>\u003c/p>\n\u003cp class=\"p2\">\u003cspan class=\"s1\">Or achieved these kind of results. Liu cautioned that not all spinal injury victims will benefit from this type of treatment, but he said it does offer hope that there may be a remedy for some spinal injuries.\u003c/span>\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "floatright"
},
"numeric": [
"floatright"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp class=\"p2\">Data from patients in the study is set to be released on Wednesday.\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/242687/stem-cells-may-have-restored-use-of-hands-and-arms-in-paralyzed-man",
"authors": [
"8656"
],
"categories": [
"futureofyou_1062"
],
"tags": [
"futureofyou_80",
"futureofyou_1042",
"futureofyou_680"
],
"featImg": "futureofyou_242691",
"label": "source_futureofyou_242687"
},
"stateofhealth_239875": {
"type": "posts",
"id": "stateofhealth_239875",
"meta": {
"index": "posts_1716263798",
"site": "stateofhealth",
"id": "239875",
"score": null,
"sort": [
1474486082000
]
},
"parent": 0,
"labelTerm": {
"site": "stateofhealth"
},
"blocks": [],
"publishDate": 1474486082,
"format": "standard",
"disqusTitle": "Zuckerberg, Chan Just Pledged $3 Billion to Cure All Diseases",
"title": "Zuckerberg, Chan Just Pledged $3 Billion to Cure All Diseases",
"headTitle": "State of Health | KQED News",
"content": "\u003cp>Facebook CEO Mark Zuckerberg has a goal that's even more ambitious than connecting the entire world to the internet: He and his wife, Priscilla Chan, a pediatrician, want to help eradicate all disease by the end of this century.\u003c/p>\n\u003cp>Zuckerberg and Chan are committing $3 billion over the next 10 years to accelerate basic scientific research, including the creation of research tools — from software to hardware to yet-undiscovered techniques — they hope will ultimately lead to scientific breakthroughs, the way the microscope and DNA sequencing have in generations past.\u003c/p>\n\u003cp>The goal, which they are unlikely to live to see accomplished, is to \"cure, prevent or manage all disease\" in the next 80 or so years. They acknowledge that this might sound a crazy, but point to how far medicine and science have come in the last century — with vaccines, statins for heart disease, chemotherapy, and so on — following millennia with little progress.\u003c/p>\n\u003cp>\"So if you even just assume that we'll be able to continue to make progress on that same trajectory, then that implies that by the end of this century we will have been able to solve most of these types of things,\" Zuckerberg said in an interview. He and Chan have spent the past two years speaking to scientists and other experts to plan the endeavor. He emphasized \"that this isn't something where we just read a book and decided we're going to do.\"\u003c/p>\n\u003cp>Through their philanthropic organization, the Chan Zuckerberg Initiative, the commitment includes $600 million to fund a new research center in San Francisco where scientific and medical researchers will work alongside engineers on long-term projects spanning years or even decades. The goal is not to focus narrowly on specific ailments, such as bone cancer or Parkinson's disease, but rather to do basic research. One example: a cell atlas that maps out all the different types of cells in the body, which could help researchers create various types of drugs.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>Chan's work as a pediatrician seems to be a big driver in their couple's decision to take up this latest cause.\u003c/p>\n\u003cp>\"I've been with families where we've hit the limit of what's possible through medicine and science,\" Chan said. \"I've had to tell families devastating diagnoses of leukemia, or that we just weren't able to resuscitate their child.\"\u003c/p>\n\u003cp>The couple spoke with The Associated Press in their home in Palo Alto, California, where their infant daughter, Max, had just woken from a nap. Their dog, Beast, came by to sit briefly during the 25-minute interview.\u003c/p>\n\u003cp>Zuckerberg and Chan hope that their effort will inspire other far-reaching efforts and collaboration in science, medicine and engineering, so that basic research is no longer relegated to the margins.\u003c/p>\n\u003cp>\"We spend 50 times more on health care treating people who are sick than we spend on science research (to cure) diseases so that people don't get sick in the first place,\" Zuckerberg said. He added that the approach reflects a belief that \"people are always going to suffer from disease so therefore we should focus on treating people who are sick.\"\u003c/p>\n\u003cp>Eric Lander, a professor of biology at the Massachusetts Institute of Technology and director of the Broad Institute at MIT and Harvard, said he's had some 20 conversations with Zuckerberg and Chan over the past year about the initiative and called their goal \"the right kind of goal for thinking about that kind of timeframe.\" He is not involved with the project itself, but expressed confidence in it.\u003c/p>\n\u003cp>\"Mark has brought new models to industry with Facebook,\" he said, adding that while organizations like the National Institutes of Health are \"fantastic,\" there is \"no point in replicating what existing models do.\"\u003c/p>\n\u003cp>\"It's very hard with today's science funding to build a team to work on scientific problems that are like what you would find at a world-class technology company, that are that scale,\" Zuckerberg said. \"So that's something I think we can concretely help out with.\"\u003c/p>\n\u003cp>Their new center, called Biohub, will run as an independent research center at the University of California, San Francisco in collaboration with UC Berkeley and Stanford University.\u003c/p>\n\u003cp>The Chan Zuckerberg science initiative will be headed by Cori Bargmann, a neuroscientist who is best known in scientific circles for her research on the behavior of a tiny worm called C. elegans. Bargmann said the idea of bringing engineers and scientists together presents a \"unique opportunity to take science in a new direction.\"\u003c/p>\n\u003cp>Zuckerberg said the couple decided to focus on creating better tools because this is where they see need, based on their conversations with scientists.\u003c/p>\n\u003cp>\"It's not that no one is doing this today, but out of all the money that our society spends on science funding, probably not enough is going toward tool development,\" Zuckerberg said.\u003c/p>\n\u003cp>Tools, he added, are long-term investments. It will likely take years for the first tools to be developed through this initiative, and even longer before they are used to cure diseases.\u003c/p>\n\u003cp>Zuckerberg and Chan, who have committed to donating 99 percent of their wealth, have spent the past two years meeting with scientists and other experts to come up with the endeavor. The two stressed that they believe that their goal can be accomplished, if not in their lifetime, then in their child's lifetime. It was Max's birth last November that inspired the billionaire couple to give away nearly all their money to help solve the world's problems.\u003c/p>\n\u003cp>At the time, this was valued at more than $45 billion worth of Facebook stock, which the couple transferred to the Chan Zuckerberg Initiative. The couple's philanthropy plan won't affect Zuckerberg's status as controlling shareholder of Facebook.\u003c/p>\n\u003cp>[ad floatright]\u003c/p>\n\u003cp>Zuckerberg and Chan often draw comparisons to Bill and Melinda Gates, whose philanthropic work also focuses on health and education. In an emailed statement, the Gates said investing \"in basic science research is at the root of the world's most important innovations and achievements.\" Zuckerberg and Chan, they added \"are making an incredible commitment to research and development that will lead to the breakthroughs to cure disease and lift millions out of poverty.\"\u003c/p>\n\n",
"disqusIdentifier": "239875 http://ww2.kqed.org/stateofhealth/?p=239875",
"disqusUrl": "https://ww2.kqed.org/stateofhealth/2016/09/21/zuckerberg-chan-just-pledged-3-billion-to-cure-all-diseases/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 1050,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 23
},
"modified": 1474561291,
"excerpt": "Their new center, called Biohub, will run as an independent research center at the University of California, San Francisco in collaboration with UC Berkeley and Stanford University.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Their new center, called Biohub, will run as an independent research center at the University of California, San Francisco in collaboration with UC Berkeley and Stanford University.",
"title": "Zuckerberg, Chan Just Pledged $3 Billion to Cure All Diseases | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Zuckerberg, Chan Just Pledged $3 Billion to Cure All Diseases",
"datePublished": "2016-09-21T12:28:02-07:00",
"dateModified": "2016-09-22T09:21:31-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "zuckerberg-chan-just-pledged-3-billion-to-cure-all-diseases",
"status": "publish",
"nprByline": "Associated Press",
"path": "/stateofhealth/239875/zuckerberg-chan-just-pledged-3-billion-to-cure-all-diseases",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>Facebook CEO Mark Zuckerberg has a goal that's even more ambitious than connecting the entire world to the internet: He and his wife, Priscilla Chan, a pediatrician, want to help eradicate all disease by the end of this century.\u003c/p>\n\u003cp>Zuckerberg and Chan are committing $3 billion over the next 10 years to accelerate basic scientific research, including the creation of research tools — from software to hardware to yet-undiscovered techniques — they hope will ultimately lead to scientific breakthroughs, the way the microscope and DNA sequencing have in generations past.\u003c/p>\n\u003cp>The goal, which they are unlikely to live to see accomplished, is to \"cure, prevent or manage all disease\" in the next 80 or so years. They acknowledge that this might sound a crazy, but point to how far medicine and science have come in the last century — with vaccines, statins for heart disease, chemotherapy, and so on — following millennia with little progress.\u003c/p>\n\u003cp>\"So if you even just assume that we'll be able to continue to make progress on that same trajectory, then that implies that by the end of this century we will have been able to solve most of these types of things,\" Zuckerberg said in an interview. He and Chan have spent the past two years speaking to scientists and other experts to plan the endeavor. He emphasized \"that this isn't something where we just read a book and decided we're going to do.\"\u003c/p>\n\u003cp>Through their philanthropic organization, the Chan Zuckerberg Initiative, the commitment includes $600 million to fund a new research center in San Francisco where scientific and medical researchers will work alongside engineers on long-term projects spanning years or even decades. The goal is not to focus narrowly on specific ailments, such as bone cancer or Parkinson's disease, but rather to do basic research. One example: a cell atlas that maps out all the different types of cells in the body, which could help researchers create various types of drugs.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>Chan's work as a pediatrician seems to be a big driver in their couple's decision to take up this latest cause.\u003c/p>\n\u003cp>\"I've been with families where we've hit the limit of what's possible through medicine and science,\" Chan said. \"I've had to tell families devastating diagnoses of leukemia, or that we just weren't able to resuscitate their child.\"\u003c/p>\n\u003cp>The couple spoke with The Associated Press in their home in Palo Alto, California, where their infant daughter, Max, had just woken from a nap. Their dog, Beast, came by to sit briefly during the 25-minute interview.\u003c/p>\n\u003cp>Zuckerberg and Chan hope that their effort will inspire other far-reaching efforts and collaboration in science, medicine and engineering, so that basic research is no longer relegated to the margins.\u003c/p>\n\u003cp>\"We spend 50 times more on health care treating people who are sick than we spend on science research (to cure) diseases so that people don't get sick in the first place,\" Zuckerberg said. He added that the approach reflects a belief that \"people are always going to suffer from disease so therefore we should focus on treating people who are sick.\"\u003c/p>\n\u003cp>Eric Lander, a professor of biology at the Massachusetts Institute of Technology and director of the Broad Institute at MIT and Harvard, said he's had some 20 conversations with Zuckerberg and Chan over the past year about the initiative and called their goal \"the right kind of goal for thinking about that kind of timeframe.\" He is not involved with the project itself, but expressed confidence in it.\u003c/p>\n\u003cp>\"Mark has brought new models to industry with Facebook,\" he said, adding that while organizations like the National Institutes of Health are \"fantastic,\" there is \"no point in replicating what existing models do.\"\u003c/p>\n\u003cp>\"It's very hard with today's science funding to build a team to work on scientific problems that are like what you would find at a world-class technology company, that are that scale,\" Zuckerberg said. \"So that's something I think we can concretely help out with.\"\u003c/p>\n\u003cp>Their new center, called Biohub, will run as an independent research center at the University of California, San Francisco in collaboration with UC Berkeley and Stanford University.\u003c/p>\n\u003cp>The Chan Zuckerberg science initiative will be headed by Cori Bargmann, a neuroscientist who is best known in scientific circles for her research on the behavior of a tiny worm called C. elegans. Bargmann said the idea of bringing engineers and scientists together presents a \"unique opportunity to take science in a new direction.\"\u003c/p>\n\u003cp>Zuckerberg said the couple decided to focus on creating better tools because this is where they see need, based on their conversations with scientists.\u003c/p>\n\u003cp>\"It's not that no one is doing this today, but out of all the money that our society spends on science funding, probably not enough is going toward tool development,\" Zuckerberg said.\u003c/p>\n\u003cp>Tools, he added, are long-term investments. It will likely take years for the first tools to be developed through this initiative, and even longer before they are used to cure diseases.\u003c/p>\n\u003cp>Zuckerberg and Chan, who have committed to donating 99 percent of their wealth, have spent the past two years meeting with scientists and other experts to come up with the endeavor. The two stressed that they believe that their goal can be accomplished, if not in their lifetime, then in their child's lifetime. It was Max's birth last November that inspired the billionaire couple to give away nearly all their money to help solve the world's problems.\u003c/p>\n\u003cp>At the time, this was valued at more than $45 billion worth of Facebook stock, which the couple transferred to the Chan Zuckerberg Initiative. The couple's philanthropy plan won't affect Zuckerberg's status as controlling shareholder of Facebook.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "floatright"
},
"numeric": [
"floatright"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>Zuckerberg and Chan often draw comparisons to Bill and Melinda Gates, whose philanthropic work also focuses on health and education. In an emailed statement, the Gates said investing \"in basic science research is at the root of the world's most important innovations and achievements.\" Zuckerberg and Chan, they added \"are making an incredible commitment to research and development that will lead to the breakthroughs to cure disease and lift millions out of poverty.\"\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/stateofhealth/239875/zuckerberg-chan-just-pledged-3-billion-to-cure-all-diseases",
"authors": [
"byline_stateofhealth_239875"
],
"categories": [
"stateofhealth_2407",
"stateofhealth_2746"
],
"tags": [
"stateofhealth_2932",
"stateofhealth_2933",
"stateofhealth_2808",
"stateofhealth_2519",
"stateofhealth_2898",
"stateofhealth_461",
"stateofhealth_308",
"stateofhealth_2931"
],
"featImg": "stateofhealth_239878",
"label": "stateofhealth"
},
"science_993029": {
"type": "posts",
"id": "science_993029",
"meta": {
"index": "posts_1716263798",
"site": "science",
"id": "993029",
"score": null,
"sort": [
1474422025000
]
},
"parent": 0,
"labelTerm": {
"site": "science"
},
"blocks": [],
"publishDate": 1474422025,
"format": "standard",
"title": "Drinking Water of Some Californians Exceeds Limit for ‘Erin Brockovich’ Chemical",
"headTitle": "Drinking Water of Some Californians Exceeds Limit for ‘Erin Brockovich’ Chemical | KQED",
"content": "\u003cp>When Erin Brockovich went after PG&E for poisoning groundwater in the desert town of Hinkley, California — a campaign that later became a film starring Julia Roberts — the toxic chemical was a heavy metal called hexavalent chromium.\u003c/p>\n\u003cp>Also known as chromium 6, the chemical is listed under California’s \u003ca href=\"http://oehha.ca.gov/media/downloads/proposition-65//p65single080516.pdf\" target=\"_blank\" rel=\"noopener\">Prop 65 \u003c/a>as causing cancer, \u003ca href=\"http://oehha.ca.gov/media/downloads/proposition-65/chemicals/chrome0908.pdf\" target=\"_blank\" rel=\"noopener\">developmental harm and reproductive harm\u003c/a> in both men and women.\u003c/p>\n\u003cp>A new \u003ca href=\"http://www.ewg.org/enviroblog/2016/09/erin-brockovich-chemical-drinking-water-more-200-million-americans\" target=\"_blank\" rel=\"noopener\">report \u003c/a>out today finds Hinkley isn’t the only California city with chromium 6 contamination.\u003c/p>\n\u003cp>The report found 11 water districts serving some 400,000 Californians had hexavalent chromium in their tap water at levels above the state’s legal limit.\u003c/p>\n\u003cp>\u003cstrong>Above the Legal Limit\u003c/strong>\u003cbr>\n\u003cem>The state’s limit for chromium 6 in drinking water is 10 parts per billion. A part per billion is about a drop of water in an Olympic-sized swimming pool.\u003c/em>\u003cbr>\n\u003c!-- iframe plugin v.4.3 wordpress.org/plugins/iframe/ -->\u003cbr>\n\u003ciframe loading=\"lazy\" width=\"100%\" height=\"520\" frameborder=\"0\" src=\"https://kqednews.carto.com/viz/aa656a24-7e8c-11e6-94fa-0e3ff518bd15/embed_map\" scrolling=\"yes\" class=\"iframe-class\">\u003c/iframe>\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>The report also found the vast majority of samples from water districts serving roughly 8.5 million Californians across the state had hexavalent chromium at levels below the legal limit, but above the public health goal set by state scientists.\u003c/p>\n\u003cp>The \u003ca href=\"http://www.ewg.org/research/chromium-six-found-in-us-tap-water\" target=\"_blank\" rel=\"noopener\">report \u003c/a>is from the \u003ca href=\"http://www.ewg.org/\" target=\"_blank\" rel=\"noopener\">Environmental Working Group\u003c/a>, a watchdog agency based in Washington, D.C. The non-profit analyzed data the U.S. Environmental Protection Agency collected from water utilities across the country between 2013 and 2015. An \u003ca href=\"http://www.ewg.org/interactive-maps/2016-chromium6-lower-48.php\" target=\"_blank\" rel=\"noopener\">interactive map\u003c/a> developed from the data shows chromium 6 levels in California and throughout the U.S.\u003c/p>\n\u003cp>“It was eye opening,” says Bill Walker, co-author of the Environmental Working Group report.\u003c/p>\n\u003cp>“We’re not trying to say the chromium 6 situation is as bad as the Flint situation but we’re saying if you start to look at it more closely you can find some really disturbing things.”\u003c/p>\n\u003cp>\u003c!-- iframe plugin v.4.3 wordpress.org/plugins/iframe/ -->\u003cbr>\n\u003ciframe loading=\"lazy\" id=\"datawrapper-chart-KU9ds\" src=\"//datawrapper.dwcdn.net/KU9ds/2/\" frameborder=\"0\" allowtransparency=\"true\" allowfullscreen=\"allowfullscreen\" webkitallowfullscreen=\"webkitallowfullscreen\" mozallowfullscreen=\"mozallowfullscreen\" oallowfullscreen=\"oallowfullscreen\" msallowfullscreen=\"msallowfullscreen\" width=\"100%\" height=\"400\" scrolling=\"yes\" class=\"iframe-class\">\u003c/iframe>\u003cbr>\nThe chemical occurs naturally in the environment from \u003cspan style=\"font-weight: 400\">the erosion of \u003c/span>natural\u003cspan style=\"font-weight: 400\"> chromium deposits\u003c/span> but it’s also manufactured and used in stainless steel production, metal finishing, chrome plating, leather tanning, and to prevent corrosion in electrical plant cooling towers, as was the case in Hinkley.\u003c/p>\n\u003cp>Outside of the workplace, the main way people might be exposed to chromium 6 is through drinking water.\u003c/p>\n\u003cp>And although the U.S. Occupational Safety and Health Administration regulates \u003ca href=\"https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=13096\" target=\"_blank\" rel=\"noopener\">chromium 6 in work environments\u003c/a>, the EPA doesn’t regulate chromium 6 in drinking water. In fact, California is the only state that does.\u003c/p>\n\u003cp>And California has two standards: a legally enforceable \u003cem>limit\u003c/em> on chromium 6 in drinking water, and a much lower public health \u003cem>goal\u003c/em>.\u003c/p>\n\u003caside class=\"pullquote alignright\">‘Does the state want us to drink distilled water? Cause that’s basically what they’re trying to get us to do, it’s absurd.’\u003ccite>Ken Moore, Kerman City’s Public Works Director\u003c/cite>\u003c/aside>\n\u003cp>Toxicologists at the state Office of Environmental Health Hazard Assessment set the public health goal for chromium intake at .02 parts per billion. A part per billion is about a drop of water in an Olympic-sized swimming pool.\u003c/p>\n\u003cp>A public health goal must represent a negligible health risk. State scientists said at .02 ppb, the risk of developing cancer for people who drink the water daily for 70 years is no more than a one-in-a-million.\u003c/p>\n\u003cp>State law requires the legal limit be set “as close as is \u003ca href=\"http://www.waterboards.ca.gov/drinking_water/certlic/drinkingwater/Chromium6.shtml\" target=\"_blank\" rel=\"noopener\">technically and economically feasible\u003c/a>” to the public health goal.\u003c/p>\n\u003cp>When the California Department of Public Health set a legally enforceable level in 2014, it took into account factors such as how costly it would be for water districts to monitor and clean up the chemical. Public health officials set the legally enforceable level 500 times higher than the public health goal, at 10 parts per billion. It \u003ca href=\"http://www.waterboards.ca.gov/drinking_water/certlic/drinkingwater/documents/chromium6/chromium_fact_sheet_2015_final.pdf\" target=\"_blank\" rel=\"noopener\">was the first\u003c/a> drinking water standard for chromium 6 in the nation.\u003c/p>\n\u003cp>The state’s legal limit represents a cancer risk of 500 people per-one-million, for people who drink the water daily for 70 years.\u003c/p>\n\u003cp>State officials found that getting chromium 6 levels below 10 ppb added significantly to the cost of compliance. To set the legal limit only half as high, at 5 ppb, would have tripled the cost. To reach 1 ppb, the cost would have been 11 times higher.\u003c/p>\n\u003cp>In the EWG report, Los Banos water samples registered the highest level of chromium 6, at 31.5 ppb, followed by Kerman City at 19.2 ppb and Patterson City at 18 ppb.\u003c/p>\n\u003cp>The cities that tested above the state’s legal limit run from Sacramento to Los Angeles through California’s Central Valley.\u003c/p>\n\u003cp>Among the water districts that tested below the legal limit, but above the public health goal are Hollister, L.A. County Waterworks Districts and Vacaville.\u003c/p>\n\u003cp>\u003cspan style=\"font-weight: 400\">Residents concerned about elevated levels should “contact their water system to see exactly what is going on and what the treatment is,” says state water board public information officer Andrew DiLuccia.\u003c/span>\u003c/p>\n\u003cp>Since January 2015, public water systems in California have been required to test for chromium 6 in drinking water. If the contamination is above the legal limit, the district must test its water supplies four times a year. If the average of four consecutive tests exceeds the legal limit, the supplier is in violation.\u003c/p>\n\u003cp>However, since water filtration and well construction is expensive and time-consuming, \u003ca href=\"http://www.waterboards.ca.gov/drinking_water/certlic/drinkingwater/documents/lawbook/sb385_hexavalent_chromium_compliance_fnl_.pdf\" target=\"_blank\" rel=\"noopener\">Senate Bill 385\u003c/a> gives water districts until 2020 to get their chromium 6 levels below the legal limit.\u003c/p>\n\u003cp>But one city manager says California’s relatively new 10 ppb rule is too stringent.\u003c/p>\n\u003cp>“Does the state want us to drink distilled water?” asks Ken Moore, Kerman City’s Public Works Director. “Cause that’s basically what they’re trying to get us to do, it’s absurd.”\u003c/p>\n\u003cp>Results from the EWG report show Kerman’s average chromium 6 level at 19.2 ppb, nearly double the legal limit.\u003c/p>\n\u003cp>Moore says the cleaning costs would be millions of dollars and would raise residents’ water bills from $35 a month to $150 just to pay for filtering, disposal, and operational overhead associated with removing the chemical.\u003c/p>\n\u003cp>“It’s something we can’t afford,” he says. “The people of this community can’t afford to pay for it.”\u003c/p>\n\u003cp>Other districts like the \u003ca href=\"http://www.kesq.com/news/indio-water-authority-opens-chromium-6-treatment-plants/33941540\" target=\"_blank\" rel=\"noopener\">Indio Water Authority\u003c/a> and \u003ca href=\"http://www.santacruzsentinel.com/article/ZZ/20141107/NEWS/141104274\" target=\"_blank\" rel=\"noopener\">Soquel Creek\u003c/a> have been able to pay for removal and are now supplying water to their customers that tests below the legal limit for chromium 6.\u003c/p>\n\u003cp>Last Thursday, Willows, a small town between Redding and Sacramento, held a \u003ca href=\"https://www.calwater.com/latest_news/cal-water-holds-ribbon-cutting-ceremony-to-celebrate-completion-of-chromium-6-treatment-plant-2/\" target=\"_blank\" rel=\"noopener\">ribbon cutting ceremony\u003c/a> to celebrate the successful installation of an ion exchange filtration system. The state-funded water purifier removes chromium 6 from its wells.\u003c/p>\n\u003cp>Kerman has also received state funding under \u003ca href=\"http://www.waterboards.ca.gov/water_issues/programs/grants_loans/proposition1.shtml\" target=\"_blank\" rel=\"noopener\">Proposition 1\u003c/a>. But Moore says the $3.5 million won’t cover all the costs to test, install and maintain six new groundwater wells in the city.\u003c/p>\n\u003cp>[ad floatright]\u003c/p>\n\u003cp>For individuals who want to remove chromium 6 from their tap, there are several types of water filters that will do it, including reverse osmosis filters that are available at many hardware stores. The EWG also has an \u003ca href=\"http://www.ewg.org/research/ewgs-water-filter-buying-guide?system_type=&technology=&contamcode=1080&submit_ty_1=Search\" target=\"_blank\" rel=\"noopener\">online guide\u003c/a>.\u003c/p>\n\n",
"stats": {
"hasVideo": false,
"hasChartOrMap": true,
"hasAudio": false,
"hasPolis": false,
"wordCount": 1252,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [
"https://kqednews.carto.com/viz/aa656a24-7e8c-11e6-94fa-0e3ff518bd15/embed_map",
"//datawrapper.dwcdn.net/KU9ds/2/"
],
"paragraphCount": 36
},
"modified": 1704929597,
"excerpt": "A study out today reports on levels of hexavalent chromium in water districts across the country.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "A study out today reports on levels of hexavalent chromium in water districts across the country.",
"title": "Drinking Water of Some Californians Exceeds Limit for ‘Erin Brockovich’ Chemical | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Drinking Water of Some Californians Exceeds Limit for ‘Erin Brockovich’ Chemical",
"datePublished": "2016-09-20T18:40:25-07:00",
"dateModified": "2024-01-10T15:33:17-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "drinking-water-of-some-californians-exceeds-limit-for-erin-brockovich-chemical",
"status": "publish",
"sticky": false,
"path": "/science/993029/drinking-water-of-some-californians-exceeds-limit-for-erin-brockovich-chemical",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>When Erin Brockovich went after PG&E for poisoning groundwater in the desert town of Hinkley, California — a campaign that later became a film starring Julia Roberts — the toxic chemical was a heavy metal called hexavalent chromium.\u003c/p>\n\u003cp>Also known as chromium 6, the chemical is listed under California’s \u003ca href=\"http://oehha.ca.gov/media/downloads/proposition-65//p65single080516.pdf\" target=\"_blank\" rel=\"noopener\">Prop 65 \u003c/a>as causing cancer, \u003ca href=\"http://oehha.ca.gov/media/downloads/proposition-65/chemicals/chrome0908.pdf\" target=\"_blank\" rel=\"noopener\">developmental harm and reproductive harm\u003c/a> in both men and women.\u003c/p>\n\u003cp>A new \u003ca href=\"http://www.ewg.org/enviroblog/2016/09/erin-brockovich-chemical-drinking-water-more-200-million-americans\" target=\"_blank\" rel=\"noopener\">report \u003c/a>out today finds Hinkley isn’t the only California city with chromium 6 contamination.\u003c/p>\n\u003cp>The report found 11 water districts serving some 400,000 Californians had hexavalent chromium in their tap water at levels above the state’s legal limit.\u003c/p>\n\u003cp>\u003cstrong>Above the Legal Limit\u003c/strong>\u003cbr>\n\u003cem>The state’s limit for chromium 6 in drinking water is 10 parts per billion. A part per billion is about a drop of water in an Olympic-sized swimming pool.\u003c/em>\u003cbr>\n\u003c!-- iframe plugin v.4.3 wordpress.org/plugins/iframe/ -->\u003cbr>\n\u003ciframe loading=\"lazy\" width=\"100%\" height=\"520\" frameborder=\"0\" src=\"https://kqednews.carto.com/viz/aa656a24-7e8c-11e6-94fa-0e3ff518bd15/embed_map\" scrolling=\"yes\" class=\"iframe-class\">\u003c/iframe>\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>The report also found the vast majority of samples from water districts serving roughly 8.5 million Californians across the state had hexavalent chromium at levels below the legal limit, but above the public health goal set by state scientists.\u003c/p>\n\u003cp>The \u003ca href=\"http://www.ewg.org/research/chromium-six-found-in-us-tap-water\" target=\"_blank\" rel=\"noopener\">report \u003c/a>is from the \u003ca href=\"http://www.ewg.org/\" target=\"_blank\" rel=\"noopener\">Environmental Working Group\u003c/a>, a watchdog agency based in Washington, D.C. The non-profit analyzed data the U.S. Environmental Protection Agency collected from water utilities across the country between 2013 and 2015. An \u003ca href=\"http://www.ewg.org/interactive-maps/2016-chromium6-lower-48.php\" target=\"_blank\" rel=\"noopener\">interactive map\u003c/a> developed from the data shows chromium 6 levels in California and throughout the U.S.\u003c/p>\n\u003cp>“It was eye opening,” says Bill Walker, co-author of the Environmental Working Group report.\u003c/p>\n\u003cp>“We’re not trying to say the chromium 6 situation is as bad as the Flint situation but we’re saying if you start to look at it more closely you can find some really disturbing things.”\u003c/p>\n\u003cp>\u003c!-- iframe plugin v.4.3 wordpress.org/plugins/iframe/ -->\u003cbr>\n\u003ciframe loading=\"lazy\" id=\"datawrapper-chart-KU9ds\" src=\"//datawrapper.dwcdn.net/KU9ds/2/\" frameborder=\"0\" allowtransparency=\"true\" allowfullscreen=\"allowfullscreen\" webkitallowfullscreen=\"webkitallowfullscreen\" mozallowfullscreen=\"mozallowfullscreen\" oallowfullscreen=\"oallowfullscreen\" msallowfullscreen=\"msallowfullscreen\" width=\"100%\" height=\"400\" scrolling=\"yes\" class=\"iframe-class\">\u003c/iframe>\u003cbr>\nThe chemical occurs naturally in the environment from \u003cspan style=\"font-weight: 400\">the erosion of \u003c/span>natural\u003cspan style=\"font-weight: 400\"> chromium deposits\u003c/span> but it’s also manufactured and used in stainless steel production, metal finishing, chrome plating, leather tanning, and to prevent corrosion in electrical plant cooling towers, as was the case in Hinkley.\u003c/p>\n\u003cp>Outside of the workplace, the main way people might be exposed to chromium 6 is through drinking water.\u003c/p>\n\u003cp>And although the U.S. Occupational Safety and Health Administration regulates \u003ca href=\"https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=13096\" target=\"_blank\" rel=\"noopener\">chromium 6 in work environments\u003c/a>, the EPA doesn’t regulate chromium 6 in drinking water. In fact, California is the only state that does.\u003c/p>\n\u003cp>And California has two standards: a legally enforceable \u003cem>limit\u003c/em> on chromium 6 in drinking water, and a much lower public health \u003cem>goal\u003c/em>.\u003c/p>\n\u003caside class=\"pullquote alignright\">‘Does the state want us to drink distilled water? Cause that’s basically what they’re trying to get us to do, it’s absurd.’\u003ccite>Ken Moore, Kerman City’s Public Works Director\u003c/cite>\u003c/aside>\n\u003cp>Toxicologists at the state Office of Environmental Health Hazard Assessment set the public health goal for chromium intake at .02 parts per billion. A part per billion is about a drop of water in an Olympic-sized swimming pool.\u003c/p>\n\u003cp>A public health goal must represent a negligible health risk. State scientists said at .02 ppb, the risk of developing cancer for people who drink the water daily for 70 years is no more than a one-in-a-million.\u003c/p>\n\u003cp>State law requires the legal limit be set “as close as is \u003ca href=\"http://www.waterboards.ca.gov/drinking_water/certlic/drinkingwater/Chromium6.shtml\" target=\"_blank\" rel=\"noopener\">technically and economically feasible\u003c/a>” to the public health goal.\u003c/p>\n\u003cp>When the California Department of Public Health set a legally enforceable level in 2014, it took into account factors such as how costly it would be for water districts to monitor and clean up the chemical. Public health officials set the legally enforceable level 500 times higher than the public health goal, at 10 parts per billion. It \u003ca href=\"http://www.waterboards.ca.gov/drinking_water/certlic/drinkingwater/documents/chromium6/chromium_fact_sheet_2015_final.pdf\" target=\"_blank\" rel=\"noopener\">was the first\u003c/a> drinking water standard for chromium 6 in the nation.\u003c/p>\n\u003cp>The state’s legal limit represents a cancer risk of 500 people per-one-million, for people who drink the water daily for 70 years.\u003c/p>\n\u003cp>State officials found that getting chromium 6 levels below 10 ppb added significantly to the cost of compliance. To set the legal limit only half as high, at 5 ppb, would have tripled the cost. To reach 1 ppb, the cost would have been 11 times higher.\u003c/p>\n\u003cp>In the EWG report, Los Banos water samples registered the highest level of chromium 6, at 31.5 ppb, followed by Kerman City at 19.2 ppb and Patterson City at 18 ppb.\u003c/p>\n\u003cp>The cities that tested above the state’s legal limit run from Sacramento to Los Angeles through California’s Central Valley.\u003c/p>\n\u003cp>Among the water districts that tested below the legal limit, but above the public health goal are Hollister, L.A. County Waterworks Districts and Vacaville.\u003c/p>\n\u003cp>\u003cspan style=\"font-weight: 400\">Residents concerned about elevated levels should “contact their water system to see exactly what is going on and what the treatment is,” says state water board public information officer Andrew DiLuccia.\u003c/span>\u003c/p>\n\u003cp>Since January 2015, public water systems in California have been required to test for chromium 6 in drinking water. If the contamination is above the legal limit, the district must test its water supplies four times a year. If the average of four consecutive tests exceeds the legal limit, the supplier is in violation.\u003c/p>\n\u003cp>However, since water filtration and well construction is expensive and time-consuming, \u003ca href=\"http://www.waterboards.ca.gov/drinking_water/certlic/drinkingwater/documents/lawbook/sb385_hexavalent_chromium_compliance_fnl_.pdf\" target=\"_blank\" rel=\"noopener\">Senate Bill 385\u003c/a> gives water districts until 2020 to get their chromium 6 levels below the legal limit.\u003c/p>\n\u003cp>But one city manager says California’s relatively new 10 ppb rule is too stringent.\u003c/p>\n\u003cp>“Does the state want us to drink distilled water?” asks Ken Moore, Kerman City’s Public Works Director. “Cause that’s basically what they’re trying to get us to do, it’s absurd.”\u003c/p>\n\u003cp>Results from the EWG report show Kerman’s average chromium 6 level at 19.2 ppb, nearly double the legal limit.\u003c/p>\n\u003cp>Moore says the cleaning costs would be millions of dollars and would raise residents’ water bills from $35 a month to $150 just to pay for filtering, disposal, and operational overhead associated with removing the chemical.\u003c/p>\n\u003cp>“It’s something we can’t afford,” he says. “The people of this community can’t afford to pay for it.”\u003c/p>\n\u003cp>Other districts like the \u003ca href=\"http://www.kesq.com/news/indio-water-authority-opens-chromium-6-treatment-plants/33941540\" target=\"_blank\" rel=\"noopener\">Indio Water Authority\u003c/a> and \u003ca href=\"http://www.santacruzsentinel.com/article/ZZ/20141107/NEWS/141104274\" target=\"_blank\" rel=\"noopener\">Soquel Creek\u003c/a> have been able to pay for removal and are now supplying water to their customers that tests below the legal limit for chromium 6.\u003c/p>\n\u003cp>Last Thursday, Willows, a small town between Redding and Sacramento, held a \u003ca href=\"https://www.calwater.com/latest_news/cal-water-holds-ribbon-cutting-ceremony-to-celebrate-completion-of-chromium-6-treatment-plant-2/\" target=\"_blank\" rel=\"noopener\">ribbon cutting ceremony\u003c/a> to celebrate the successful installation of an ion exchange filtration system. The state-funded water purifier removes chromium 6 from its wells.\u003c/p>\n\u003cp>Kerman has also received state funding under \u003ca href=\"http://www.waterboards.ca.gov/water_issues/programs/grants_loans/proposition1.shtml\" target=\"_blank\" rel=\"noopener\">Proposition 1\u003c/a>. But Moore says the $3.5 million won’t cover all the costs to test, install and maintain six new groundwater wells in the city.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "floatright"
},
"numeric": [
"floatright"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>For individuals who want to remove chromium 6 from their tap, there are several types of water filters that will do it, including reverse osmosis filters that are available at many hardware stores. The EWG also has an \u003ca href=\"http://www.ewg.org/research/ewgs-water-filter-buying-guide?system_type=&technology=&contamcode=1080&submit_ty_1=Search\" target=\"_blank\" rel=\"noopener\">online guide\u003c/a>.\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/science/993029/drinking-water-of-some-californians-exceeds-limit-for-erin-brockovich-chemical",
"authors": [
"5432"
],
"categories": [
"science_29",
"science_39",
"science_40",
"science_98"
],
"tags": [
"science_1273"
],
"featImg": "science_1008622",
"label": "science"
},
"stateofhealth_236832": {
"type": "posts",
"id": "stateofhealth_236832",
"meta": {
"index": "posts_1716263798",
"site": "stateofhealth",
"id": "236832",
"score": null,
"sort": [
1473805866000
]
},
"parent": 0,
"labelTerm": {
"site": "stateofhealth"
},
"blocks": [],
"publishDate": 1473805866,
"format": "standard",
"disqusTitle": "Netflix Documentary Features Heartbreaking End-of-Life Care Decisions at an Oakland Hospital",
"title": "Netflix Documentary Features Heartbreaking End-of-Life Care Decisions at an Oakland Hospital",
"headTitle": "State of Health | KQED News",
"content": "\u003cp>When is more medical care helpful in end-of-life situations and when does it just lead to more suffering? How do you know when it's time to let someone you love pass away naturally?\u003c/p>\n\u003cp>These choices are heart-wrenching for patients, families, and their doctors.\u003c/p>\n\u003cp>A new Netflix documentary short called \u003ca href=\"https://www.netflix.com/title/80106307\" target=\"_blank\">\u003cem>Extremis\u003c/em>\u003c/a>, which is Latin for \"at the point of death,\" follows doctors, patients and their loved ones in various end-of-life scenarios that play out at the intensive care unit at Oakland's Highland Hospital.\u003c/p>\n\u003cp>https://www.youtube.com/watch?v=TJiY8duVgz0\u003c/p>\n\u003cp>As difficult as these choices are, it's important to figure out if an intervention will change the course for a patient, said Dr. Jessica Nutik Zitter, the Oakland palliative care physician, who is featured in the documentary.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>\"Here's the reality, we are all gonna die,\" she says to a group of medical staff in the film's trailer. \"Everyone standing in this room is gonna die one day and it's good to have a little bit of a say in how.\"\u003c/p>\n\u003cp>Every day, patients are permanently hooked up to machines, she says in the film.\u003c/p>\n\u003cp>\"My concern is we are going to cause more suffering without likely benefit,\" she tells a patient's loved one in the film. \"The other approach is let her pass naturally.\"\u003c/p>\n\u003cp>It is often difficult for doctors to fight their instinct to treat medical symptoms and know when it's time to stop, she wrote about in the \u003ca href=\"http://well.blogs.nytimes.com/2016/04/14/in-the-hospital-letting-nature-takes-its-course/\" target=\"_blank\">\u003cem>New York Times\u003c/em>\u003c/a> in April.\u003c/p>\n\u003cp>There is a growing movement within the medical field to recognize how important it is for doctors to help patients navigate care and face the end of their lives.\u003c/p>\n\u003cp>Boston surgeon Atul Gawande's recent book and movie called \u003cem>Being Mortal\u003c/em>, revealed how well-meaning doctors are often untrained and unprepared to discuss death with their patients.\u003c/p>\n\u003cp>End-of-life issues have also been at the forefront of public discussion as states like California enact legislation to allow terminally ill patients to take medicines to end their lives.\u003c/p>\n\u003cp>The Netflix documentary shows how difficult the choices are for families who have to make decisions about a dying loved one.\u003c/p>\n\u003cp>Giving consent for doctors to stop medical treatment can feel wrong and provoke tremendous feelings of guilt for a patient's family.\u003c/p>\n\u003cp>\"It would feel like murder to pull her life support,\" says one young woman when faced with this choice.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>The 24-minute documentary, directed by Dan Krauss, won the Best Documentary Short award this year when it premiered at the 2016 Tribeca Film Festival.\u003c/p>\n\n",
"disqusIdentifier": "236832 http://ww2.kqed.org/stateofhealth/?p=236832",
"disqusUrl": "https://ww2.kqed.org/stateofhealth/2016/09/13/netflix-documentary-features-heartbreaking-end-of-life-care-decisions-at-an-oakland-hospital/",
"stats": {
"hasVideo": true,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 434,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 17
},
"modified": 1473866303,
"excerpt": "The film follows doctors, patients and their loved ones in the intensive care unit at Oakland's Highland Hospital.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "The film follows doctors, patients and their loved ones in the intensive care unit at Oakland's Highland Hospital.",
"title": "Netflix Documentary Features Heartbreaking End-of-Life Care Decisions at an Oakland Hospital | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Netflix Documentary Features Heartbreaking End-of-Life Care Decisions at an Oakland Hospital",
"datePublished": "2016-09-13T15:31:06-07:00",
"dateModified": "2016-09-14T08:18:23-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "netflix-documentary-features-heartbreaking-end-of-life-care-decisions-at-an-oakland-hospital",
"status": "publish",
"path": "/stateofhealth/236832/netflix-documentary-features-heartbreaking-end-of-life-care-decisions-at-an-oakland-hospital",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>When is more medical care helpful in end-of-life situations and when does it just lead to more suffering? How do you know when it's time to let someone you love pass away naturally?\u003c/p>\n\u003cp>These choices are heart-wrenching for patients, families, and their doctors.\u003c/p>\n\u003cp>A new Netflix documentary short called \u003ca href=\"https://www.netflix.com/title/80106307\" target=\"_blank\">\u003cem>Extremis\u003c/em>\u003c/a>, which is Latin for \"at the point of death,\" follows doctors, patients and their loved ones in various end-of-life scenarios that play out at the intensive care unit at Oakland's Highland Hospital.\u003c/p>\u003c/p>\u003cp>\u003cspan class='utils-parseShortcode-shortcodes-__youtubeShortcode__embedYoutube'>\n \u003cspan class='utils-parseShortcode-shortcodes-__youtubeShortcode__embedYoutubeInside'>\n \u003ciframe\n loading='lazy'\n class='utils-parseShortcode-shortcodes-__youtubeShortcode__youtubePlayer'\n type='text/html'\n src='//www.youtube.com/embed/TJiY8duVgz0'\n title='//www.youtube.com/embed/TJiY8duVgz0'\n allowfullscreen='true'\n style='border:0;'>\u003c/iframe>\n \u003c/span>\n \u003c/span>\u003c/p>\u003cp>\u003cp>As difficult as these choices are, it's important to figure out if an intervention will change the course for a patient, said Dr. Jessica Nutik Zitter, the Oakland palliative care physician, who is featured in the documentary.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>\"Here's the reality, we are all gonna die,\" she says to a group of medical staff in the film's trailer. \"Everyone standing in this room is gonna die one day and it's good to have a little bit of a say in how.\"\u003c/p>\n\u003cp>Every day, patients are permanently hooked up to machines, she says in the film.\u003c/p>\n\u003cp>\"My concern is we are going to cause more suffering without likely benefit,\" she tells a patient's loved one in the film. \"The other approach is let her pass naturally.\"\u003c/p>\n\u003cp>It is often difficult for doctors to fight their instinct to treat medical symptoms and know when it's time to stop, she wrote about in the \u003ca href=\"http://well.blogs.nytimes.com/2016/04/14/in-the-hospital-letting-nature-takes-its-course/\" target=\"_blank\">\u003cem>New York Times\u003c/em>\u003c/a> in April.\u003c/p>\n\u003cp>There is a growing movement within the medical field to recognize how important it is for doctors to help patients navigate care and face the end of their lives.\u003c/p>\n\u003cp>Boston surgeon Atul Gawande's recent book and movie called \u003cem>Being Mortal\u003c/em>, revealed how well-meaning doctors are often untrained and unprepared to discuss death with their patients.\u003c/p>\n\u003cp>End-of-life issues have also been at the forefront of public discussion as states like California enact legislation to allow terminally ill patients to take medicines to end their lives.\u003c/p>\n\u003cp>The Netflix documentary shows how difficult the choices are for families who have to make decisions about a dying loved one.\u003c/p>\n\u003cp>Giving consent for doctors to stop medical treatment can feel wrong and provoke tremendous feelings of guilt for a patient's family.\u003c/p>\n\u003cp>\"It would feel like murder to pull her life support,\" says one young woman when faced with this choice.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>The 24-minute documentary, directed by Dan Krauss, won the Best Documentary Short award this year when it premiered at the 2016 Tribeca Film Festival.\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/stateofhealth/236832/netflix-documentary-features-heartbreaking-end-of-life-care-decisions-at-an-oakland-hospital",
"authors": [
"11105"
],
"categories": [
"stateofhealth_11",
"stateofhealth_166"
],
"tags": [
"stateofhealth_40",
"stateofhealth_2808",
"stateofhealth_2907",
"stateofhealth_2906",
"stateofhealth_2908",
"stateofhealth_2519",
"stateofhealth_145"
],
"featImg": "stateofhealth_236882",
"label": "stateofhealth"
},
"stateofhealth_236779": {
"type": "posts",
"id": "stateofhealth_236779",
"meta": {
"index": "posts_1716263798",
"site": "stateofhealth",
"id": "236779",
"score": null,
"sort": [
1473785035000
]
},
"parent": 0,
"labelTerm": {
"site": "stateofhealth"
},
"blocks": [],
"publishDate": 1473785035,
"format": "standard",
"disqusTitle": "California Could Soon Legalize Marijuana But Pot’s Brain Effects Remain a Mystery",
"title": "California Could Soon Legalize Marijuana But Pot’s Brain Effects Remain a Mystery",
"headTitle": "State of Health | KQED News",
"content": "\u003cdiv id=\"storytext\" class=\"storytext storylocation linkLocation\">\n\u003cp>Five states are voting this fall on whether marijuana should be legal, like alcohol, for recreational use. That has sparked questions about what we know — and don't know — about marijuana's effect on the brain.\u003c/p>\n\u003cp>Research is scarce. The U.S. Drug Enforcement Agency classifies marijuana as a \u003ca href=\"https://www.dea.gov/druginfo/ds.shtml\">Schedule I drug\u003c/a>. That classification puts up barriers to conducting research on it, including a cumbersome \u003ca href=\"http://www.deadiversion.usdoj.gov/21cfr/cfr/1301/1301_18.htm\">DEA approval\u003c/a> application and a requirement that scientists \u003ca href=\"http://grants.nih.gov/grants/guide/notice-files/not99-091.html\">procure\u003c/a> very specific marijuana plants.\u003c/p>\n\u003cp>One long-term study in New Zealand compared the IQs of people at age 13 and then through adolescence and adulthood to age 38. Those who used pot heavily from adolescence onward showed an average 8 percent drop in IQ. People who never smoked, by contrast, showed slightly increased IQ.\u003c/p>\n\u003cp>Critics pounced on \u003ca href=\"http://www.pnas.org/content/109/40/E2657.full.pdf\">the study\u003c/a>, which was published in 2012, because it didn't adjust for many other things that affect IQ such as home life or family income. And there's no proof the IQ differences are due to pot.\u003c/p>\n\u003cp>One of those critics, \u003ca href=\"http://domstat.med.ucla.edu/pages/nicholas-jackson\">Nicholas Jackson\u003c/a>, now a senior statistician at the University of California, Los Angeles, wondered what would happen if he could rule out some of those elements by comparing twins.\u003c/p>\n\u003cp>\"Individuals that share the same genes, grew up in the same household, where the difference between them was that one of the twins was using marijuana and one was not,\" Jackson says.\u003c/p>\n\u003cp>Jackson and \u003ca href=\"https://www.researchgate.net/profile/Joshua_Isen\">Joshua Isen\u003c/a>, now an assistant professor of psychology at the University of South Alabama, conducted \u003ca href=\"http://www.pnas.org/content/113/5/E500.abstract\">a study\u003c/a> comparing IQ tests of twins age 9 to 12, before either had smoked marijuana, and then seven to 10 years later, after one had started.\u003c/p>\n\u003cp>\"If marijuana was causing IQ decline, what we would expect to see is that the twin who goes on and uses marijuana should have IQ deficits,\" Jackson says. \"We don't find that.\"\u003c/p>\n\u003cp>IQ scores for both twins varied slightly over time. And for twins who smoked marijuana, there was no significant difference in effect between daily and occasional use. So was the New Zealand finding wrong? The authors did not comment for this story, but have said that the twins study of teenagers does not address the effects of decades of heavy marijuana use.\u003c/p>\n\u003cp>Marijuana seems to affect a particular kind of intelligence, like short term retention of vocabulary words and other information that you might learn in school, says \u003ca href=\"http://www.albany.edu/psychology/20874.php\">Mitch Earleywine\u003c/a>, a professor of psychology at the University of Albany.\u003c/p>\n\u003cp>\"They haven't learned a whole lot of vocabulary words or they never learned the capital of Maine because they were high at school that day,\" he says. \"But when it comes to things that are more liquid intelligence, more fluid intelligence, they're usually pretty good at those because it requires just intelligence in the moment, so to speak.\"\u003c/p>\n\u003cp>It's not clear how marijuana use may keep Augusta from being filed next to \"capital of Maine\" in the brain. Some studies that \u003ca href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930618/\">compare brain scans\u003c/a> of teenagers who use marijuana to those who don't show thinner, less dense connections between lobes. \u003ca href=\"https://www.drugabuse.gov/about-nida/directors-page/biography-dr-nora-volkow\">Nora Volkow\u003c/a>, director of the National Institute on Drug Abuse, says brains with less connectivity don't work as well as they should.\u003c/p>\n\u003cp>\"You could expect that that will decrease your capacity to memorize things and to learn them which is necessary to you to actually further develop your cognitive abilities,\" she says.\u003c/p>\n\u003cp>Volkow says there's little proof that marijuana causes poor brain connections. Studies so far have not compared brains before and after pot. Maybe kids who are already having trouble in school are more likely to try marijuana. Still, she is convinced that marijuana is bad for the brains of adults who began smoking in their youth.\u003c/p>\n\u003cp>People who regularly smoked marijuana as teens, \"are achieving much less both in their education as well as their profession as well as their economic earnings,\" Volkow says. \"They also tend to be much more dissatisfied with life. Many studies have shown that.\"\u003c/p>\n\u003cp>NIDA is one of several agencies behind a major study that will map the effects of marijuana and other substances on brain development. The Adolescent Brain and Cognitive Development Study (ABCD) will follow 10,000 9- to 10- year-olds through early adulthood, using neuroimaging to map changes in the brain.\u003c/p>\n\u003cp>But as of now, the research suggests if you don't start young and don't use marijuana often, there's not much evidence of permanent harm to the brain. That's led some experts in marijuana brain science to say it might be OK to make pot legal, with strong oversight. That includes \u003ca href=\"http://drkevinhill.com/three-big-reasons-marijuana-is-misunderstood/\">Kevin Hill,\u003c/a> an assistant professor of psychiatry at Harvard Medical School.\u003c/p>\n\u003cp>\"I'm not sure how I would vote [on the Massachusetts ballot question] at this point. I want to see sensible marijuana policy that works, that gives people what they want while limiting risk,\" says Hill, who wrote \u003ca href=\"https://www.amazon.com/Marijuana-Unbiased-Truth-World%C2%92s-Popular/dp/1616495596\">Marijuana: The Unbiased Truth about the World's Most Popular Weed\u003c/a>.\u003c/p>\n\u003cp>Massachusetts is one of five states, including Arizona, California, Maine and Nevada, that will vote in November on legalizing recreational marijuana.\u003c/p>\n\u003cp>Hill would like to see stronger regulation of marijuana if it becomes legal, with limits on advertising and of edible products that attract children, as well as a higher rate of taxation than the proposed 12 percent. If Massachusetts approves marijuana for recreational use, it would not be legal for anyone under age 21, when most, but not all, brain development occurs.\u003c/p>\n\u003cp>\u003cem>This story is part of a reporting partnership with NPR, WBUR and \u003c/em>\u003ca href=\"http://www.kaiserhealthnews.org/\">Kaiser Health News\u003c/a>.\u003c/p>\n\u003c/div>\n\u003cdiv class=\"tags\">\u003c/div>\n\u003cp>[ad fullwidth]\u003c/p>\u003cp>\u003c/p>\n",
"disqusIdentifier": "236779 http://ww2.kqed.org/stateofhealth/?p=236779",
"disqusUrl": "https://ww2.kqed.org/stateofhealth/2016/09/13/california-could-soon-legalize-marijuana-but-pots-brain-effects-remain-a-mystery/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 937,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 23
},
"modified": 1473788862,
"excerpt": "The U.S. Drug Enforcement Agency's classification of Marijuana puts up barriers to conducting research on it.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "The U.S. Drug Enforcement Agency's classification of Marijuana puts up barriers to conducting research on it.",
"title": "California Could Soon Legalize Marijuana But Pot’s Brain Effects Remain a Mystery | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "California Could Soon Legalize Marijuana But Pot’s Brain Effects Remain a Mystery",
"datePublished": "2016-09-13T09:43:55-07:00",
"dateModified": "2016-09-13T10:47:42-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "california-could-soon-legalize-marijuana-but-pots-brain-effects-remain-a-mystery",
"status": "publish",
"nprByline": "Martha Bebinger \u003cbr />\u003ca href=\"http://www.npr.org/sections/health-shots/\">NPR Shots\u003c/a>",
"path": "/stateofhealth/236779/california-could-soon-legalize-marijuana-but-pots-brain-effects-remain-a-mystery",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cdiv id=\"storytext\" class=\"storytext storylocation linkLocation\">\n\u003cp>Five states are voting this fall on whether marijuana should be legal, like alcohol, for recreational use. That has sparked questions about what we know — and don't know — about marijuana's effect on the brain.\u003c/p>\n\u003cp>Research is scarce. The U.S. Drug Enforcement Agency classifies marijuana as a \u003ca href=\"https://www.dea.gov/druginfo/ds.shtml\">Schedule I drug\u003c/a>. That classification puts up barriers to conducting research on it, including a cumbersome \u003ca href=\"http://www.deadiversion.usdoj.gov/21cfr/cfr/1301/1301_18.htm\">DEA approval\u003c/a> application and a requirement that scientists \u003ca href=\"http://grants.nih.gov/grants/guide/notice-files/not99-091.html\">procure\u003c/a> very specific marijuana plants.\u003c/p>\n\u003cp>One long-term study in New Zealand compared the IQs of people at age 13 and then through adolescence and adulthood to age 38. Those who used pot heavily from adolescence onward showed an average 8 percent drop in IQ. People who never smoked, by contrast, showed slightly increased IQ.\u003c/p>\n\u003cp>Critics pounced on \u003ca href=\"http://www.pnas.org/content/109/40/E2657.full.pdf\">the study\u003c/a>, which was published in 2012, because it didn't adjust for many other things that affect IQ such as home life or family income. And there's no proof the IQ differences are due to pot.\u003c/p>\n\u003cp>One of those critics, \u003ca href=\"http://domstat.med.ucla.edu/pages/nicholas-jackson\">Nicholas Jackson\u003c/a>, now a senior statistician at the University of California, Los Angeles, wondered what would happen if he could rule out some of those elements by comparing twins.\u003c/p>\n\u003cp>\"Individuals that share the same genes, grew up in the same household, where the difference between them was that one of the twins was using marijuana and one was not,\" Jackson says.\u003c/p>\n\u003cp>Jackson and \u003ca href=\"https://www.researchgate.net/profile/Joshua_Isen\">Joshua Isen\u003c/a>, now an assistant professor of psychology at the University of South Alabama, conducted \u003ca href=\"http://www.pnas.org/content/113/5/E500.abstract\">a study\u003c/a> comparing IQ tests of twins age 9 to 12, before either had smoked marijuana, and then seven to 10 years later, after one had started.\u003c/p>\n\u003cp>\"If marijuana was causing IQ decline, what we would expect to see is that the twin who goes on and uses marijuana should have IQ deficits,\" Jackson says. \"We don't find that.\"\u003c/p>\n\u003cp>IQ scores for both twins varied slightly over time. And for twins who smoked marijuana, there was no significant difference in effect between daily and occasional use. So was the New Zealand finding wrong? The authors did not comment for this story, but have said that the twins study of teenagers does not address the effects of decades of heavy marijuana use.\u003c/p>\n\u003cp>Marijuana seems to affect a particular kind of intelligence, like short term retention of vocabulary words and other information that you might learn in school, says \u003ca href=\"http://www.albany.edu/psychology/20874.php\">Mitch Earleywine\u003c/a>, a professor of psychology at the University of Albany.\u003c/p>\n\u003cp>\"They haven't learned a whole lot of vocabulary words or they never learned the capital of Maine because they were high at school that day,\" he says. \"But when it comes to things that are more liquid intelligence, more fluid intelligence, they're usually pretty good at those because it requires just intelligence in the moment, so to speak.\"\u003c/p>\n\u003cp>It's not clear how marijuana use may keep Augusta from being filed next to \"capital of Maine\" in the brain. Some studies that \u003ca href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930618/\">compare brain scans\u003c/a> of teenagers who use marijuana to those who don't show thinner, less dense connections between lobes. \u003ca href=\"https://www.drugabuse.gov/about-nida/directors-page/biography-dr-nora-volkow\">Nora Volkow\u003c/a>, director of the National Institute on Drug Abuse, says brains with less connectivity don't work as well as they should.\u003c/p>\n\u003cp>\"You could expect that that will decrease your capacity to memorize things and to learn them which is necessary to you to actually further develop your cognitive abilities,\" she says.\u003c/p>\n\u003cp>Volkow says there's little proof that marijuana causes poor brain connections. Studies so far have not compared brains before and after pot. Maybe kids who are already having trouble in school are more likely to try marijuana. Still, she is convinced that marijuana is bad for the brains of adults who began smoking in their youth.\u003c/p>\n\u003cp>People who regularly smoked marijuana as teens, \"are achieving much less both in their education as well as their profession as well as their economic earnings,\" Volkow says. \"They also tend to be much more dissatisfied with life. Many studies have shown that.\"\u003c/p>\n\u003cp>NIDA is one of several agencies behind a major study that will map the effects of marijuana and other substances on brain development. The Adolescent Brain and Cognitive Development Study (ABCD) will follow 10,000 9- to 10- year-olds through early adulthood, using neuroimaging to map changes in the brain.\u003c/p>\n\u003cp>But as of now, the research suggests if you don't start young and don't use marijuana often, there's not much evidence of permanent harm to the brain. That's led some experts in marijuana brain science to say it might be OK to make pot legal, with strong oversight. That includes \u003ca href=\"http://drkevinhill.com/three-big-reasons-marijuana-is-misunderstood/\">Kevin Hill,\u003c/a> an assistant professor of psychiatry at Harvard Medical School.\u003c/p>\n\u003cp>\"I'm not sure how I would vote [on the Massachusetts ballot question] at this point. I want to see sensible marijuana policy that works, that gives people what they want while limiting risk,\" says Hill, who wrote \u003ca href=\"https://www.amazon.com/Marijuana-Unbiased-Truth-World%C2%92s-Popular/dp/1616495596\">Marijuana: The Unbiased Truth about the World's Most Popular Weed\u003c/a>.\u003c/p>\n\u003cp>Massachusetts is one of five states, including Arizona, California, Maine and Nevada, that will vote in November on legalizing recreational marijuana.\u003c/p>\n\u003cp>Hill would like to see stronger regulation of marijuana if it becomes legal, with limits on advertising and of edible products that attract children, as well as a higher rate of taxation than the proposed 12 percent. If Massachusetts approves marijuana for recreational use, it would not be legal for anyone under age 21, when most, but not all, brain development occurs.\u003c/p>\n\u003cp>\u003cem>This story is part of a reporting partnership with NPR, WBUR and \u003c/em>\u003ca href=\"http://www.kaiserhealthnews.org/\">Kaiser Health News\u003c/a>.\u003c/p>\n\u003c/div>\n\u003cdiv class=\"tags\">\u003c/div>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/stateofhealth/236779/california-could-soon-legalize-marijuana-but-pots-brain-effects-remain-a-mystery",
"authors": [
"byline_stateofhealth_236779"
],
"categories": [
"stateofhealth_166"
],
"tags": [
"stateofhealth_2902",
"stateofhealth_2722",
"stateofhealth_2808",
"stateofhealth_2907",
"stateofhealth_2906",
"stateofhealth_2901",
"stateofhealth_2622",
"stateofhealth_2519",
"stateofhealth_2898"
],
"featImg": "stateofhealth_236793",
"label": "stateofhealth"
}
},
"podcastsReducer": {
"isFetching": false,
"fetchFailed": false,
"hasFetched": false,
"podcasts": {}
},
"radioProgramsReducer": {
"isFetching": false,
"fetchFailed": false,
"hasFetched": false,
"radioPrograms": {}
},
"radioSearchSegmentsReducer": {},
"programsReducer": {
"all-things-considered": {
"id": "all-things-considered",
"title": "All Things Considered",
"info": "Every weekday, \u003cem>All Things Considered\u003c/em> hosts Robert Siegel, Audie Cornish, Ari Shapiro, and Kelly McEvers present the program's trademark mix of news, interviews, commentaries, reviews, and offbeat features. Michel Martin hosts on the weekends.",
"airtime": "MON-FRI 1pm-2pm, 4:30pm-6:30pm\u003cbr />SAT-SUN 5pm-6pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/All-Things-Considered-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/all-things-considered/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/all-things-considered"
},
"american-suburb-podcast": {
"id": "american-suburb-podcast",
"title": "American Suburb: The Podcast",
"tagline": "The flip side of gentrification, told through one town",
"info": "Gentrification is changing cities across America, forcing people from neighborhoods they have long called home. Call them the displaced. Now those priced out of the Bay Area are looking for a better life in an unlikely place. American Suburb follows this migration to one California town along the Delta, 45 miles from San Francisco. But is this once sleepy suburb ready for them?",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/American-Suburb-Podcast-Tile-703x703-1.jpg",
"officialWebsiteLink": "/news/series/american-suburb-podcast",
"meta": {
"site": "news",
"source": "kqed",
"order": 19
},
"link": "/news/series/american-suburb-podcast/",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/RBrW",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?mt=2&id=1287748328",
"tuneIn": "https://tunein.com/radio/American-Suburb-p1086805/",
"rss": "https://ww2.kqed.org/news/series/american-suburb-podcast/feed/podcast",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkMzMDExODgxNjA5"
}
},
"baycurious": {
"id": "baycurious",
"title": "Bay Curious",
"tagline": "Exploring the Bay Area, one question at a time",
"info": "KQED’s new podcast, Bay Curious, gets to the bottom of the mysteries — both profound and peculiar — that give the Bay Area its unique identity. And we’ll do it with your help! You ask the questions. You decide what Bay Curious investigates. And you join us on the journey to find the answers.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Bay-Curious-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Bay Curious",
"officialWebsiteLink": "/news/series/baycurious",
"meta": {
"site": "news",
"source": "kqed",
"order": 3
},
"link": "/podcasts/baycurious",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/bay-curious/id1172473406",
"npr": "https://www.npr.org/podcasts/500557090/bay-curious",
"rss": "https://ww2.kqed.org/news/category/bay-curious-podcast/feed/podcast",
"amazon": "https://music.amazon.com/podcasts/9a90d476-aa04-455d-9a4c-0871ed6216d4/bay-curious",
"stitcher": "https://www.stitcher.com/podcast/kqed/bay-curious",
"spotify": "https://open.spotify.com/show/6O76IdmhixfijmhTZLIJ8k"
}
},
"bbc-world-service": {
"id": "bbc-world-service",
"title": "BBC World Service",
"info": "The day's top stories from BBC News compiled twice daily in the week, once at weekends.",
"airtime": "MON-FRI 9pm-10pm, TUE-FRI 1am-2am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/BBC-World-Service-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.bbc.co.uk/sounds/play/live:bbc_world_service",
"meta": {
"site": "news",
"source": "BBC World Service"
},
"link": "/radio/program/bbc-world-service",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/global-news-podcast/id135067274?mt=2",
"tuneIn": "https://tunein.com/radio/BBC-World-Service-p455581/",
"rss": "https://podcasts.files.bbci.co.uk/p02nq0gn.rss"
}
},
"californiareport": {
"id": "californiareport",
"title": "The California Report",
"tagline": "California, day by day",
"info": "KQED’s statewide radio news program providing daily coverage of issues, trends and public policy decisions.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-California-Report-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The California Report",
"officialWebsiteLink": "/californiareport",
"meta": {
"site": "news",
"source": "kqed",
"order": 8
},
"link": "/californiareport",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/kqeds-the-california-report/id79681292",
"amazon": "https://music.amazon.com/podcasts/26099305-72af-4542-9dde-ac1807fe36d5/kqed-s-the-california-report",
"npr": "https://www.npr.org/podcasts/432285393/the-california-report",
"stitcher": "https://www.stitcher.com/podcast/kqedfm-kqeds-the-california-report-podcast-8838",
"rss": "https://ww2.kqed.org/news/tag/tcram/feed/podcast"
}
},
"californiareportmagazine": {
"id": "californiareportmagazine",
"title": "The California Report Magazine",
"tagline": "Your state, your stories",
"info": "Every week, The California Report Magazine takes you on a road trip for the ears: to visit the places and meet the people who make California unique. The in-depth storytelling podcast from the California Report.",
"airtime": "FRI 4:30pm-5pm, 6:30pm-7pm, 11pm-11:30pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-California-Report-Magazine-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The California Report Magazine",
"officialWebsiteLink": "/californiareportmagazine",
"meta": {
"site": "news",
"source": "kqed",
"order": 10
},
"link": "/californiareportmagazine",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-california-report-magazine/id1314750545",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkM3NjkwNjk1OTAz",
"npr": "https://www.npr.org/podcasts/564733126/the-california-report-magazine",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-california-report-magazine",
"rss": "https://ww2.kqed.org/news/tag/tcrmag/feed/podcast"
}
},
"city-arts": {
"id": "city-arts",
"title": "City Arts & Lectures",
"info": "A one-hour radio program to hear celebrated writers, artists and thinkers address contemporary ideas and values, often discussing the creative process. Please note: tapes or transcripts are not available",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/05/cityartsandlecture-300x300.jpg",
"officialWebsiteLink": "https://www.cityarts.net/",
"airtime": "SUN 1pm-2pm, TUE 10pm, WED 1am",
"meta": {
"site": "news",
"source": "City Arts & Lectures"
},
"link": "https://www.cityarts.net",
"subscribe": {
"tuneIn": "https://tunein.com/radio/City-Arts-and-Lectures-p692/",
"rss": "https://www.cityarts.net/feed/"
}
},
"closealltabs": {
"id": "closealltabs",
"title": "Close All Tabs",
"tagline": "Your irreverent guide to the trends redefining our world",
"info": "Close All Tabs breaks down how digital culture shapes our world through thoughtful insights and irreverent humor.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/02/CAT_2_Tile-scaled.jpg",
"imageAlt": "KQED Close All Tabs",
"officialWebsiteLink": "/podcasts/closealltabs",
"meta": {
"site": "news",
"source": "kqed",
"order": 1
},
"link": "/podcasts/closealltabs",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/close-all-tabs/id214663465",
"rss": "https://feeds.megaphone.fm/KQINC6993880386",
"amazon": "https://music.amazon.com/podcasts/92d9d4ac-67a3-4eed-b10a-fb45d45b1ef2/close-all-tabs",
"spotify": "https://open.spotify.com/show/6LAJFHnGK1pYXYzv6SIol6?si=deb0cae19813417c"
}
},
"code-switch-life-kit": {
"id": "code-switch-life-kit",
"title": "Code Switch / Life Kit",
"info": "\u003cem>Code Switch\u003c/em>, which listeners will hear in the first part of the hour, has fearless and much-needed conversations about race. Hosted by journalists of color, the show tackles the subject of race head-on, exploring how it impacts every part of society — from politics and pop culture to history, sports and more.\u003cbr />\u003cbr />\u003cem>Life Kit\u003c/em>, which will be in the second part of the hour, guides you through spaces and feelings no one prepares you for — from finances to mental health, from workplace microaggressions to imposter syndrome, from relationships to parenting. The show features experts with real world experience and shares their knowledge. Because everyone needs a little help being human.\u003cbr />\u003cbr />\u003ca href=\"https://www.npr.org/podcasts/510312/codeswitch\">\u003cem>Code Switch\u003c/em> offical site and podcast\u003c/a>\u003cbr />\u003ca href=\"https://www.npr.org/lifekit\">\u003cem>Life Kit\u003c/em> offical site and podcast\u003c/a>\u003cbr />",
"airtime": "SUN 9pm-10pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Code-Switch-Life-Kit-Podcast-Tile-360x360-1.jpg",
"meta": {
"site": "radio",
"source": "npr"
},
"link": "/radio/program/code-switch-life-kit",
"subscribe": {
"apple": "https://podcasts.apple.com/podcast/1112190608?mt=2&at=11l79Y&ct=nprdirectory",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly93d3cubnByLm9yZy9yc3MvcG9kY2FzdC5waHA_aWQ9NTEwMzEy",
"spotify": "https://open.spotify.com/show/3bExJ9JQpkwNhoHvaIIuyV",
"rss": "https://feeds.npr.org/510312/podcast.xml"
}
},
"commonwealth-club": {
"id": "commonwealth-club",
"title": "Commonwealth Club of California Podcast",
"info": "The Commonwealth Club of California is the nation's oldest and largest public affairs forum. As a non-partisan forum, The Club brings to the public airwaves diverse viewpoints on important topics. The Club's weekly radio broadcast - the oldest in the U.S., dating back to 1924 - is carried across the nation on public radio stations and is now podcasting. Our website archive features audio of our recent programs, as well as selected speeches from our long and distinguished history. This podcast feed is usually updated twice a week and is always un-edited.",
"airtime": "THU 10pm, FRI 1am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Commonwealth-Club-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.commonwealthclub.org/podcasts",
"meta": {
"site": "news",
"source": "Commonwealth Club of California"
},
"link": "/radio/program/commonwealth-club",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/commonwealth-club-of-california-podcast/id976334034?mt=2",
"google": "https://podcasts.google.com/feed/aHR0cDovL3d3dy5jb21tb253ZWFsdGhjbHViLm9yZy9hdWRpby9wb2RjYXN0L3dlZWtseS54bWw",
"tuneIn": "https://tunein.com/radio/Commonwealth-Club-of-California-p1060/"
}
},
"forum": {
"id": "forum",
"title": "Forum",
"tagline": "The conversation starts here",
"info": "KQED’s live call-in program discussing local, state, national and international issues, as well as in-depth interviews.",
"airtime": "MON-FRI 9am-11am, 10pm-11pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Forum-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Forum with Mina Kim and Alexis Madrigal",
"officialWebsiteLink": "/forum",
"meta": {
"site": "news",
"source": "kqed",
"order": 9
},
"link": "/forum",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/kqeds-forum/id73329719",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkM5NTU3MzgxNjMz",
"npr": "https://www.npr.org/podcasts/432307980/forum",
"stitcher": "https://www.stitcher.com/podcast/kqedfm-kqeds-forum-podcast",
"rss": "https://feeds.megaphone.fm/KQINC9557381633"
}
},
"freakonomics-radio": {
"id": "freakonomics-radio",
"title": "Freakonomics Radio",
"info": "Freakonomics Radio is a one-hour award-winning podcast and public-radio project hosted by Stephen Dubner, with co-author Steve Levitt as a regular guest. It is produced in partnership with WNYC.",
"imageSrc": "https://ww2.kqed.org/news/wp-content/uploads/sites/10/2018/05/freakonomicsRadio.png",
"officialWebsiteLink": "http://freakonomics.com/",
"airtime": "SUN 1am-2am, SAT 3pm-4pm",
"meta": {
"site": "radio",
"source": "WNYC"
},
"link": "/radio/program/freakonomics-radio",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/4s8b",
"apple": "https://itunes.apple.com/us/podcast/freakonomics-radio/id354668519",
"tuneIn": "https://tunein.com/podcasts/WNYC-Podcasts/Freakonomics-Radio-p272293/",
"rss": "https://feeds.feedburner.com/freakonomicsradio"
}
},
"fresh-air": {
"id": "fresh-air",
"title": "Fresh Air",
"info": "Hosted by Terry Gross, \u003cem>Fresh Air from WHYY\u003c/em> is the Peabody Award-winning weekday magazine of contemporary arts and issues. One of public radio's most popular programs, Fresh Air features intimate conversations with today's biggest luminaries.",
"airtime": "MON-FRI 7pm-8pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Fresh-Air-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/fresh-air/",
"meta": {
"site": "radio",
"source": "npr"
},
"link": "/radio/program/fresh-air",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/4s8b",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=214089682&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Fresh-Air-p17/",
"rss": "https://feeds.npr.org/381444908/podcast.xml"
}
},
"here-and-now": {
"id": "here-and-now",
"title": "Here & Now",
"info": "A live production of NPR and WBUR Boston, in collaboration with stations across the country, Here & Now reflects the fluid world of news as it's happening in the middle of the day, with timely, in-depth news, interviews and conversation. Hosted by Robin Young, Jeremy Hobson and Tonya Mosley.",
"airtime": "MON-THU 11am-12pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Here-And-Now-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "http://www.wbur.org/hereandnow",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/here-and-now",
"subsdcribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?mt=2&id=426698661",
"tuneIn": "https://tunein.com/radio/Here--Now-p211/",
"rss": "https://feeds.npr.org/510051/podcast.xml"
}
},
"hidden-brain": {
"id": "hidden-brain",
"title": "Hidden Brain",
"info": "Shankar Vedantam uses science and storytelling to reveal the unconscious patterns that drive human behavior, shape our choices and direct our relationships.",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/05/hiddenbrain.jpg",
"officialWebsiteLink": "https://www.npr.org/series/423302056/hidden-brain",
"airtime": "SUN 7pm-8pm",
"meta": {
"site": "news",
"source": "NPR"
},
"link": "/radio/program/hidden-brain",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/hidden-brain/id1028908750?mt=2",
"tuneIn": "https://tunein.com/podcasts/Science-Podcasts/Hidden-Brain-p787503/",
"rss": "https://feeds.npr.org/510308/podcast.xml"
}
},
"how-i-built-this": {
"id": "how-i-built-this",
"title": "How I Built This with Guy Raz",
"info": "Guy Raz dives into the stories behind some of the world's best known companies. How I Built This weaves a narrative journey about innovators, entrepreneurs and idealists—and the movements they built.",
"imageSrc": "https://ww2.kqed.org/news/wp-content/uploads/sites/10/2018/05/howIBuiltThis.png",
"officialWebsiteLink": "https://www.npr.org/podcasts/510313/how-i-built-this",
"airtime": "SUN 7:30pm-8pm",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/how-i-built-this",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/3zxy",
"apple": "https://itunes.apple.com/us/podcast/how-i-built-this-with-guy-raz/id1150510297?mt=2",
"tuneIn": "https://tunein.com/podcasts/Arts--Culture-Podcasts/How-I-Built-This-p910896/",
"rss": "https://feeds.npr.org/510313/podcast.xml"
}
},
"hyphenacion": {
"id": "hyphenacion",
"title": "Hyphenación",
"tagline": "Where conversation and cultura meet",
"info": "What kind of no sabo word is Hyphenación? For us, it’s about living within a hyphenation. Like being a third-gen Mexican-American from the Texas border now living that Bay Area Chicano life. Like Xorje! Each week we bring together a couple of hyphenated Latinos to talk all about personal life choices: family, careers, relationships, belonging … everything is on the table. ",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/03/Hyphenacion_FinalAssets_PodcastTile.png",
"imageAlt": "KQED Hyphenación",
"officialWebsiteLink": "/podcasts/hyphenacion",
"meta": {
"site": "news",
"source": "kqed",
"order": 15
},
"link": "/podcasts/hyphenacion",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/hyphenaci%C3%B3n/id1191591838",
"spotify": "https://open.spotify.com/show/2p3Fifq96nw9BPcmFdIq0o?si=39209f7b25774f38",
"youtube": "https://www.youtube.com/c/kqedarts",
"amazon": "https://music.amazon.com/podcasts/6c3dd23c-93fb-4aab-97ba-1725fa6315f1/hyphenaci%C3%B3n",
"rss": "https://feeds.megaphone.fm/KQINC2275451163"
}
},
"jerrybrown": {
"id": "jerrybrown",
"title": "The Political Mind of Jerry Brown",
"tagline": "Lessons from a lifetime in politics",
"info": "The Political Mind of Jerry Brown brings listeners the wisdom of the former Governor, Mayor, and presidential candidate. Scott Shafer interviewed Brown for more than 40 hours, covering the former governor's life and half-century in the political game – and Brown has some lessons he'd like to share. ",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Political-Mind-of-Jerry-Brown-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Political Mind of Jerry Brown",
"officialWebsiteLink": "/podcasts/jerrybrown",
"meta": {
"site": "news",
"source": "kqed",
"order": 18
},
"link": "/podcasts/jerrybrown",
"subscribe": {
"npr": "https://www.npr.org/podcasts/790253322/the-political-mind-of-jerry-brown",
"apple": "https://itunes.apple.com/us/podcast/id1492194549",
"rss": "https://ww2.kqed.org/news/series/jerrybrown/feed/podcast/",
"tuneIn": "http://tun.in/pjGcK",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-political-mind-of-jerry-brown",
"spotify": "https://open.spotify.com/show/54C1dmuyFyKMFttY6X2j6r?si=K8SgRCoISNK6ZbjpXrX5-w",
"amazon": "https://music.amazon.com/podcasts/44420f75-3b0e-4301-ab3b-16da6b09e543/the-political-mind-of-jerry-brown"
}
},
"latino-usa": {
"id": "latino-usa",
"title": "Latino USA",
"airtime": "MON 1am-2am, SUN 6pm-7pm",
"info": "Latino USA, the radio journal of news and culture, is the only national, English-language radio program produced from a Latino perspective.",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/latinoUsa.jpg",
"officialWebsiteLink": "http://latinousa.org/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/latino-usa",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/xtTd",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=79681317&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Latino-USA-p621/",
"rss": "https://feeds.npr.org/510016/podcast.xml"
}
},
"marketplace": {
"id": "marketplace",
"title": "Marketplace",
"info": "Our flagship program, helmed by Kai Ryssdal, examines what the day in money delivered, through stories, conversations, newsworthy numbers and more. Updated Monday through Friday at about 3:30 p.m. PT.",
"airtime": "MON-FRI 4pm-4:30pm, MON-WED 6:30pm-7pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Marketplace-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.marketplace.org/",
"meta": {
"site": "news",
"source": "American Public Media"
},
"link": "/radio/program/marketplace",
"subscribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=201853034&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/APM-Marketplace-p88/",
"rss": "https://feeds.publicradio.org/public_feeds/marketplace-pm/rss/rss"
}
},
"masters-of-scale": {
"id": "masters-of-scale",
"title": "Masters of Scale",
"info": "Masters of Scale is an original podcast in which LinkedIn co-founder and Greylock Partner Reid Hoffman sets out to describe and prove theories that explain how great entrepreneurs take their companies from zero to a gazillion in ingenious fashion.",
"airtime": "Every other Wednesday June 12 through October 16 at 8pm (repeats Thursdays at 2am)",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Masters-of-Scale-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://mastersofscale.com/",
"meta": {
"site": "radio",
"source": "WaitWhat"
},
"link": "/radio/program/masters-of-scale",
"subscribe": {
"apple": "http://mastersofscale.app.link/",
"rss": "https://rss.art19.com/masters-of-scale"
}
},
"mindshift": {
"id": "mindshift",
"title": "MindShift",
"tagline": "A podcast about the future of learning and how we raise our kids",
"info": "The MindShift podcast explores the innovations in education that are shaping how kids learn. Hosts Ki Sung and Katrina Schwartz introduce listeners to educators, researchers, parents and students who are developing effective ways to improve how kids learn. We cover topics like how fed-up administrators are developing surprising tactics to deal with classroom disruptions; how listening to podcasts are helping kids develop reading skills; the consequences of overparenting; and why interdisciplinary learning can engage students on all ends of the traditional achievement spectrum. This podcast is part of the MindShift education site, a division of KQED News. KQED is an NPR/PBS member station based in San Francisco. You can also visit the MindShift website for episodes and supplemental blog posts or tweet us \u003ca href=\"https://twitter.com/MindShiftKQED\">@MindShiftKQED\u003c/a> or visit us at \u003ca href=\"/mindshift\">MindShift.KQED.org\u003c/a>",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Mindshift-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED MindShift: How We Will Learn",
"officialWebsiteLink": "/mindshift/",
"meta": {
"site": "news",
"source": "kqed",
"order": 12
},
"link": "/podcasts/mindshift",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/mindshift-podcast/id1078765985",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkM1NzY0NjAwNDI5",
"npr": "https://www.npr.org/podcasts/464615685/mind-shift-podcast",
"stitcher": "https://www.stitcher.com/podcast/kqed/stories-teachers-share",
"spotify": "https://open.spotify.com/show/0MxSpNYZKNprFLCl7eEtyx"
}
},
"morning-edition": {
"id": "morning-edition",
"title": "Morning Edition",
"info": "\u003cem>Morning Edition\u003c/em> takes listeners around the country and the world with multi-faceted stories and commentaries every weekday. Hosts Steve Inskeep, David Greene and Rachel Martin bring you the latest breaking news and features to prepare you for the day.",
"airtime": "MON-FRI 3am-9am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Morning-Edition-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/morning-edition/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/morning-edition"
},
"onourwatch": {
"id": "onourwatch",
"title": "On Our Watch",
"tagline": "Deeply-reported investigative journalism",
"info": "For decades, the process for how police police themselves has been inconsistent – if not opaque. In some states, like California, these proceedings were completely hidden. After a new police transparency law unsealed scores of internal affairs files, our reporters set out to examine these cases and the shadow world of police discipline. On Our Watch brings listeners into the rooms where officers are questioned and witnesses are interrogated to find out who this system is really protecting. Is it the officers, or the public they've sworn to serve?",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/On-Our-Watch-Podcast-Tile-703x703-1.jpg",
"imageAlt": "On Our Watch from NPR and KQED",
"officialWebsiteLink": "/podcasts/onourwatch",
"meta": {
"site": "news",
"source": "kqed",
"order": 11
},
"link": "/podcasts/onourwatch",
"subscribe": {
"apple": "https://podcasts.apple.com/podcast/id1567098962",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5ucHIub3JnLzUxMDM2MC9wb2RjYXN0LnhtbD9zYz1nb29nbGVwb2RjYXN0cw",
"npr": "https://rpb3r.app.goo.gl/onourwatch",
"spotify": "https://open.spotify.com/show/0OLWoyizopu6tY1XiuX70x",
"tuneIn": "https://tunein.com/radio/On-Our-Watch-p1436229/",
"stitcher": "https://www.stitcher.com/show/on-our-watch",
"rss": "https://feeds.npr.org/510360/podcast.xml"
}
},
"on-the-media": {
"id": "on-the-media",
"title": "On The Media",
"info": "Our weekly podcast explores how the media 'sausage' is made, casts an incisive eye on fluctuations in the marketplace of ideas, and examines threats to the freedom of information and expression in America and abroad. For one hour a week, the show tries to lift the veil from the process of \"making media,\" especially news media, because it's through that lens that we see the world and the world sees us",
"airtime": "SUN 2pm-3pm, MON 12am-1am",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/onTheMedia.png",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/otm",
"meta": {
"site": "news",
"source": "wnyc"
},
"link": "/radio/program/on-the-media",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/on-the-media/id73330715?mt=2",
"tuneIn": "https://tunein.com/radio/On-the-Media-p69/",
"rss": "http://feeds.wnyc.org/onthemedia"
}
},
"pbs-newshour": {
"id": "pbs-newshour",
"title": "PBS NewsHour",
"info": "Analysis, background reports and updates from the PBS NewsHour putting today's news in context.",
"airtime": "MON-FRI 3pm-4pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/PBS-News-Hour-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.pbs.org/newshour/",
"meta": {
"site": "news",
"source": "pbs"
},
"link": "/radio/program/pbs-newshour",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/pbs-newshour-full-show/id394432287?mt=2",
"tuneIn": "https://tunein.com/radio/PBS-NewsHour---Full-Show-p425698/",
"rss": "https://www.pbs.org/newshour/feeds/rss/podcasts/show"
}
},
"perspectives": {
"id": "perspectives",
"title": "Perspectives",
"tagline": "KQED's series of daily listener commentaries since 1991",
"info": "KQED's series of daily listener commentaries since 1991.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/01/Perspectives_Tile_Final.jpg",
"imageAlt": "KQED Perspectives",
"officialWebsiteLink": "/perspectives/",
"meta": {
"site": "radio",
"source": "kqed",
"order": 14
},
"link": "/perspectives",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/id73801135",
"npr": "https://www.npr.org/podcasts/432309616/perspectives",
"rss": "https://ww2.kqed.org/perspectives/category/perspectives/feed/",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly93dzIua3FlZC5vcmcvcGVyc3BlY3RpdmVzL2NhdGVnb3J5L3BlcnNwZWN0aXZlcy9mZWVkLw"
}
},
"planet-money": {
"id": "planet-money",
"title": "Planet Money",
"info": "The economy explained. Imagine you could call up a friend and say, Meet me at the bar and tell me what's going on with the economy. Now imagine that's actually a fun evening.",
"airtime": "SUN 3pm-4pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/planetmoney.jpg",
"officialWebsiteLink": "https://www.npr.org/sections/money/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/planet-money",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/M4f5",
"apple": "https://itunes.apple.com/us/podcast/planet-money/id290783428?mt=2",
"tuneIn": "https://tunein.com/podcasts/Business--Economics-Podcasts/Planet-Money-p164680/",
"rss": "https://feeds.npr.org/510289/podcast.xml"
}
},
"politicalbreakdown": {
"id": "politicalbreakdown",
"title": "Political Breakdown",
"tagline": "Politics from a personal perspective",
"info": "Political Breakdown is a new series that explores the political intersection of California and the nation. Each week hosts Scott Shafer and Marisa Lagos are joined with a new special guest to unpack politics -- with personality — and offer an insider’s glimpse at how politics happens.",
"airtime": "THU 6:30pm-7pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Political-Breakdown-2024-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Political Breakdown",
"officialWebsiteLink": "/podcasts/politicalbreakdown",
"meta": {
"site": "radio",
"source": "kqed",
"order": 5
},
"link": "/podcasts/politicalbreakdown",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/political-breakdown/id1327641087",
"amazon": "https://music.amazon.com/podcasts/e0c2d153-ad36-4c8d-901d-f1da6a724824/political-breakdown",
"npr": "https://www.npr.org/podcasts/572155894/political-breakdown",
"stitcher": "https://www.stitcher.com/podcast/kqed/political-breakdown",
"spotify": "https://open.spotify.com/show/07RVyIjIdk2WDuVehvBMoN",
"rss": "https://ww2.kqed.org/news/tag/political-breakdown/feed/podcast"
}
},
"possible": {
"id": "possible",
"title": "Possible",
"info": "Possible is hosted by entrepreneur Reid Hoffman and writer Aria Finger. Together in Possible, Hoffman and Finger lead enlightening discussions about building a brighter collective future. The show features interviews with visionary guests like Trevor Noah, Sam Altman and Janette Sadik-Khan. Possible paints an optimistic portrait of the world we can create through science, policy, business, art and our shared humanity. It asks: What if everything goes right for once? How can we get there? Each episode also includes a short fiction story generated by advanced AI GPT-4, serving as a thought-provoking springboard to speculate how humanity could leverage technology for good.",
"airtime": "SUN 2pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Possible-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.possible.fm/",
"meta": {
"site": "news",
"source": "Possible"
},
"link": "/radio/program/possible",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/possible/id1677184070",
"spotify": "https://open.spotify.com/show/730YpdUSNlMyPQwNnyjp4k"
}
},
"pri-the-world": {
"id": "pri-the-world",
"title": "PRI's The World: Latest Edition",
"info": "Each weekday, host Marco Werman and his team of producers bring you the world's most interesting stories in an hour of radio that reminds us just how small our planet really is.",
"airtime": "MON-FRI 2pm-3pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-World-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.pri.org/programs/the-world",
"meta": {
"site": "news",
"source": "PRI"
},
"link": "/radio/program/pri-the-world",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/pris-the-world-latest-edition/id278196007?mt=2",
"tuneIn": "https://tunein.com/podcasts/News--Politics-Podcasts/PRIs-The-World-p24/",
"rss": "http://feeds.feedburner.com/pri/theworld"
}
},
"radiolab": {
"id": "radiolab",
"title": "Radiolab",
"info": "A two-time Peabody Award-winner, Radiolab is an investigation told through sounds and stories, and centered around one big idea. In the Radiolab world, information sounds like music and science and culture collide. Hosted by Jad Abumrad and Robert Krulwich, the show is designed for listeners who demand skepticism, but appreciate wonder. WNYC Studios is the producer of other leading podcasts including Freakonomics Radio, Death, Sex & Money, On the Media and many more.",
"airtime": "SUN 12am-1am, SAT 2pm-3pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/radiolab1400.png",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/radiolab/",
"meta": {
"site": "science",
"source": "WNYC"
},
"link": "/radio/program/radiolab",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/radiolab/id152249110?mt=2",
"tuneIn": "https://tunein.com/radio/RadioLab-p68032/",
"rss": "https://feeds.wnyc.org/radiolab"
}
},
"reveal": {
"id": "reveal",
"title": "Reveal",
"info": "Created by The Center for Investigative Reporting and PRX, Reveal is public radios first one-hour weekly radio show and podcast dedicated to investigative reporting. Credible, fact based and without a partisan agenda, Reveal combines the power and artistry of driveway moment storytelling with data-rich reporting on critically important issues. The result is stories that inform and inspire, arming our listeners with information to right injustices, hold the powerful accountable and improve lives.Reveal is hosted by Al Letson and showcases the award-winning work of CIR and newsrooms large and small across the nation. In a radio and podcast market crowded with choices, Reveal focuses on important and often surprising stories that illuminate the world for our listeners.",
"airtime": "SAT 4pm-5pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/reveal300px.png",
"officialWebsiteLink": "https://www.revealnews.org/episodes/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/reveal",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/reveal/id886009669",
"tuneIn": "https://tunein.com/radio/Reveal-p679597/",
"rss": "http://feeds.revealradio.org/revealpodcast"
}
},
"rightnowish": {
"id": "rightnowish",
"title": "Rightnowish",
"tagline": "Art is where you find it",
"info": "Rightnowish digs into life in the Bay Area right now… ish. Journalist Pendarvis Harshaw takes us to galleries painted on the sides of liquor stores in West Oakland. We'll dance in warehouses in the Bayview, make smoothies with kids in South Berkeley, and listen to classical music in a 1984 Cutlass Supreme in Richmond. Every week, Pen talks to movers and shakers about how the Bay Area shapes what they create, and how they shape the place we call home.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Rightnowish-Podcast-Tile-500x500-1.jpg",
"imageAlt": "KQED Rightnowish with Pendarvis Harshaw",
"officialWebsiteLink": "/podcasts/rightnowish",
"meta": {
"site": "arts",
"source": "kqed",
"order": 16
},
"link": "/podcasts/rightnowish",
"subscribe": {
"npr": "https://www.npr.org/podcasts/721590300/rightnowish",
"rss": "https://ww2.kqed.org/arts/programs/rightnowish/feed/podcast",
"apple": "https://podcasts.apple.com/us/podcast/rightnowish/id1482187648",
"stitcher": "https://www.stitcher.com/podcast/kqed/rightnowish",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkMxMjU5MTY3NDc4",
"spotify": "https://open.spotify.com/show/7kEJuafTzTVan7B78ttz1I"
}
},
"science-friday": {
"id": "science-friday",
"title": "Science Friday",
"info": "Science Friday is a weekly science talk show, broadcast live over public radio stations nationwide. Each week, the show focuses on science topics that are in the news and tries to bring an educated, balanced discussion to bear on the scientific issues at hand. Panels of expert guests join host Ira Flatow, a veteran science journalist, to discuss science and to take questions from listeners during the call-in portion of the program.",
"airtime": "FRI 11am-1pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Science-Friday-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/science-friday",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/science-friday",
"subscribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=73329284&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Science-Friday-p394/",
"rss": "http://feeds.wnyc.org/science-friday"
}
},
"snap-judgment": {
"id": "snap-judgment",
"title": "Snap Judgment",
"tagline": "Real stories with killer beats",
"info": "The Snap Judgment radio show and podcast mixes real stories with killer beats to produce cinematic, dramatic radio. Snap's musical brand of storytelling dares listeners to see the world through the eyes of another. This is storytelling... with a BEAT!! Snap first aired on public radio stations nationwide in July 2010. Today, Snap Judgment airs on over 450 public radio stations and is brought to the airwaves by KQED & PRX.",
"airtime": "SAT 1pm-2pm, 9pm-10pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/05/Snap-Judgment-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Snap Judgment",
"officialWebsiteLink": "https://snapjudgment.org",
"meta": {
"site": "arts",
"source": "kqed",
"order": 4
},
"link": "https://snapjudgment.org",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/snap-judgment/id283657561",
"npr": "https://www.npr.org/podcasts/449018144/snap-judgment",
"stitcher": "https://www.pandora.com/podcast/snap-judgment/PC:241?source=stitcher-sunset",
"spotify": "https://open.spotify.com/show/3Cct7ZWmxHNAtLgBTqjC5v",
"rss": "https://snap.feed.snapjudgment.org/"
}
},
"soldout": {
"id": "soldout",
"title": "SOLD OUT: Rethinking Housing in America",
"tagline": "A new future for housing",
"info": "Sold Out: Rethinking Housing in America",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Sold-Out-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Sold Out: Rethinking Housing in America",
"officialWebsiteLink": "/podcasts/soldout",
"meta": {
"site": "news",
"source": "kqed",
"order": 13
},
"link": "/podcasts/soldout",
"subscribe": {
"npr": "https://www.npr.org/podcasts/911586047/s-o-l-d-o-u-t-a-new-future-for-housing",
"apple": "https://podcasts.apple.com/us/podcast/introducing-sold-out-rethinking-housing-in-america/id1531354937",
"rss": "https://feeds.megaphone.fm/soldout",
"spotify": "https://open.spotify.com/show/38dTBSk2ISFoPiyYNoKn1X",
"stitcher": "https://www.stitcher.com/podcast/kqed/sold-out-rethinking-housing-in-america",
"tunein": "https://tunein.com/radio/SOLD-OUT-Rethinking-Housing-in-America-p1365871/"
}
},
"spooked": {
"id": "spooked",
"title": "Spooked",
"tagline": "True-life supernatural stories",
"info": "",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/10/Spooked-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Spooked",
"officialWebsiteLink": "https://spookedpodcast.org/",
"meta": {
"site": "news",
"source": "kqed",
"order": 7
},
"link": "https://spookedpodcast.org/",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/spooked/id1279361017",
"npr": "https://www.npr.org/podcasts/549547848/snap-judgment-presents-spooked",
"spotify": "https://open.spotify.com/show/76571Rfl3m7PLJQZKQIGCT",
"rss": "https://feeds.simplecast.com/TBotaapn"
}
},
"tech-nation": {
"id": "tech-nation",
"title": "Tech Nation Radio Podcast",
"info": "Tech Nation is a weekly public radio program, hosted by Dr. Moira Gunn. Founded in 1993, it has grown from a simple interview show to a multi-faceted production, featuring conversations with noted technology and science leaders, and a weekly science and technology-related commentary.",
"airtime": "FRI 10pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Tech-Nation-Radio-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "http://technation.podomatic.com/",
"meta": {
"site": "science",
"source": "Tech Nation Media"
},
"link": "/radio/program/tech-nation",
"subscribe": {
"rss": "https://technation.podomatic.com/rss2.xml"
}
},
"ted-radio-hour": {
"id": "ted-radio-hour",
"title": "TED Radio Hour",
"info": "The TED Radio Hour is a journey through fascinating ideas, astonishing inventions, fresh approaches to old problems, and new ways to think and create.",
"airtime": "SUN 3pm-4pm, SAT 10pm-11pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/tedRadioHour.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/ted-radio-hour/?showDate=2018-06-22",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/ted-radio-hour",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/8vsS",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=523121474&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/TED-Radio-Hour-p418021/",
"rss": "https://feeds.npr.org/510298/podcast.xml"
}
},
"thebay": {
"id": "thebay",
"title": "The Bay",
"tagline": "Local news to keep you rooted",
"info": "Host Devin Katayama walks you through the biggest story of the day with reporters and newsmakers.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Bay-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Bay",
"officialWebsiteLink": "/podcasts/thebay",
"meta": {
"site": "radio",
"source": "kqed",
"order": 2
},
"link": "/podcasts/thebay",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-bay/id1350043452",
"amazon": "https://music.amazon.com/podcasts/d800ea4c-7a2c-42f2-b861-edaf78a5db0b/the-bay",
"npr": "https://www.npr.org/podcasts/586725995/the-bay",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-bay",
"spotify": "https://open.spotify.com/show/4BIKBKIujizLHlIlBNaAqQ",
"rss": "https://feeds.megaphone.fm/KQINC8259786327"
}
},
"thelatest": {
"id": "thelatest",
"title": "The Latest",
"tagline": "Trusted local news in real time",
"info": "",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/05/The-Latest-2025-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Latest",
"officialWebsiteLink": "/thelatest",
"meta": {
"site": "news",
"source": "kqed",
"order": 6
},
"link": "/thelatest",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-latest-from-kqed/id1197721799",
"npr": "https://www.npr.org/podcasts/1257949365/the-latest-from-k-q-e-d",
"spotify": "https://open.spotify.com/show/5KIIXMgM9GTi5AepwOYvIZ?si=bd3053fec7244dba",
"rss": "https://feeds.megaphone.fm/KQINC9137121918"
}
},
"theleap": {
"id": "theleap",
"title": "The Leap",
"tagline": "What if you closed your eyes, and jumped?",
"info": "Stories about people making dramatic, risky changes, told by award-winning public radio reporter Judy Campbell.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Leap-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Leap",
"officialWebsiteLink": "/podcasts/theleap",
"meta": {
"site": "news",
"source": "kqed",
"order": 17
},
"link": "/podcasts/theleap",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-leap/id1046668171",
"npr": "https://www.npr.org/podcasts/447248267/the-leap",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-leap",
"spotify": "https://open.spotify.com/show/3sSlVHHzU0ytLwuGs1SD1U",
"rss": "https://ww2.kqed.org/news/programs/the-leap/feed/podcast"
}
},
"the-moth-radio-hour": {
"id": "the-moth-radio-hour",
"title": "The Moth Radio Hour",
"info": "Since its launch in 1997, The Moth has presented thousands of true stories, told live and without notes, to standing-room-only crowds worldwide. Moth storytellers stand alone, under a spotlight, with only a microphone and a roomful of strangers. The storyteller and the audience embark on a high-wire act of shared experience which is both terrifying and exhilarating. Since 2008, The Moth podcast has featured many of our favorite stories told live on Moth stages around the country. For information on all of our programs and live events, visit themoth.org.",
"airtime": "SAT 8pm-9pm and SUN 11am-12pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/theMoth.jpg",
"officialWebsiteLink": "https://themoth.org/",
"meta": {
"site": "arts",
"source": "prx"
},
"link": "/radio/program/the-moth-radio-hour",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/the-moth-podcast/id275699983?mt=2",
"tuneIn": "https://tunein.com/radio/The-Moth-p273888/",
"rss": "http://feeds.themoth.org/themothpodcast"
}
},
"the-new-yorker-radio-hour": {
"id": "the-new-yorker-radio-hour",
"title": "The New Yorker Radio Hour",
"info": "The New Yorker Radio Hour is a weekly program presented by the magazine's editor, David Remnick, and produced by WNYC Studios and The New Yorker. Each episode features a diverse mix of interviews, profiles, storytelling, and an occasional burst of humor inspired by the magazine, and shaped by its writers, artists, and editors. This isn't a radio version of a magazine, but something all its own, reflecting the rich possibilities of audio storytelling and conversation. Theme music for the show was composed and performed by Merrill Garbus of tUnE-YArDs.",
"airtime": "SAT 10am-11am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-New-Yorker-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/tnyradiohour",
"meta": {
"site": "arts",
"source": "WNYC"
},
"link": "/radio/program/the-new-yorker-radio-hour",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/id1050430296",
"tuneIn": "https://tunein.com/podcasts/WNYC-Podcasts/New-Yorker-Radio-Hour-p803804/",
"rss": "https://feeds.feedburner.com/newyorkerradiohour"
}
},
"the-sam-sanders-show": {
"id": "the-sam-sanders-show",
"title": "The Sam Sanders Show",
"info": "One of public radio's most dynamic voices, Sam Sanders helped launch The NPR Politics Podcast and hosted NPR's hit show It's Been A Minute. Now, the award-winning host returns with something brand new, The Sam Sanders Show. Every week, Sam Sanders and friends dig into the culture that shapes our lives: what's driving the biggest trends, how artists really think, and even the memes you can't stop scrolling past. Sam is beloved for his way of unpacking the world and bringing you up close to fresh currents and engaging conversations. The Sam Sanders Show is smart, funny and always a good time.",
"airtime": "FRI 12-1pm AND SAT 11am-12pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/11/The-Sam-Sanders-Show-Podcast-Tile-400x400-1.jpg",
"officialWebsiteLink": "https://www.kcrw.com/shows/the-sam-sanders-show/latest",
"meta": {
"site": "arts",
"source": "KCRW"
},
"link": "https://www.kcrw.com/shows/the-sam-sanders-show/latest",
"subscribe": {
"rss": "https://feed.cdnstream1.com/zjb/feed/download/ac/28/59/ac28594c-e1d0-4231-8728-61865cdc80e8.xml"
}
},
"the-splendid-table": {
"id": "the-splendid-table",
"title": "The Splendid Table",
"info": "\u003cem>The Splendid Table\u003c/em> hosts our nation's conversations about cooking, sustainability and food culture.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Splendid-Table-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.splendidtable.org/",
"airtime": "SUN 10-11 pm",
"meta": {
"site": "radio",
"source": "npr"
},
"link": "/radio/program/the-splendid-table"
},
"this-american-life": {
"id": "this-american-life",
"title": "This American Life",
"info": "This American Life is a weekly public radio show, heard by 2.2 million people on more than 500 stations. Another 2.5 million people download the weekly podcast. It is hosted by Ira Glass, produced in collaboration with Chicago Public Media, delivered to stations by PRX The Public Radio Exchange, and has won all of the major broadcasting awards.",
"airtime": "SAT 12pm-1pm, 7pm-8pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/thisAmericanLife.png",
"officialWebsiteLink": "https://www.thisamericanlife.org/",
"meta": {
"site": "news",
"source": "wbez"
},
"link": "/radio/program/this-american-life",
"subscribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=201671138&at=11l79Y&ct=nprdirectory",
"rss": "https://www.thisamericanlife.org/podcast/rss.xml"
}
},
"tinydeskradio": {
"id": "tinydeskradio",
"title": "Tiny Desk Radio",
"info": "We're bringing the best of Tiny Desk to the airwaves, only on public radio.",
"airtime": "SUN 8pm and SAT 9pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/04/300x300-For-Member-Station-Logo-Tiny-Desk-Radio-@2x.png",
"officialWebsiteLink": "https://www.npr.org/series/g-s1-52030/tiny-desk-radio",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/tinydeskradio",
"subscribe": {
"rss": "https://feeds.npr.org/g-s1-52030/rss.xml"
}
},
"wait-wait-dont-tell-me": {
"id": "wait-wait-dont-tell-me",
"title": "Wait Wait... Don't Tell Me!",
"info": "Peter Sagal and Bill Kurtis host the weekly NPR News quiz show alongside some of the best and brightest news and entertainment personalities.",
"airtime": "SUN 10am-11am, SAT 11am-12pm, SAT 6pm-7pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Wait-Wait-Podcast-Tile-300x300-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/wait-wait-dont-tell-me/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/wait-wait-dont-tell-me",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/Xogv",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=121493804&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Wait-Wait-Dont-Tell-Me-p46/",
"rss": "https://feeds.npr.org/344098539/podcast.xml"
}
},
"weekend-edition-saturday": {
"id": "weekend-edition-saturday",
"title": "Weekend Edition Saturday",
"info": "Weekend Edition Saturday wraps up the week's news and offers a mix of analysis and features on a wide range of topics, including arts, sports, entertainment, and human interest stories. The two-hour program is hosted by NPR's Peabody Award-winning Scott Simon.",
"airtime": "SAT 5am-10am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Weekend-Edition-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/weekend-edition-saturday/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/weekend-edition-saturday"
},
"weekend-edition-sunday": {
"id": "weekend-edition-sunday",
"title": "Weekend Edition Sunday",
"info": "Weekend Edition Sunday features interviews with newsmakers, artists, scientists, politicians, musicians, writers, theologians and historians. The program has covered news events from Nelson Mandela's 1990 release from a South African prison to the capture of Saddam Hussein.",
"airtime": "SUN 5am-10am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Weekend-Edition-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/weekend-edition-sunday/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/weekend-edition-sunday"
}
},
"racesReducer": {},
"racesGenElectionReducer": {},
"racesGenElection2026Reducer": {},
"radioSchedulesReducer": {},
"listsReducer": {
"posts/science?category=health": {
"isFetching": false,
"latestQuery": {
"from": 660,
"size": 12
},
"vitalsOnly": false,
"totalRequested": 12,
"isLoading": false,
"isLoadingMore": true,
"total": {
"value": 1299,
"relation": "eq"
},
"items": [
"futureofyou_262412",
"stateofhealth_248365",
"futureofyou_258717",
"science_1048487",
"futureofyou_256179",
"futureofyou_256129",
"futureofyou_254629",
"futureofyou_242687",
"stateofhealth_239875",
"science_993029",
"stateofhealth_236832",
"stateofhealth_236779"
],
"complete": true
}
},
"recallGuideReducer": {
"intros": {},
"policy": {},
"candidates": {}
},
"savedArticleReducer": {
"articles": [],
"status": {}
},
"newslettersReducer": {
"isFetching": false,
"fetchFailed": false,
"hasFetched": false,
"newsletters": {},
"isSubscribing": false,
"isUnsubscribing": false,
"subscribedNewsletters": {}
},
"termsReducer": {
"about": {
"name": "About",
"type": "terms",
"id": "about",
"slug": "about",
"link": "/about",
"taxonomy": "site"
},
"arts": {
"name": "Arts & Culture",
"grouping": [
"arts",
"pop",
"trulyca"
],
"description": "KQED Arts provides daily in-depth coverage of the Bay Area's music, art, film, performing arts, literature and arts news, as well as cultural commentary and criticism.",
"type": "terms",
"id": "arts",
"slug": "arts",
"link": "/arts",
"taxonomy": "site"
},
"artschool": {
"name": "Art School",
"parent": "arts",
"type": "terms",
"id": "artschool",
"slug": "artschool",
"link": "/artschool",
"taxonomy": "site"
},
"bayareabites": {
"name": "KQED food",
"grouping": [
"food",
"bayareabites",
"checkplease"
],
"parent": "food",
"type": "terms",
"id": "bayareabites",
"slug": "bayareabites",
"link": "/food",
"taxonomy": "site"
},
"bayareahiphop": {
"name": "Bay Area Hiphop",
"type": "terms",
"id": "bayareahiphop",
"slug": "bayareahiphop",
"link": "/bayareahiphop",
"taxonomy": "site"
},
"campaign21": {
"name": "Campaign 21",
"type": "terms",
"id": "campaign21",
"slug": "campaign21",
"link": "/campaign21",
"taxonomy": "site"
},
"careers": {
"name": "Careers",
"type": "terms",
"id": "careers",
"slug": "careers",
"link": "/careers",
"taxonomy": "site"
},
"checkplease": {
"name": "KQED food",
"grouping": [
"food",
"bayareabites",
"checkplease"
],
"parent": "food",
"type": "terms",
"id": "checkplease",
"slug": "checkplease",
"link": "/food",
"taxonomy": "site"
},
"education": {
"name": "Education",
"grouping": [
"education"
],
"type": "terms",
"id": "education",
"slug": "education",
"link": "/education",
"taxonomy": "site"
},
"elections": {
"name": "Elections",
"type": "terms",
"id": "elections",
"slug": "elections",
"link": "/elections",
"taxonomy": "site"
},
"events": {
"name": "Events",
"type": "terms",
"id": "events",
"slug": "events",
"link": "/events",
"taxonomy": "site"
},
"event": {
"name": "Event",
"alias": "events",
"type": "terms",
"id": "event",
"slug": "event",
"link": "/event",
"taxonomy": "site"
},
"filmschoolshorts": {
"name": "Film School Shorts",
"type": "terms",
"id": "filmschoolshorts",
"slug": "filmschoolshorts",
"link": "/filmschoolshorts",
"taxonomy": "site"
},
"food": {
"name": "KQED food",
"grouping": [
"food",
"bayareabites",
"checkplease"
],
"type": "terms",
"id": "food",
"slug": "food",
"link": "/food",
"taxonomy": "site"
},
"forum": {
"name": "Forum",
"relatedContentQuery": "posts/forum?",
"parent": "news",
"type": "terms",
"id": "forum",
"slug": "forum",
"link": "/forum",
"taxonomy": "site"
},
"futureofyou": {
"name": "Future of You",
"grouping": [
"science",
"futureofyou"
],
"parent": "science",
"type": "terms",
"id": "futureofyou",
"slug": "futureofyou",
"link": "/futureofyou",
"taxonomy": "site"
},
"jpepinheart": {
"name": "KQED food",
"relatedContentQuery": "posts/food,bayareabites,checkplease",
"parent": "food",
"type": "terms",
"id": "jpepinheart",
"slug": "jpepinheart",
"link": "/food",
"taxonomy": "site"
},
"liveblog": {
"name": "Live Blog",
"type": "terms",
"id": "liveblog",
"slug": "liveblog",
"link": "/liveblog",
"taxonomy": "site"
},
"livetv": {
"name": "Live TV",
"parent": "tv",
"type": "terms",
"id": "livetv",
"slug": "livetv",
"link": "/livetv",
"taxonomy": "site"
},
"lowdown": {
"name": "The Lowdown",
"relatedContentQuery": "posts/lowdown?",
"parent": "news",
"type": "terms",
"id": "lowdown",
"slug": "lowdown",
"link": "/lowdown",
"taxonomy": "site"
},
"mindshift": {
"name": "Mindshift",
"parent": "news",
"description": "MindShift explores the future of education by highlighting the innovative – and sometimes counterintuitive – ways educators and parents are helping all children succeed.",
"type": "terms",
"id": "mindshift",
"slug": "mindshift",
"link": "/mindshift",
"taxonomy": "site"
},
"news": {
"name": "News",
"grouping": [
"news",
"forum"
],
"type": "terms",
"id": "news",
"slug": "news",
"link": "/news",
"taxonomy": "site"
},
"newsletters": {
"name": "newsletters",
"type": "terms",
"id": "newsletters",
"slug": "newsletters",
"link": "/newsletters",
"taxonomy": "site"
},
"perspectives": {
"name": "Perspectives",
"parent": "radio",
"type": "terms",
"id": "perspectives",
"slug": "perspectives",
"link": "/perspectives",
"taxonomy": "site"
},
"podcasts": {
"name": "Podcasts",
"type": "terms",
"id": "podcasts",
"slug": "podcasts",
"link": "/podcasts",
"taxonomy": "site"
},
"pop": {
"name": "Pop",
"parent": "arts",
"type": "terms",
"id": "pop",
"slug": "pop",
"link": "/pop",
"taxonomy": "site"
},
"pressroom": {
"name": "Pressroom",
"type": "terms",
"id": "pressroom",
"slug": "pressroom",
"link": "/pressroom",
"taxonomy": "site"
},
"quest": {
"name": "Quest",
"parent": "science",
"type": "terms",
"id": "quest",
"slug": "quest",
"link": "/quest",
"taxonomy": "site"
},
"radio": {
"name": "Radio",
"grouping": [
"forum",
"perspectives"
],
"description": "Listen to KQED Public Radio – home of Forum and The California Report – on 88.5 FM in San Francisco, 89.3 FM in Sacramento, 88.3 FM in Santa Rosa and 88.1 FM in Martinez.",
"type": "terms",
"id": "radio",
"slug": "radio",
"link": "/radio",
"taxonomy": "site"
},
"root": {
"name": "KQED",
"image": "https://ww2.kqed.org/app/uploads/2020/02/KQED-OG-Image@1x.png",
"imageWidth": 1200,
"imageHeight": 630,
"headData": {
"title": "KQED | News, Radio, Podcasts, TV | Public Media for Northern California",
"description": "KQED provides public radio, television, and independent reporting on issues that matter to the Bay Area. We’re the NPR and PBS member station for Northern California."
},
"type": "terms",
"id": "root",
"slug": "root",
"link": "/root",
"taxonomy": "site"
},
"science": {
"name": "Science",
"grouping": [
"science",
"futureofyou"
],
"description": "KQED Science brings you award-winning science and environment coverage from the Bay Area and beyond.",
"type": "terms",
"id": "science",
"slug": "science",
"link": "/science",
"taxonomy": "site"
},
"stateofhealth": {
"name": "State of Health",
"parent": "science",
"type": "terms",
"id": "stateofhealth",
"slug": "stateofhealth",
"link": "/stateofhealth",
"taxonomy": "site"
},
"support": {
"name": "Support",
"type": "terms",
"id": "support",
"slug": "support",
"link": "/support",
"taxonomy": "site"
},
"thedolist": {
"name": "The Do List",
"parent": "arts",
"type": "terms",
"id": "thedolist",
"slug": "thedolist",
"link": "/thedolist",
"taxonomy": "site"
},
"trulyca": {
"name": "Truly CA",
"grouping": [
"arts",
"pop",
"trulyca"
],
"parent": "arts",
"type": "terms",
"id": "trulyca",
"slug": "trulyca",
"link": "/trulyca",
"taxonomy": "site"
},
"tv": {
"name": "TV",
"type": "terms",
"id": "tv",
"slug": "tv",
"link": "/tv",
"taxonomy": "site"
},
"voterguide": {
"name": "Voter Guide",
"parent": "elections",
"alias": "elections",
"type": "terms",
"id": "voterguide",
"slug": "voterguide",
"link": "/voterguide",
"taxonomy": "site"
},
"guiaelectoral": {
"name": "Guia Electoral",
"parent": "elections",
"alias": "elections",
"type": "terms",
"id": "guiaelectoral",
"slug": "guiaelectoral",
"link": "/guiaelectoral",
"taxonomy": "site"
},
"science_category_health": {
"isLoading": true
},
"science_39": {
"type": "terms",
"id": "science_39",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "39",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Health",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Health Archives | KQED Science",
"ogDescription": null
},
"ttid": 41,
"slug": "health",
"isLoading": false,
"link": "/science/category/health"
},
"source_stateofhealth_248365": {
"type": "terms",
"id": "source_stateofhealth_248365",
"meta": {
"override": true
},
"name": "NPR",
"isLoading": false
},
"source_futureofyou_258717": {
"type": "terms",
"id": "source_futureofyou_258717",
"meta": {
"override": true
},
"name": "Hope/Hype",
"isLoading": false
},
"source_futureofyou_256179": {
"type": "terms",
"id": "source_futureofyou_256179",
"meta": {
"override": true
},
"name": "Future of You",
"isLoading": false
},
"source_futureofyou_242687": {
"type": "terms",
"id": "source_futureofyou_242687",
"meta": {
"override": true
},
"name": "Future of You",
"isLoading": false
},
"futureofyou_452": {
"type": "terms",
"id": "futureofyou_452",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "452",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Health Policy",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Health Policy Archives | KQED Arts",
"ogDescription": null
},
"ttid": 452,
"slug": "health-policy",
"isLoading": false,
"link": "/futureofyou/category/health-policy"
},
"futureofyou_73": {
"type": "terms",
"id": "futureofyou_73",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "73",
"found": true
},
"relationships": {},
"featImg": null,
"name": "KQED News",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "KQED News Archives | KQED Arts",
"ogDescription": null
},
"ttid": 73,
"slug": "kqed-news",
"isLoading": false,
"link": "/futureofyou/category/kqed-news"
},
"futureofyou_1061": {
"type": "terms",
"id": "futureofyou_1061",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1061",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Your Brain on Tech",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Your Brain on Tech Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1061,
"slug": "your-brain-on-tech",
"isLoading": false,
"link": "/futureofyou/category/your-brain-on-tech"
},
"futureofyou_56": {
"type": "terms",
"id": "futureofyou_56",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "56",
"found": true
},
"relationships": {},
"featImg": null,
"name": "brain",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "brain Archives | KQED Arts",
"ogDescription": null
},
"ttid": 56,
"slug": "brain",
"isLoading": false,
"link": "/futureofyou/tag/brain"
},
"futureofyou_1103": {
"type": "terms",
"id": "futureofyou_1103",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1103",
"found": true
},
"relationships": {},
"featImg": null,
"name": "focus",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "focus Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1103,
"slug": "focus",
"isLoading": false,
"link": "/futureofyou/tag/focus"
},
"futureofyou_80": {
"type": "terms",
"id": "futureofyou_80",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "80",
"found": true
},
"relationships": {},
"featImg": null,
"name": "kqedscience",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "kqedscience Archives | KQED Arts",
"ogDescription": null
},
"ttid": 80,
"slug": "kqedscience",
"isLoading": false,
"link": "/futureofyou/tag/kqedscience"
},
"futureofyou_59": {
"type": "terms",
"id": "futureofyou_59",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "59",
"found": true
},
"relationships": {},
"featImg": null,
"name": "neuroscience",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "neuroscience Archives | KQED Arts",
"ogDescription": null
},
"ttid": 59,
"slug": "neuroscience",
"isLoading": false,
"link": "/futureofyou/tag/neuroscience"
},
"stateofhealth_1": {
"type": "terms",
"id": "stateofhealth_1",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "1",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Uncategorized",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Uncategorized Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1,
"slug": "uncategorized",
"isLoading": false,
"link": "/stateofhealth/category/uncategorized"
},
"stateofhealth_2808": {
"type": "terms",
"id": "stateofhealth_2808",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "2808",
"found": true
},
"relationships": {},
"featImg": null,
"name": "featured",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "featured Archives | KQED Arts",
"ogDescription": null
},
"ttid": 2817,
"slug": "featured",
"isLoading": false,
"link": "/stateofhealth/tag/featured"
},
"stateofhealth_2519": {
"type": "terms",
"id": "stateofhealth_2519",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "2519",
"found": true
},
"relationships": {},
"featImg": null,
"name": "News",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "News Archives | KQED Arts",
"ogDescription": null
},
"ttid": 2528,
"slug": "news",
"isLoading": false,
"link": "/stateofhealth/tag/news"
},
"stateofhealth_2898": {
"type": "terms",
"id": "stateofhealth_2898",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "2898",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Research",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Research Archives | KQED Arts",
"ogDescription": null
},
"ttid": 2907,
"slug": "research",
"isLoading": false,
"link": "/stateofhealth/tag/research"
},
"stateofhealth_461": {
"type": "terms",
"id": "stateofhealth_461",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "461",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Science",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Science Archives | KQED Arts",
"ogDescription": null
},
"ttid": 462,
"slug": "science",
"isLoading": false,
"link": "/stateofhealth/tag/science"
},
"futureofyou_1062": {
"type": "terms",
"id": "futureofyou_1062",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1062",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Hope/Hype",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Hope/Hype Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1062,
"slug": "hopehype",
"isLoading": false,
"link": "/futureofyou/category/hopehype"
},
"futureofyou_1": {
"type": "terms",
"id": "futureofyou_1",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1",
"found": true
},
"relationships": {},
"featImg": null,
"name": "KQED Future Of You",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "KQED Future Of You Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1,
"slug": "future-of-you",
"isLoading": false,
"link": "/futureofyou/category/future-of-you"
},
"futureofyou_1081": {
"type": "terms",
"id": "futureofyou_1081",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1081",
"found": true
},
"relationships": {},
"featImg": null,
"name": "clinical trial",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "clinical trial Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1081,
"slug": "clinical-trial",
"isLoading": false,
"link": "/futureofyou/tag/clinical-trial"
},
"futureofyou_1080": {
"type": "terms",
"id": "futureofyou_1080",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1080",
"found": true
},
"relationships": {},
"featImg": null,
"name": "dialysis",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "dialysis Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1080,
"slug": "dialysis",
"isLoading": false,
"link": "/futureofyou/tag/dialysis"
},
"futureofyou_801": {
"type": "terms",
"id": "futureofyou_801",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "801",
"found": true
},
"relationships": {},
"featImg": null,
"name": "stem cell",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "stem cell Archives | KQED Arts",
"ogDescription": null
},
"ttid": 801,
"slug": "stem-cell",
"isLoading": false,
"link": "/futureofyou/tag/stem-cell"
},
"futureofyou_647": {
"type": "terms",
"id": "futureofyou_647",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "647",
"found": true
},
"relationships": {},
"featImg": null,
"name": "biotechnology",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "biotechnology Archives | KQED Arts",
"ogDescription": null
},
"ttid": 647,
"slug": "biotechnology",
"isLoading": false,
"link": "/futureofyou/tag/biotechnology"
},
"futureofyou_692": {
"type": "terms",
"id": "futureofyou_692",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "692",
"found": true
},
"relationships": {},
"featImg": null,
"name": "brain-training",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "brain-training Archives | KQED Arts",
"ogDescription": null
},
"ttid": 692,
"slug": "brain-training",
"isLoading": false,
"link": "/futureofyou/tag/brain-training"
},
"futureofyou_691": {
"type": "terms",
"id": "futureofyou_691",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "691",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Lumosity",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Lumosity Archives | KQED Arts",
"ogDescription": null
},
"ttid": 691,
"slug": "lumosity",
"isLoading": false,
"link": "/futureofyou/tag/lumosity"
},
"futureofyou_1000": {
"type": "terms",
"id": "futureofyou_1000",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1000",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Posit Science",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Posit Science Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1000,
"slug": "posit-science",
"isLoading": false,
"link": "/futureofyou/tag/posit-science"
},
"futureofyou_309": {
"type": "terms",
"id": "futureofyou_309",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "309",
"found": true
},
"relationships": {},
"featImg": null,
"name": "diabetes",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "diabetes Archives | KQED Arts",
"ogDescription": null
},
"ttid": 309,
"slug": "diabetes",
"isLoading": false,
"link": "/futureofyou/tag/diabetes"
},
"futureofyou_1071": {
"type": "terms",
"id": "futureofyou_1071",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1071",
"found": true
},
"relationships": {},
"featImg": null,
"name": "insulin",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "insulin Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1071,
"slug": "insulin",
"isLoading": false,
"link": "/futureofyou/tag/insulin"
},
"futureofyou_1042": {
"type": "terms",
"id": "futureofyou_1042",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1042",
"found": true
},
"relationships": {},
"featImg": null,
"name": "spine injuries",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "spine injuries Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1042,
"slug": "spine-injuries",
"isLoading": false,
"link": "/futureofyou/tag/spine-injuries"
},
"futureofyou_680": {
"type": "terms",
"id": "futureofyou_680",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "680",
"found": true
},
"relationships": {},
"featImg": null,
"name": "stem cells",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "stem cells Archives | KQED Arts",
"ogDescription": null
},
"ttid": 680,
"slug": "stem-cells",
"isLoading": false,
"link": "/futureofyou/tag/stem-cells"
},
"stateofhealth_2407": {
"type": "terms",
"id": "stateofhealth_2407",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "2407",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Digital Health",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Digital Health Archives | KQED Arts",
"ogDescription": null
},
"ttid": 2418,
"slug": "digital-health",
"isLoading": false,
"link": "/stateofhealth/category/digital-health"
},
"stateofhealth_2746": {
"type": "terms",
"id": "stateofhealth_2746",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "2746",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Public Health",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Public Health Archives | KQED Arts",
"ogDescription": null
},
"ttid": 2755,
"slug": "public-health",
"isLoading": false,
"link": "/stateofhealth/category/public-health"
},
"stateofhealth_2932": {
"type": "terms",
"id": "stateofhealth_2932",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "2932",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Chan",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Chan Archives | KQED Arts",
"ogDescription": null
},
"ttid": 2941,
"slug": "chan",
"isLoading": false,
"link": "/stateofhealth/tag/chan"
},
"stateofhealth_2933": {
"type": "terms",
"id": "stateofhealth_2933",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "2933",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Donate",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Donate Archives | KQED Arts",
"ogDescription": null
},
"ttid": 2942,
"slug": "donate",
"isLoading": false,
"link": "/stateofhealth/tag/donate"
},
"stateofhealth_308": {
"type": "terms",
"id": "stateofhealth_308",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "308",
"found": true
},
"relationships": {},
"featImg": null,
"name": "UCSF",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "UCSF Archives | KQED Arts",
"ogDescription": null
},
"ttid": 309,
"slug": "ucsf",
"isLoading": false,
"link": "/stateofhealth/tag/ucsf"
},
"stateofhealth_2931": {
"type": "terms",
"id": "stateofhealth_2931",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "2931",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Zuckerberg",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Zuckerberg Archives | KQED Arts",
"ogDescription": null
},
"ttid": 2940,
"slug": "zuckerberg",
"isLoading": false,
"link": "/stateofhealth/tag/zuckerberg"
},
"science_29": {
"type": "terms",
"id": "science_29",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "29",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Chemistry",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Chemistry Archives | KQED Science",
"ogDescription": null
},
"ttid": 31,
"slug": "chemistry",
"isLoading": false,
"link": "/science/category/chemistry"
},
"science_40": {
"type": "terms",
"id": "science_40",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "40",
"found": true
},
"relationships": {},
"featImg": null,
"name": "News",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "News Archives | KQED Science",
"ogDescription": null
},
"ttid": 42,
"slug": "news",
"isLoading": false,
"link": "/science/category/news"
},
"science_98": {
"type": "terms",
"id": "science_98",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "98",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Water",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Water Archives | KQED Science",
"ogDescription": null
},
"ttid": 102,
"slug": "water",
"isLoading": false,
"link": "/science/category/water"
},
"science_1273": {
"type": "terms",
"id": "science_1273",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "1273",
"found": true
},
"relationships": {},
"featImg": null,
"name": "drinking water",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "drinking water Archives | KQED Science",
"ogDescription": null
},
"ttid": 1282,
"slug": "drinking-water",
"isLoading": false,
"link": "/science/tag/drinking-water"
},
"stateofhealth_11": {
"type": "terms",
"id": "stateofhealth_11",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "11",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Community Health",
"description": "\r\n\r\nFrom rural California to urban neighborhoods, where you live affects your health",
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": "From rural California to urban neighborhoods, where you live affects your health",
"title": "Community Health Archives | KQED Arts",
"ogDescription": null
},
"ttid": 11,
"slug": "place-matters",
"isLoading": false,
"link": "/stateofhealth/category/place-matters"
},
"stateofhealth_166": {
"type": "terms",
"id": "stateofhealth_166",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "166",
"found": true
},
"relationships": {},
"featImg": null,
"name": "KQED blogs",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "KQED blogs Archives | KQED Arts",
"ogDescription": null
},
"ttid": 166,
"slug": "kqed-blogs",
"isLoading": false,
"link": "/stateofhealth/category/kqed-blogs"
},
"stateofhealth_40": {
"type": "terms",
"id": "stateofhealth_40",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "40",
"found": true
},
"relationships": {},
"featImg": null,
"name": "End of Life Care",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "End of Life Care Archives | KQED Arts",
"ogDescription": null
},
"ttid": 40,
"slug": "end-of-life-care",
"isLoading": false,
"link": "/stateofhealth/tag/end-of-life-care"
},
"stateofhealth_2907": {
"type": "terms",
"id": "stateofhealth_2907",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "2907",
"found": true
},
"relationships": {},
"featImg": null,
"name": "KQED Future of You",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "KQED Future of You Archives | KQED Arts",
"ogDescription": null
},
"ttid": 2916,
"slug": "kqed-future-of-you",
"isLoading": false,
"link": "/stateofhealth/tag/kqed-future-of-you"
},
"stateofhealth_2906": {
"type": "terms",
"id": "stateofhealth_2906",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "2906",
"found": true
},
"relationships": {},
"featImg": null,
"name": "KQED Science",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "KQED Science Archives | KQED Arts",
"ogDescription": null
},
"ttid": 2915,
"slug": "kqed-science",
"isLoading": false,
"link": "/stateofhealth/tag/kqed-science"
},
"stateofhealth_2908": {
"type": "terms",
"id": "stateofhealth_2908",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "2908",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Netflix",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Netflix Archives | KQED Arts",
"ogDescription": null
},
"ttid": 2917,
"slug": "netflix",
"isLoading": false,
"link": "/stateofhealth/tag/netflix"
},
"stateofhealth_145": {
"type": "terms",
"id": "stateofhealth_145",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "145",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Oakland",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Oakland Archives | KQED Arts",
"ogDescription": null
},
"ttid": 145,
"slug": "oakland",
"isLoading": false,
"link": "/stateofhealth/tag/oakland"
},
"stateofhealth_2902": {
"type": "terms",
"id": "stateofhealth_2902",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "2902",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Brain",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Brain Archives | KQED Arts",
"ogDescription": null
},
"ttid": 2911,
"slug": "brain",
"isLoading": false,
"link": "/stateofhealth/tag/brain"
},
"stateofhealth_2722": {
"type": "terms",
"id": "stateofhealth_2722",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "2722",
"found": true
},
"relationships": {},
"featImg": null,
"name": "California",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "California Archives | KQED Arts",
"ogDescription": null
},
"ttid": 2731,
"slug": "california",
"isLoading": false,
"link": "/stateofhealth/tag/california"
},
"stateofhealth_2901": {
"type": "terms",
"id": "stateofhealth_2901",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "2901",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Legalize",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Legalize Archives | KQED Arts",
"ogDescription": null
},
"ttid": 2910,
"slug": "legalize",
"isLoading": false,
"link": "/stateofhealth/tag/legalize"
},
"stateofhealth_2622": {
"type": "terms",
"id": "stateofhealth_2622",
"meta": {
"index": "terms_1716263798",
"site": "stateofhealth",
"id": "2622",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Marijuana",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Marijuana Archives | KQED Arts",
"ogDescription": null
},
"ttid": 2631,
"slug": "marijuana",
"isLoading": false,
"link": "/stateofhealth/tag/marijuana"
}
},
"userPermissionsReducer": {
"wpLoggedIn": false
},
"eventsReducer": {},
"fssReducer": {},
"tvDailyScheduleReducer": {},
"tvWeeklyScheduleReducer": {},
"tvPrimetimeScheduleReducer": {},
"tvMonthlyScheduleReducer": {},
"userAccountReducer": {
"user": {
"email": null,
"emailStatus": "EMAIL_UNVALIDATED",
"loggedStatus": "LOGGED_OUT",
"loggingChecked": false,
"articles": [],
"firstName": null,
"lastName": null,
"phoneNumber": null,
"fetchingMembership": false,
"membershipError": false,
"memberships": [
{
"id": null,
"startDate": null,
"firstName": null,
"lastName": null,
"familyNumber": null,
"memberNumber": null,
"memberSince": null,
"expirationDate": null,
"pfsEligible": false,
"isSustaining": false,
"membershipLevel": "Prospect",
"membershipStatus": "Non Member",
"lastGiftDate": null,
"renewalDate": null,
"lastDonationAmount": null
}
]
},
"authModal": {
"isOpen": false,
"view": "LANDING_VIEW"
},
"error": null
},
"youthMediaReducer": {},
"checkPleaseReducer": {
"filterData": {
"region": {
"key": "Restaurant Region",
"filters": [
"Any Region"
]
},
"cuisine": {
"key": "Restaurant Cuisine",
"filters": [
"Any Cuisine"
]
}
},
"restaurantDataById": {},
"restaurantIdsSorted": [],
"error": null
},
"userAgentReducer": {
"userAgent": "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)",
"isBot": true
},
"requestOutcomesReducer": {
"notFound": []
}
}
